Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Schizophrenia

  Free Subscription


Articles published in Psychiatry Res

Retrieve available abstracts of 774 articles:
HTML format



Single Articles


    July 2021
  1. SNELLEKSZ M, Dean B
    Lower levels of tubulin alpha 1b in the frontal pole in schizophrenia supports a role for changed cytoskeletal dynamics in the aetiology of the disorder.
    Psychiatry Res. 2021;303:114096.
    PubMed     Abstract available


  2. VASKINN A, Engelstad KN, Torgalsboen AK, Rund BR, et al
    Childhood trauma, social cognition and schizophrenia: Specific association between physical neglect and cognitive theory of mind in homicide offenders.
    Psychiatry Res. 2021;303:114093.
    PubMed     Abstract available


  3. JAGADHEESAN K, Danivas V, Itrat Q, Shekaran L, et al
    A 6-month study on the pattern of emergency department presentations for schizophrenia and other psychotic disorders during COVID-19 lockdown.
    Psychiatry Res. 2021;303:114081.
    PubMed     Abstract available


    June 2021
  4. CORBERA S, Wexler BE, Bell MD, Pearlson G, et al
    Predictors of social functioning and quality of life in schizophrenia and autism spectrum disorder.
    Psychiatry Res. 2021;303:114087.
    PubMed     Abstract available


  5. LI S, DeLisi LE, McDonough SI
    Rare germline variants in individuals diagnosed with schizophrenia within multiplex families.
    Psychiatry Res. 2021;303:114038.
    PubMed     Abstract available


  6. CASADO-ORTEGA A, Vila-Badia R, Butjosa A, Del Cacho N, et al
    Social cognition and its relationship with sociodemographic, clinical, and psychosocial variables in first-episode psychosis.
    Psychiatry Res. 2021;302:114040.
    PubMed     Abstract available


    May 2021
  7. KELLY DL, Claxton A, Bidollari I, Du Y, et al
    Analysis of prolactin and sexual side effects in patients with schizophrenia who switched from paliperidone palmitate to aripiprazole lauroxil.
    Psychiatry Res. 2021;302:114030.
    PubMed     Abstract available


  8. GUILLAUME F, Thomas E
    Recollection and familiarity in schizophrenia:An ERP investigation using face recognition exclusion tasks.
    Psychiatry Res. 2021;302:113973.
    PubMed     Abstract available


  9. SCHEFFLER F, Phahladira L, Luckhoff H, du Plessis S, et al
    Cannabis use and clinical outcome in people with first-episode schizophrenia spectrum disorders over 24 months of treatment.
    Psychiatry Res. 2021;302:114022.
    PubMed     Abstract available


  10. MUNOZ-SAMONS D, Tor J, Rodriguez-Pascual M, Alvarez-Subiela X, et al
    Recent stressful life events and stress sensitivity in children and adolescents at clinical risk for psychosis.
    Psychiatry Res. 2021;303:114017.
    PubMed     Abstract available


  11. HELLER C, Weiss T, Del Re EC, Swago S, et al
    Smaller subcortical volumes and enlarged lateral ventricles are associated with higher global functioning in young adults with 22q11.2 deletion syndrome with prodromal symptoms of schizophrenia.
    Psychiatry Res. 2021;301:113979.
    PubMed     Abstract available


  12. ABEL DB, Salyers MP, Wu W, Monette MA, et al
    Quality versus quantity: Determining real-world social functioning deficits in schizophrenia.
    Psychiatry Res. 2021;301:113980.
    PubMed     Abstract available


    April 2021
  13. ALBA L, Coll C, Saez S, Alonso L, et al
    New-onset psychosis: A case report of brief psychosis related to COVID-19 infection.
    Psychiatry Res. 2021;301:113975.
    PubMed    


  14. UCOK A, Karakas B, Sahin OS
    Formal thought disorder in patients with first-episode schizophrenia: Results of a one-year follow-up study.
    Psychiatry Res. 2021;301:113972.
    PubMed     Abstract available



  15. Discrepancies between staff and gold standard ratings of schizophrenia symptom severity.
    Psychiatry Res. 2021;301:113963.
    PubMed    


  16. DE PERI L, Deste G, Vita A
    Strucutural brain imaging at the onset of schizophrenia:What have we learned and what have we missed.
    Psychiatry Res. 2021;301:113962.
    PubMed     Abstract available


  17. MEDALIA A, Saperstein AM, Stefancic A, Meyler S, et al
    Feasibility and acceptability of remotely accessed cognitive remediation for schizophrenia in public health settings.
    Psychiatry Res. 2021;301:113956.
    PubMed     Abstract available


  18. XIE YJ, Xi YB, Cui LB, Guan MZ, et al
    Functional connectivity of cerebellar dentate nucleus and cognitive impairments in patients with drug-naive and first-episode schizophrenia.
    Psychiatry Res. 2021;300:113937.
    PubMed     Abstract available


  19. PENNOU A, Lecomte T, Khazaal Y, Potvin S, et al
    Does theory of mind predict specific domains of social functioning in individuals following a first episode psychosis?
    Psychiatry Res. 2021;301:113933.
    PubMed     Abstract available


  20. WANG YY, Hsu SH, Tsai HY, Cheng MC, et al
    Sequencing of the coding regions of GNBIL on chromosome 22q11.2 as a risk gene of schizophrenia.
    Psychiatry Res. 2021;300:113943.
    PubMed     Abstract available


  21. SCHURHOFF F, Corfdir C, Pignon B, Lajnef M, et al
    No alteration of leukocyte telomere length in first episode psychosis.
    Psychiatry Res. 2021;301:113941.
    PubMed     Abstract available


  22. VAERNES TG, Rossberg JI, Melle I, Nelson B, et al
    Basic self-disturbance in subjects at clinical high risk for psychosis: Relationship with clinical and functional outcomes at one year follow-up.
    Psychiatry Res. 2021;300:113942.
    PubMed     Abstract available


  23. STRASSNIG MT, Miller ML, Moore R, Depp CA, et al
    Evidence for avolition in bipolar disorder? A 30-day ecological momentary assessment comparison of daily activities in bipolar disorder and schizophrenia.
    Psychiatry Res. 2021;300:113924.
    PubMed     Abstract available


  24. SIDDIQUI SV, Nizamie SH, Siddiqui MA, Jahan M, et al
    Evaluation of N-400 Evoked Response Potential in schizophrenia: An endophenotype or a disease marker?
    Psychiatry Res. 2021;300:113907.
    PubMed     Abstract available


    March 2021
  25. AU RWC, Sezto HNW, Lam VWM, Wan YT, et al
    Brief report: A randomized controlled trial of a compensatory cognitive training to improve prospective memory performance in people with schizophrenia or depression.
    Psychiatry Res. 2021;300:113914.
    PubMed     Abstract available


  26. LI M, Liu Y, Qiu Y, Zhang J, et al
    The effect of berberine adjunctive treatment on glycolipid metabolism in patients with schizophrenia: A randomized, double-blind, placebo-controlled clinical trial.
    Psychiatry Res. 2021;300:113899.
    PubMed     Abstract available


  27. GAN H, Zhu J, Zhuo K, Zhang J, et al
    High frequency repetitive transcranial magnetic stimulation of dorsomedial prefrontal cortex for negative symptoms in patients with schizophrenia: A double-blind, randomized controlled trial.
    Psychiatry Res. 2021;299:113876.
    PubMed     Abstract available


  28. PAN Z, Xiong D, Xiao H, Li J, et al
    The Effects of Repetitive Transcranial Magnetic Stimulation in Patients with Chronic Schizophrenia: Insights from EEG Microstates.
    Psychiatry Res. 2021;299:113866.
    PubMed     Abstract available


  29. LUCKHOFF HK, Asmal L, Scheffler F, du Plessis S, et al
    Gender role endorsement in first-episode schizophrenia spectrum disorders.
    Psychiatry Res. 2021;299:113867.
    PubMed     Abstract available


  30. YANG F, Ma H, Yuan J, Wei Y, et al
    Correlation of abnormalities in resting state fMRI with executive functioning in chronic schizophrenia.
    Psychiatry Res. 2021;299:113862.
    PubMed     Abstract available


  31. BERTRAND T, Tavitian A, Galindez JM, Kothari V, et al
    Heme oxygenase-1 in blood and saliva during acute psychosis: A pilot study.
    Psychiatry Res. 2021;299:113857.
    PubMed     Abstract available


  32. PARK HJ, Kang WS, Kim JW
    Association between the promoter haplotype of RTN4 gene and schizophrenia in a Korean population.
    Psychiatry Res. 2021;299:113841.
    PubMed     Abstract available


  33. BIAN Y, Lin C, Ma B, Han X, et al
    Effect of subjective sleep quality on learning and memory in drug-free patients with schizophrenia.
    Psychiatry Res. 2021;299:113849.
    PubMed     Abstract available


  34. CANTY AL, Cao Y, Neumann D, Shum DHK, et al
    The functional significance of cognitive empathy and theory of mind in early and chronic schizophrenia.
    Psychiatry Res. 2021;299:113852.
    PubMed     Abstract available


    February 2021
  35. CRUZ BF, de Campos-Carli SM, de Oliveira AM, de Brito CB, et al
    Investigating potential associations between neurocognition/social cognition and oxidative stress in schizophrenia.
    Psychiatry Res. 2021;298:113832.
    PubMed     Abstract available


  36. GOGOS A, Sun J, Udawela M, Gibbons A, et al
    Cortical expression of the RAPGEF1 gene in schizophrenia: investigating regional differences and suicide.
    Psychiatry Res. 2021;298:113818.
    PubMed     Abstract available


  37. BELVEDERI MURRI M, Zotos S, Cantarelli L, Berardi L, et al
    Between China and Italy: A case report of first-episode schizophrenia in the Covid-19 era.
    Psychiatry Res. 2021;298:113804.
    PubMed    


  38. ESPOSITO CM, D'Agostino A, Dell Osso B, Fiorentini A, et al
    Impact of the first Covid-19 pandemic wave on first episode psychosis in Milan, italy.
    Psychiatry Res. 2021;298:113802.
    PubMed     Abstract available


  39. BJORKLY S, Laake P, Roaldset JO, Douglas KS, et al
    The Safe pilot study: A prospective naturalistic study with repeated measures design to test the psychosis - violence link in and after discharge from forensic facilities.
    Psychiatry Res. 2021;298:113793.
    PubMed     Abstract available


  40. RENDON-QUINTERO E, Ortiz K, Vallejo Silva A
    SCHIZOPHRENIA in the midst of a COVID-19 outbreak in a psychiatric hospital in COLOMBIA.
    Psychiatry Res. 2021;298:113785.
    PubMed     Abstract available


  41. BERNARDIN F, Schwitzer T, Angioi-Duprez K, Giersch A, et al
    Retinal ganglion cell dysfunction is correlated with disturbed visual cognition in schizophrenia patients with visual hallucinations.
    Psychiatry Res. 2021;298:113780.
    PubMed     Abstract available


  42. SREERAJ VS, Holla B, Ithal D, Nadella RK, et al
    Psychiatric symptoms and syndromes transcending diagnostic boundaries in Indian multiplex families: The cohort of ADBS study.
    Psychiatry Res. 2021;296:113647.
    PubMed     Abstract available


  43. MORRIS E, Batallones R, Ryan J, Slomp C, et al
    Psychiatric genetic counseling for serious mental illness: Impact on psychopathology and psychotropic medication adherence.
    Psychiatry Res. 2021;296:113663.
    PubMed     Abstract available


  44. CAMUS D, Dan Glauser ES, Gholamrezaee M, Gasser J, et al
    Factors associated with repetitive violent behavior of psychiatric inpatients.
    Psychiatry Res. 2021;296:113643.
    PubMed     Abstract available


  45. GURCAN G, Senol SH, Yagcioglu AEA, Ertugrul A, et al
    Clinical risk factors, phenomenology and the impact of clozapine induced obsessive compulsive symptoms.
    Psychiatry Res. 2021;296:113665.
    PubMed     Abstract available


  46. KHARE C, Mueser KT, Bahaley M, Vax S, et al
    Employment in people with severe mental illnesses receiving public sector psychiatric services in India.
    Psychiatry Res. 2021;296:113673.
    PubMed     Abstract available


    January 2021
  47. PHAHLADIRA L, Asmal L, Luckhoff HK, du Plessis S, et al
    The course and concomitants of depression in first-episode schizophrenia spectrum disorders: A 24-month longitudinal study.
    Psychiatry Res. 2021;298:113767.
    PubMed     Abstract available


  48. GOSEK P, Kotowska J, Rowinska-Garbien E, Bartczak D, et al
    Treatment resistance and prolonged length of stay among schizophrenia inpatients in forensic institutions.
    Psychiatry Res. 2021;298:113771.
    PubMed     Abstract available


  49. TRONCHIN G, McPhilemy G, Ahmed M, Kilmartin L, et al
    White matter microstructure and structural networks in treatment-resistant schizophrenia patients after commencing clozapine treatment: A longitudinal diffusion imaging study.
    Psychiatry Res. 2021;298:113772.
    PubMed     Abstract available


  50. KLAUS F, Guetter K, Schlegel R, Seifritz E, et al
    Peripheral biopterin and neopterin in schizophrenia and depression.
    Psychiatry Res. 2021;297:113745.
    PubMed     Abstract available


  51. MOTA P
    "I have no disease and weed just relaxes me!": The therapeutic challenge in young patients with psychosis and cannabis abuse.
    Psychiatry Res. 2021;297:113741.
    PubMed    


  52. LUCA P, Rafael T, Emilio B, Antonio V, et al
    Are Schizophrenic disorders with or without early cannabis use neurobiologically distinct disease entities? A meta-analysis of magnetic resonance imaging studies.
    Psychiatry Res. 2021;297:113731.
    PubMed     Abstract available


  53. ZAHID A, Best MW
    Stigma towards individuals with schizophrenia: Examining the effects of negative symptoms and diagnosis awareness on preference for social distance.
    Psychiatry Res. 2021;297:113724.
    PubMed     Abstract available


  54. CHEN D, Li H, Zhao Q, Song J, et al
    Effect of risperidone treatment on insulin-like growth factor-1 and interleukin-17 in drug naive first-episode schizophrenia.
    Psychiatry Res. 2021;297:113717.
    PubMed     Abstract available


  55. FATTAHI C, Hamada K, Chiang M, Kosuru S, et al
    A narrative review of mindfulness-based therapy for schizophrenia, co-occurring substance use and comorbid cardiometabolic problems.
    Psychiatry Res. 2021;296:113707.
    PubMed     Abstract available


  56. SERRA-MAYORAL A, Mareca C, Cano R, Romaguera A, et al
    The BAT: A videotaped battery to assess theory of mind in schizophrenia.
    Psychiatry Res. 2021;297:113709.
    PubMed     Abstract available


  57. SELVARAJ S, Chhabra H, Dinakaran D, Sreeraj VS, et al
    Auditory signal detection in schizophrenia: Correlates with auditory verbal hallucinations & effect of single session transcranial direct current stimulation (tDCS).
    Psychiatry Res. 2021;297:113704.
    PubMed     Abstract available


  58. SEILER N, Hunter J, Waterdrinker A, Das S, et al
    Psychopathological consequences of the COVID-19 pandemic: A case report of psychosis.
    Psychiatry Res. 2021;296:113703.
    PubMed    


  59. KETHARANATHAN T, Pereira A, Reets U, Walker D, et al
    Brain changes in NF-kappaB1 and epidermal growth factor system markers at peri-pubescence in the spiny mouse following maternal immune activation.
    Psychiatry Res. 2021;295:113564.
    PubMed     Abstract available


    December 2020
  60. MARTINI F, Spangaro M, Buonocore M, Bechi M, et al
    Clozapine tolerability in Treatment Resistant Schizophrenia: exploring the role of sex.
    Psychiatry Res. 2020;297:113698.
    PubMed     Abstract available


  61. ROSEBROCK LE, Waite F, Diamond R, Collett N, et al
    Anticipatory pleasure in current psychosis: Cognitive and emotional correlates.
    Psychiatry Res. 2020;297:113697.
    PubMed     Abstract available


  62. MAAGENSEN H, Larsen JR, Jorgensen NR, Fink-Jensen A, et al
    Liraglutide does not change bone turnover in clozapine- and olanzapine-treated schizophrenia overweight patients with prediabetes - randomized controlled trial.
    Psychiatry Res. 2020;296:113670.
    PubMed     Abstract available


  63. LIU Y, Gu N, Cao X, Zhu Y, et al
    Effects of transcranial electrical stimulation on working memory in patients with schizophrenia: A systematic review and meta-analysis.
    Psychiatry Res. 2020;296:113656.
    PubMed     Abstract available


  64. DADA O, Adanty C, Dai N, Jeremian R, et al
    Biological aging in schizophrenia and psychosis severity: DNA methylation analysis.
    Psychiatry Res. 2020;296:113646.
    PubMed     Abstract available


  65. NG QX, Chong JWX, Yong CSK, Sivalingam V, et al
    Re-considering the use of bupropion in schizophrenia: A case report and review of literature.
    Psychiatry Res. 2020;295:113636.
    PubMed    


  66. SURMANN M, Falke S, von Gruchalla L, Maisch B, et al
    Understanding the multidimensional phenomenon of medication adherence attitudes in psychosis.
    Psychiatry Res. 2020;295:113601.
    PubMed     Abstract available


  67. MAHMOOD Z, Van Patten R, Keller AV, Lykins HC, et al
    Reducing negative symptoms in schizophrenia: Feasibility and acceptability of a combined cognitive-behavioral social skills training and compensatory cognitive training intervention.
    Psychiatry Res. 2020;295:113620.
    PubMed     Abstract available


    November 2020
  68. STEFANOVA M, Taylor G, Jacobsen P
    Who gets evidence-based therapy for psychosis following a psychiatric hospital admission? Follow-up data from an inpatient randomised controlled trial.
    Psychiatry Res. 2020;295:113605.
    PubMed     Abstract available


  69. THOMAS M, Szentgyorgyi T, Vanes LD, Mouchlianitis E, et al
    Cognitive performance in early, treatment-resistant psychosis patients: Could cognitive control play a role in persistent symptoms?
    Psychiatry Res. 2020;295:113607.
    PubMed     Abstract available


  70. TOUS-ESPELOSIN M, de Azua SR, Iriarte-Yoller N, MartinezAguirre-Betolaza A, et al
    Clinical, physical, physiological, and cardiovascular risk patterns of adults with schizophrenia: CORTEX-SP study: Characterization of adults with schizophrenia.
    Psychiatry Res. 2020 Nov 18:113580. doi: 10.1016/j.psychres.2020.113580.
    PubMed     Abstract available


  71. PENG Y, Zhang S, Zhou Y, Song Y, et al
    Abnormal functional connectivity based on nodes of the default mode network in first-episode drug-naive early-onset schizophrenia.
    Psychiatry Res. 2020 Nov 18:113578. doi: 10.1016/j.psychres.2020.113578.
    PubMed     Abstract available


  72. DELISI LE
    A commentary revisiting the viral hypothesis of schizophrenia: Onset of a schizophreniform disorder subsequent to SARS CoV-2 infection.
    Psychiatry Res. 2020 Nov 16:113573. doi: 10.1016/j.psychres.2020.113573.
    PubMed     Abstract available


  73. HOPKINS SC, Ogirala A, Loebel A, Koblan KS, et al
    Characterization of specific and distinct patient types in clinical trials of acute schizophrenia using an uncorrelated PANSS score matrix transform (UPSM).
    Psychiatry Res. 2020 Nov 11:113569. doi: 10.1016/j.psychres.2020.113569.
    PubMed     Abstract available


  74. PALOMAR-CIRIA N, Alonso-Alvarez D, Vazquez-Beltran P, Blanco Del Valle P, et al
    Commentary to "Schizophrenia and COVID-19 Delirium", an update.
    Psychiatry Res. 2020;294:113555.
    PubMed    


  75. GUIDARA W, Messedi M, Naifar M, Maalej M, et al
    Predictive value of oxidative stress biomarkers in drugfree patients with schizophrenia and schizo-affective disorder.
    Psychiatry Res. 2020;293:113467.
    PubMed     Abstract available


  76. LOU S, Xue X
    Application of electroencephalographic (EEG) biofeedback therapy in the rehabilitation of patients with chronic diseases.
    Psychiatry Res. 2020;293:113371.
    PubMed     Abstract available


    October 2020
  77. PELIZZA L, Maestri D, Leuci E, Quattrone E, et al
    Negative symptom configuration within and outside schizophrenia spectrum disorders: results from the "Parma Early Psychosis" program.
    Psychiatry Res. 2020;294:113519.
    PubMed     Abstract available


  78. GRIMES KM DR, Foussias G, Remington G, Kalahani-Bargis K, et al
    Stability of Verbal Fluency in Outpatients with Schizophrenia.
    Psychiatry Res. 2020 Oct 23:113528. doi: 10.1016/j.psychres.2020.113528.
    PubMed     Abstract available


  79. GRATTAN RE, Tryon VL, Carter CS, Niendam TA, et al
    Suicide behavior is associated with childhood emotion dysregulation but not trait impulsivity in first episode psychosis.
    Psychiatry Res. 2020;294:113517.
    PubMed     Abstract available


  80. AJNAKINA O, Agbedjro D, Lally J, Forti MD, et al
    Predicting onset of early- and late-treatment resistance in first-episode schizophrenia patients using advanced shrinkage statistical methods in a small sample.
    Psychiatry Res. 2020;294:113527.
    PubMed     Abstract available


  81. SIMOILA L, Isometsa E, Gissler M, Suvisaari J, et al
    Pregnancy, delivery and postpartum in women with schizophrenia or schizoaffective disorder in Finland: a national register-based comparative study.
    Psychiatry Res. 2020;294:113504.
    PubMed     Abstract available


  82. SCOTT M, Rossell SL, Toh WL, Thomas N, et al
    The relationship between anxiety, depression, and subtypes of negative auditory verbal hallucination (AVH) content in affective and non-affective psychosis.
    Psychiatry Res. 2020;294:113500.
    PubMed     Abstract available


  83. MCGOVERN JE, Masucci MD, Le TP, Cohen AS, et al
    The (b)link between amotivation and psychosis: Insights through phasic eye blink rate.
    Psychiatry Res. 2020;294:113490.
    PubMed     Abstract available


  84. RANDERS L, Fagerlund B, Jepsen JRM, Nordholm D, et al
    Interview and questionnaire assessment of cognitive impairment in subjects at ultra-high risk for psychosis: Associations with cognitive test performance, psychosocial functioning, and positive symptoms.
    Psychiatry Res. 2020;294:113498.
    PubMed     Abstract available


  85. KELLY DL, Spaderna M, Hodzic V, Nair S, et al
    Blinded Clinical Ratings of Social Media Data are Correlated with In-Person Clinical Ratings in Participants Diagnosed with Either Depression, Schizophrenia, or Healthy Controls.
    Psychiatry Res. 2020;294:113496.
    PubMed     Abstract available


  86. TALIERCIO J, Bonasera B, Portillo C, Ramjas E, et al
    Physical Activity, Sleep-related Behaviors and Severity of Symptoms in Schizophrenia.
    Psychiatry Res. 2020;294:113489.
    PubMed     Abstract available


  87. SCHUTTE MJL, Linszen MMJ, Marschall TM, Ffytche DH, et al
    Hallucinations and other psychotic experiences across diagnoses: A comparison of phenomenological features.
    Psychiatry Res. 2020;292:113314.
    PubMed     Abstract available


    September 2020
  88. MA C, Li Y, Li X, Liu J, et al
    Identification of a functional SNP rs7304782 at schizophrenia risk locus 12q24.31 and validation of its association with schiz ophrenia in Chinese populations.
    Psychiatry Res. 2020;294:113491.
    PubMed     Abstract available


  89. YAN P, Song M, Gao B, Wang S, et al
    Association of the genetic polymorphisms of metabolizing enzymes, transporters, target receptors and their interactions with treatment response to olanzapine in chinese han schizophrenia patients.
    Psychiatry Res. 2020;293:113470.
    PubMed     Abstract available


  90. JIA R, Liang D, Yu J, Lu G, et al
    The effectiveness of adjunct music therapy for patients with schizophrenia: A meta-analysis.
    Psychiatry Res. 2020;293:113464.
    PubMed     Abstract available


  91. CUI Y, Piao Y, Kim SW, Lee BJ, et al
    Psychological factors intervening between childhood trauma and suicidality in first-episode psychosis.
    Psychiatry Res. 2020;293:113465.
    PubMed     Abstract available


  92. CAO B, Chen Y, McIntyre RS, Yan L, et al
    Acyl-Carnitine plasma levels and their association with metabolic syndrome in individuals with schizophrenia.
    Psychiatry Res. 2020;293:113458.
    PubMed     Abstract available


  93. BEN AFIA A, Aflouk Y, Saoud H, Zaafrane F, et al
    Inteurleukin-8 gene variations and the susceptibility to schizophrenia.
    Psychiatry Res. 2020;293:113421.
    PubMed     Abstract available


  94. HATANO M, Kamei H, Shimato A, Yamada S, et al
    Trend survey on adverse event profiles of antipsychotic long-acting injections and oral agents using the Japanese adverse drug event report database.
    Psychiatry Res. 2020;291:113249.
    PubMed     Abstract available


  95. KATINA S, Kelly BD, Rojas MA, Sukno FM, et al
    Refining the resolution of craniofacial dysmorphology in bipolar disorder as an index of brain dysmorphogenesis.
    Psychiatry Res. 2020;291:113243.
    PubMed     Abstract available


  96. PEREDO R, Gagne AM, Gilbert E, Hebert M, et al
    Electroretinography may reveal cognitive impairment among a cohort of subjects at risk of a major psychiatric disorder.
    Psychiatry Res. 2020;291:113227.
    PubMed     Abstract available


  97. LANGLOIS T, Sanchez-Rodriguez R, Bourcier A, Lamy P, et al
    Impact of the group intervention "Accept Voices(c)" for the management of auditory hallucinations.
    Psychiatry Res. 2020;291:113159.
    PubMed     Abstract available


    August 2020
  98. MELAMED SB, Farfel A, Gur S, Krivoy A, et al
    Thyroid function assessment before and after diagnosis of schizophrenia: A community-based study.
    Psychiatry Res. 2020;293:113356.
    PubMed     Abstract available


  99. ADAMS SW, Yanos PT
    Pathways to aggression and violence in psychosis without longstanding antisocial behavior: A review and proposed psychosocial model for integrative clinical interventions.
    Psychiatry Res. 2020;293:113427.
    PubMed     Abstract available


  100. DE VOS C, Leopold K, Blanke ES, Siebert S, et al
    The relationship between cannabis use and cognition in people diagnosed with first-episode psychosis.
    Psychiatry Res. 2020;293:113424.
    PubMed     Abstract available


  101. SHANNON A, McGuire D, Brown E, O'Donoghue B, et al
    A systematic review of the effectiveness of group-based exercise interventions for individuals with first episode psychosis.
    Psychiatry Res. 2020;293:113402.
    PubMed     Abstract available


  102. CUESTA MJ, Sanchez-Torres AM, Lorente-Omenaca R, Zandio M, et al
    Validity and utility of a set of clinical criteria for cognitive impairment associated with psychosis (CIAPs).
    Psychiatry Res. 2020;293:113404.
    PubMed     Abstract available


  103. PROKOPEZ CR, Vallejos M, Farinola R, Alberio G, et al
    The history of multiple adverse childhood experiences in patients with schizophrenia is associated with more severe symptomatology and suicidal behavior with gender-specific characteristics.
    Psychiatry Res. 2020;293:113411.
    PubMed     Abstract available


  104. STRASSNIG M, Jones MT, Pinkham A, Penn D, et al
    Depression, hostility, attributional biases, and paranoia in schizophrenia and healthy controls: intercorrelations and associations with self-assessment of social functioning.
    Psychiatry Res. 2020;293:113388.
    PubMed    


  105. WANG YY, Hsu SH, Tsai HY, Cheng MC, et al
    Genetic analysis of the NR2E1 gene as a candidate gene of schizophrenia.
    Psychiatry Res. 2020;293:113386.
    PubMed     Abstract available


  106. GIBSON CL, Bassir Nia A, Spriggs SA, DeFrancisco D, et al
    Cannabinoid use in psychotic patients impacts inflammatory levels and their association with psychosis severity.
    Psychiatry Res. 2020;293:113380.
    PubMed     Abstract available


  107. BOKA E, Pozzo JD, Goetz D, Remsen B, et al
    Ineffective risk-reward learning in schizophrenia.
    Psychiatry Res. 2020;293:113370.
    PubMed     Abstract available


  108. WAMBUA GN, Kilian S, Ntlantsana V, Chiliza B, et al
    The association between resilience and psychosocial functioning in schizophrenia: A systematic review and meta-analysis.
    Psychiatry Res. 2020;293:113374.
    PubMed     Abstract available


  109. LIN X, Deng J, Dong G, Li S, et al
    Effects of Chronic Pharmacological Treatment on Functional Brain Network Connectivity in Patients with Schizophrenia.
    Psychiatry Res. 2020 Aug 4:113338. doi: 10.1016/j.psychres.2020.113338.
    PubMed     Abstract available


  110. GRIGORIOU M, Upthegrove R
    Blunted affect and suicide in schizophrenia: A systematic review.
    Psychiatry Res. 2020;293:113355.
    PubMed     Abstract available


  111. JENSEN RAA, Thomsen DK, Bliksted VF, Ladegaard N, et al
    Narrative Identity in Psychopathology: A Negative Past and a Bright but Foreshortened Future.
    Psychiatry Res. 2020;290:113103.
    PubMed     Abstract available


  112. LALOYAUX J, Collazzoni A, Hirnstein M, Kusztrits I, et al
    Personal resilience factors protect against distressing auditory hallucinations: A study comparing psychotic patients with auditory hallucinations, non-patients with auditory hallucinations, and healthy controls.
    Psychiatry Res. 2020;290:113058.
    PubMed     Abstract available


    July 2020
  113. CULLEN BA, Rodriguez K, Eaton WW, Mojtabai R, et al
    Clinical outcomes from the texting for relapse prevention (T4RP) in schizophrenia and schizoaffective disorder study.
    Psychiatry Res. 2020;292:113346.
    PubMed     Abstract available


  114. CAQUEO-URIZAR A, Ferrer R, Ponce F, Urzua A, et al
    Clinical outcomes of schizophrenia: A differential study among Latin-American countries.
    Psychiatry Res. 2020;292:113334.
    PubMed    


  115. QING L, Liu L, Zhou L, Zhang F, et al
    Sex-dependent association of mineralocorticoid receptor gene (NR3C2) DNA methylation and schizophrenia.
    Psychiatry Res. 2020;292:113318.
    PubMed     Abstract available


  116. PU J, Liu Y, Gui S, Tian L, et al
    Vascular endothelial growth factor in major depressive disorder, schizophrenia, and bipolar disorder: A network meta-analysis.
    Psychiatry Res. 2020;292:113319.
    PubMed     Abstract available


  117. OHAYON S, Yitzhaky A, Hertzberg L
    Gene expression meta-analysis reveals the up-regulation of CREB1 and CREBBP in Brodmann Area 10 of patients with schizophrenia.
    Psychiatry Res. 2020;292:113311.
    PubMed     Abstract available


  118. HE Q, You Y, Yu L, Yao L, et al
    Uric acid levels in subjects with schizophrenia: A systematic review and meta-analysis.
    Psychiatry Res. 2020;292:113305.
    PubMed     Abstract available


  119. CEYLAN D, Akdede BB, Bora E, Aktener AY, et al
    Neurocognitive functioning during symptomatic states and remission in bipolar disorder and schizophrenia: A comparative study.
    Psychiatry Res. 2020;292:113292.
    PubMed     Abstract available


  120. KEZAI AM, Lecoeur C, Hot D, Bounechada M, et al
    Association between schizophrenia and Toxoplasma gondii infection in Algeria.
    Psychiatry Res. 2020;291:113293.
    PubMed     Abstract available


  121. FIERINI F, Moretti D, Ballerini A
    Psychosis spectrum disorders during and after the COVID-19 pandemic: Warning signs of "stress incubation".
    Psychiatry Res. 2020;291:113291.
    PubMed    


  122. OLUWOYE O, Stokes B, Stiles B, Monroe-DeVita M, et al
    Understanding differences in family engagement and provider outreach in New Journeys: A coordinated specialty care program for first episode psychosis.
    Psychiatry Res. 2020;291:113286.
    PubMed     Abstract available


  123. KOOLA MM, Looney SW, Hong H, Pillai A, et al
    Meta-analysis of randomized controlled trials of galantamine in schizophrenia: significant cognitive enhancement.
    Psychiatry Res. 2020;291:113285.
    PubMed     Abstract available


  124. FORTGANG RG, Hoff RA, Potenza MN
    Schizophrenia symptom severity and motivations for gambling in individuals with schizophrenia or schizoaffective disorder.
    Psychiatry Res. 2020;291:113281.
    PubMed     Abstract available


  125. KONJEVOD M, Nikolac Perkovic M, Svob Strac D, Uzun S, et al
    Significant association of mu-opioid receptor 1 haplotype with tobacco smoking in healthy control subjects but not in patients with schizophrenia and alcohol dependence.
    Psychiatry Res. 2020;291:113278.
    PubMed     Abstract available


  126. KERN RS, Reddy LF, Cohen AN, Young AS, et al
    Effects of aerobic exercise on cardiorespiratory fitness and social functioning in veterans 40 to 65 years old with schizophrenia.
    Psychiatry Res. 2020;291:113258.
    PubMed     Abstract available


  127. SUMNER PJ, Carruthers SP, Rossell SL
    Examining Self-Reported Thought Disorder: Continuous Variation, Convergence with Schizotypy, and Cognitive Correlates.
    Psychiatry Res. 2020;289:112943.
    PubMed     Abstract available


    June 2020
  128. PAN R, Zhang X, Gao J, Yi W, et al
    Analysis of the diversity of intestinal microbiome and its potential value as a biomarker in patients with schizophrenia: A cohort study.
    Psychiatry Res. 2020;291:113260.
    PubMed     Abstract available


  129. KOPELLI E, Samara M, Siargkas A, Goulas A, et al
    The role of cannabidiol oil in schizophrenia treatment. a systematic review and meta-analysis.
    Psychiatry Res. 2020;291:113246.
    PubMed     Abstract available


  130. DICKERSON F, Schroeder JR, Nimgaonkar V, Gold J, et al
    The association between exposure to herpes simplex virus type 1 (HSV-1) and cognitive functioning in schizophrenia: A meta-analysis.
    Psychiatry Res. 2020;291:113157.
    PubMed     Abstract available


  131. MOSCHOPOULOS N, Nimatoudis I, Kaprinis S, Sidiras C, et al
    Auditory processing disorder may be present in schizophrenia and it is highly correlated with formal thought disorder.
    Psychiatry Res. 2020;291:113222.
    PubMed     Abstract available


  132. VUKOJEVIC J, Susac J, Brecic P
    Psychosis and pandemics: Is there a secret protector?
    Psychiatry Res. 2020;291:113199.
    PubMed    


  133. MENEGHELLI A, Barbera S, Meliante M, Monzani E, et al
    Outcome at 2-year of treatment in first-episode psychosis patients who were enrolled in a specialized early intervention program.
    Psychiatry Res. 2020;291:113200.
    PubMed     Abstract available


  134. HAGEN JM, Sutterland AL, Edrisy S, Tan HL, et al
    Accumulation rate of advanced glycation end products in recent onset psychosis: A longitudinal study.
    Psychiatry Res. 2020;291:113192.
    PubMed     Abstract available


  135. LYSAKER PH, Chernov N, Moiseeva T, Sozinova M, et al
    Contrasting metacognitive profiles and their association with negative symptoms in groups with schizophrenia, early psychosis and depression in a Russian sample.
    Psychiatry Res. 2020;291:113177.
    PubMed     Abstract available


  136. HOLZLE P, Aly L, Frank W, Forstl H, et al
    COVID-19 distresses the depressed while schizophrenic patients are unimpressed: A study on psychiatric inpatients.
    Psychiatry Res. 2020;291:113175.
    PubMed    


  137. ZHAND N, Osborne R, Stuyt M, Hatko A, et al
    Incidental finding of age and time disorientation in a clinical sample of patients with schizophrenia: Findings from a short term follow up survey regarding cannabis use.
    Psychiatry Res. 2020;290:113150.
    PubMed     Abstract available


  138. TOH WL, Thomas N, Hollander Y, Rossell SL, et al
    On the phenomenology of auditory verbal hallucinations in affective and non-affective psychosis.
    Psychiatry Res. 2020;290:113147.
    PubMed     Abstract available


  139. MICHAEL GA, Dorey JM, Rey R, D'Amato T, et al
    Attention in schizophrenia: Impaired inhibitory control, faulty attentional resources, or both?
    Psychiatry Res. 2020;290:113164.
    PubMed     Abstract available


  140. COOK JA, Burke-Miller JK, Jonikas JA, Aranda F, et al
    Factors associated with 30-day readmissions following medical hospitalizations among Medicaid beneficiaries with schizophrenia, bipolar disorder, and major depressive disorder.
    Psychiatry Res. 2020;291:113168.
    PubMed     Abstract available


    May 2020
  141. LANDGREN V
    Commentary on "Psychosis associated to CASPR2 autoantibodies and ovarian teratoma: A case report".
    Psychiatry Res. 2020;290:113144.
    PubMed    


  142. MAVROGIORGOU P, Haller K, Juckel G
    Death anxiety and attitude to death in patients with schizophrenia and depression.
    Psychiatry Res. 2020;290:113148.
    PubMed     Abstract available


  143. LI J, Cao X, Liu S, Li X, et al
    Efficacy of repetitive transcranial magnetic stimulation on auditory hallucinations in schizophrenia: A meta-analysis.
    Psychiatry Res. 2020;290:113141.
    PubMed     Abstract available


  144. KHOBRAGADE B, Sharma V, Deshpande SN
    A study on tobacco use in women with major mental illnesses- schizophrenia, bipolar disorder and recurrent depression.
    Psychiatry Res. 2020;290:113121.
    PubMed     Abstract available


  145. PALOMAR-CIRIA N, Blanco Del Valle P, Hernandez-Las Heras MA, Martinez-Gallardo R, et al
    Schizophrenia and COVID-19 delirium.
    Psychiatry Res. 2020;290:113137.
    PubMed     Abstract available


  146. CHANDRA PS, Shiva L, Nagendrappa S, Ganjekar S, et al
    COVID 19 related Psychosis as an interface of fears, socio-cultural issues and vulnerability- case report of two women from India.
    Psychiatry Res. 2020;290:113136.
    PubMed    


  147. VALERY KM, Prouteau A
    Schizophrenia stigma in mental health professionals and associated factors: A systematic review.
    Psychiatry Res. 2020;290:113068.
    PubMed     Abstract available


  148. SREERAJ VS, Suhas S, Parlikar R, Selvaraj S, et al
    Effect of add-on transcranial alternating current stimulation (tACS) on persistent delusions in schizophrenia.
    Psychiatry Res. 2020;290:113106.
    PubMed     Abstract available


  149. SAKANAKA S, Tsujii N, Morimoto H, Shirakawa O, et al
    Aggressiveness is associated with excitement on the five-factor model of the positive and negative syndrome scale and prefrontal function in patients with stable schizophrenia.
    Psychiatry Res. 2020;290:113054.
    PubMed     Abstract available


  150. CORREA-PALACIO AF, Hernandez-Huerta D, Gomez-Arnau J, Loeck C, et al
    Affective psychosis after COVID-19 infection in a previously healthy patient: a case report.
    Psychiatry Res. 2020;290:113115.
    PubMed    


  151. KANG Y, Huang K, Lin Y, Xu H, et al
    Abnormalities of effective connectivity and white matter microstructure in the triple network in patients with schizophrenia.
    Psychiatry Res. 2020;290:113019.
    PubMed     Abstract available


  152. VEGA-SEVEY JG, Martinez-Magana JJ, Genis-Mendoza AD, Escamilla M, et al
    Copy number variants in siblings of Mexican origin concordant for schizophrenia or bipolar disorder.
    Psychiatry Res. 2020;291:113018.
    PubMed     Abstract available


  153. JOHANSSON M, Hjarthag F, Helldin L
    Cognitive markers related to long-term remission status in Schizophrenia Spectrum Disorders.
    Psychiatry Res. 2020;289:113035.
    PubMed     Abstract available


  154. SJOLIE C, Meyn EK, Raudeberg R, Andreassen OA, et al
    Nonsocial cognitive underpinnings of theory of mind in schizophrenia.
    Psychiatry Res. 2020;289:113055.
    PubMed     Abstract available


  155. KITOKO GMB, Maurage P, Ma Miezi SM, Gillain B, et al
    Inter-individual variability of social perception and social knowledge impairments among patients with schizophrenia.
    Psychiatry Res. 2020;290:112951.
    PubMed     Abstract available


  156. HERMANS K, van der Steen Y, Kasanova Z, van Winkel R, et al
    Temporal dynamics of suspiciousness and hallucinations in clinical high risk and first episode psychosis.
    Psychiatry Res. 2020;290:113039.
    PubMed     Abstract available


  157. MARTIN DR, Gonzalez AJ, Perez CPL, Sesmero SA, et al
    New-onset psychosis in COVID-19 pandemic: a case series in Madrid.
    Psychiatry Res. 2020 May 13:113097. doi: 10.1016/j.psychres.2020.113097.
    PubMed    


  158. RENTERO D, Juanes A, Losada CP, Alvarez S, et al
    New-onset psychosis in COVID-19 pandemic: a case series in Madrid.
    Psychiatry Res. 2020;290:113097.
    PubMed    


  159. HUARCAYA-VICTORIA J, Herrera D, Castillo C
    Psychosis in a patient with anxiety related to COVID-19: A case report.
    Psychiatry Res. 2020;289:113052.
    PubMed    


  160. HOSSAIN MM, Khan N, Sultana A, Ma P, et al
    Prevalence of comorbid psychiatric disorders among people with autism spectrum disorder: An umbrella review of systematic reviews and meta-analyses.
    Psychiatry Res. 2020;287:112922.
    PubMed     Abstract available


    April 2020
  161. MASAOKA Y, Velakoulis D, Brewer WJ, Cropley VL, et al
    Impaired olfactory ability associated with larger left hippocampus and rectus volumes at earliest stages of schizophrenia: A sign of neuroinflammation?
    Psychiatry Res. 2020;289:112909.
    PubMed     Abstract available


  162. KILIAN S, Asmal L, Phahladira L, Plessis SD, et al
    The association between childhood trauma and treatment outcomes in schizophrenia spectrum disorders.
    Psychiatry Res. 2020;289:113004.
    PubMed     Abstract available


  163. RANDERS L, Jepsen JRM, Fagerlund B, Nordholm D, et al
    Associations between facial affect recognition and neurocognition in subjects at ultra-high risk for psychosis: A case-control study.
    Psychiatry Res. 2020;290:112969.
    PubMed     Abstract available


  164. GAINSFORD K, Fitzgibbon B, Fitzgerald PB, Hoy KE, et al
    Transforming treatments for schizophrenia: Virtual reality, brain stimulation and social cognition.
    Psychiatry Res. 2020;288:112974.
    PubMed     Abstract available


  165. ZHU JL, Luo WW, Cheng X, Li Y, et al
    Vitamin D deficiency and Schizophrenia in Adults: A Systematic Review and Meta-analysis of Observational Studies.
    Psychiatry Res. 2020;288:112959.
    PubMed     Abstract available


  166. BAANDRUP L, Allerup P, Nielsen MO, Bak N, et al
    Rasch analysis of the PANSS negative subscale and exploration of negative symptom trajectories in first-episode schizophrenia - data from the OPTiMiSE trial.
    Psychiatry Res. 2020;289:112970.
    PubMed     Abstract available


  167. FISCHER M, Coogan AN, Faltraco F, Thome J, et al
    COVID-19 paranoia in a patient suffering from schizophrenic psychosis - a case report.
    Psychiatry Res. 2020;288:113001.
    PubMed    


  168. VIDARSDOTTIR OG, Twamley EW, Roberts DL, Sigurdsson E, et al
    Integrative cognitive remediation for early psychosis: A 12-month follow-up.
    Psychiatry Res. 2020;288:112964.
    PubMed     Abstract available


  169. ADHAN I, Lizano P, Bannai D, Lutz O, et al
    Visual Cortical Alterations and their Association with Negative Symptoms in Antipsychotic-Naive First Episode Psychosis.
    Psychiatry Res. 2020;288:112957.
    PubMed     Abstract available


  170. CHEN S, Xia X, Deng C, Wu X, et al
    The correlation between metabolic syndrome and neurocognitive and social cognitive performance of patients with schizophrenia.
    Psychiatry Res. 2020;288:112941.
    PubMed     Abstract available


  171. TATAR O, Bastien G, Abdel-Baki A, Huynh C, et al
    A systematic review of technology-based psychotherapeutic interventions for decreasing cannabis use in patients with psychosis.
    Psychiatry Res. 2020;288:112940.
    PubMed     Abstract available


  172. DEAN B, Scarr E
    Muscarinic M1 and M4 receptors: Hypothesis driven drug development for schizophrenia.
    Psychiatry Res. 2020;288:112989.
    PubMed     Abstract available


  173. WANG KZ, Bani-Fatemi A, Adanty C, Harripaul R, et al
    Prediction of physical violence in schizophrenia with machine learning algorithms.
    Psychiatry Res. 2020;289:112960.
    PubMed     Abstract available


  174. BARADITS M, Bitter I, Czobor P
    Multivariate patterns of EEG microstate parameters and their role in the discrimination of patients with schizophrenia from healthy controls.
    Psychiatry Res. 2020;288:112938.
    PubMed     Abstract available


  175. ZANDIFAR A, Badrfam R
    COVID-19: Considering the prevalence of schizophrenia in the coming decades.
    Psychiatry Res. 2020;288:112982.
    PubMed    


  176. DEL CACHO N, Vila-Badia R, Butjosa A, Cuadras D, et al
    Sexual dysfunction in drug- naive first episode nonaffective psychosis patients. Relationship with prolactin and psychotic symptoms. Gender differences.
    Psychiatry Res. 2020;289:112985.
    PubMed     Abstract available


    March 2020
  177. KAYO M, Scemes S, Savoia MG, Bichuette A, et al
    A randomized controlled trial of social skills training for patients with treatment-resistant schizophrenia with predominantly negative symptoms.
    Psychiatry Res. 2020;287:112914.
    PubMed     Abstract available


  178. ZHU X, Fan H, Fan F, Zhao Y, et al
    Improving social functioning in community-dwelling patients with schizophrenia: a randomized controlled computer cognitive remediation therapy trial with six months follow-up.
    Psychiatry Res. 2020;287:112913.
    PubMed     Abstract available


  179. SUH DY, Vandekar SN, Heckers S, Avery SN, et al
    Visual exploration differences during relational memory encoding in early psychosis.
    Psychiatry Res. 2020;287:112910.
    PubMed     Abstract available


  180. ZHUO C, Ji F, Xiao B, Lin X, et al
    Antipsychotic agent-induced deterioration of the visual system in first-episode untreated patients with schizophrenia maybe self-limited: Findings from a secondary small sample follow-up study based on a pilot follow-up study.
    Psychiatry Res. 2020;286:112906.
    PubMed     Abstract available


    February 2020
  181. HALVERSON TF, Hajduk M, Pinkham AE, Harvey PD, et al
    Psychometric properties of the Observable Social Cognition Rating Scale (OSCARS): Self-report and informant-rated social cognitive abilities in schizophrenia.
    Psychiatry Res. 2020;286:112891.
    PubMed     Abstract available


  182. GHABRASH MF, Coronado-Montoya S, Aoun J, Gagne AA, et al
    Cannabidiol for the treatment of psychosis among patients with schizophrenia and other primary psychotic disorders: A systematic review with a risk of bias assessment.
    Psychiatry Res. 2020;286:112890.
    PubMed     Abstract available


  183. TOH WL, McCarthy-Jones S, Copolov D, Rossell SL, et al
    Corrigendum to 'Have we overlooked the significance of multinodal hallucinations in schizophrenia?' [Psychiatry Research 279 (2019) 358-360].
    Psychiatry Res. 2020;286:112849.
    PubMed    


  184. SALMINEN I, Read S, Hurd P, Crespi B, et al
    Does SNORD116 mediate aspects of psychosis in Prader-Willi syndrome? Evidence from a non-clinical population.
    Psychiatry Res. 2020;286:112858.
    PubMed     Abstract available


  185. SHIMADA T, Ito S, Makabe A, Yamanushi A, et al
    Aerobic exercise and cognitive functioning in schizophrenia: Results of a 1-year follow-up from a randomized controlled trial.
    Psychiatry Res. 2020;286:112854.
    PubMed     Abstract available


  186. LE L, R K, B M, Mj G, et al
    Risk of schizophrenia in relatives of individuals affected by schizophrenia: A meta-analysis.
    Psychiatry Res. 2020;286:112852.
    PubMed     Abstract available


  187. FISHER E, Wood SJ, Upthegrove R, Aldred S, et al
    Designing a feasible exercise intervention in first-episode psychosis: Exercise quality, engagement and effect.
    Psychiatry Res. 2020;286:112840.
    PubMed     Abstract available


  188. BAUER CCC, Okano K, Ghosh SS, Lee YJ, et al
    Real-time fMRI neurofeedback reduces auditory hallucinations and modulates resting state connectivity of involved brain regions: Part 2: Default mode network -preliminary evidence.
    Psychiatry Res. 2020;284:112770.
    PubMed     Abstract available


  189. DICKERSON F, Gennusa JV 3rd, Stallings C, Origoni A, et al
    Protein intake is associated with cognitive functioning in individuals with psychiatric disorders.
    Psychiatry Res. 2020;284:112700.
    PubMed     Abstract available


  190. ROSSELL SL, Labuschagne I, Castle DJ, Toh WL, et al
    Delusional themes in Body Dysmorphic Disorder (BDD): Comparisons with psychotic disorders and non-clinical Controls.
    Psychiatry Res. 2020;284:112694.
    PubMed     Abstract available


  191. DODELL-FEDER D, Shovestul B, Woodyatt J, Popov V, et al
    Social anhedonia, social networks, and psychotic-like experiences: A test of social deafferentation.
    Psychiatry Res. 2020;284:112682.
    PubMed     Abstract available


    January 2020
  192. ALLE MC, Berna F, Danion JM, Berntsen D, et al
    Seeing or hearing one's memories: Manipulating autobiographical memory imagery in schizophrenia.
    Psychiatry Res. 2020;286:112835.
    PubMed     Abstract available


  193. STEPHAN-OTTO C, Lombardini F, Nunez C, Senior C, et al
    Fluctuating asymmetry in patients with schizophrenia is related to hallucinations and thought disorganisation.
    Psychiatry Res. 2020;285:112816.
    PubMed     Abstract available


  194. TESSIER A, Dupuy M, Bayle FJ, Herse C, et al
    Brief interventions for improving adherence in schizophrenia: A pilot study using electronic medication event monitoring.
    Psychiatry Res. 2020 Jan 15:112780. doi: 10.1016/j.psychres.2020.112780.
    PubMed     Abstract available


  195. DIETRICHKEIT M, Grzella K, Nagel M, Moritz S, et al
    Using virtual reality to explore differences in memory biases and cognitive insight in people with psychosis and healthy controls.
    Psychiatry Res. 2020;285:112787.
    PubMed     Abstract available


  196. MA J, Yan L, Guo T, Yang S, et al
    A pilot study of biomarkers of oxidative stress in serum and schizophrenia.
    Psychiatry Res. 2020;284:112757.
    PubMed     Abstract available


  197. SERRANO-GUERRERO E, Ruiz-Veguilla M, Martin-Rodriguez A, Rodriguez-Testal JF, et al
    Inflexibility of beliefs and jumping to conclusions in active schizophrenia.
    Psychiatry Res. 2020;284:112776.
    PubMed     Abstract available


  198. TOR PC, Bin Abdin E, Hadzi-Pavlovic D, Loo C, et al
    Relief of expressed suicidality in schizophrenia after electroconvulsive therapy: A naturalistic cohort study.
    Psychiatry Res. 2020;284:112759.
    PubMed     Abstract available


  199. BOHLKEN J, Konrad M, Kostev K
    Adherence to neuroleptic treatment in psychiatric practices: A retrospective study of 55 practices with more than 5000 bipolar and schizophrenic patients in Germany.
    Psychiatry Res. 2020;284:112758.
    PubMed     Abstract available


  200. OSSOLA P, Fortunati R, Marchesi C, Rossi A, et al
    Basic symptoms in schizophrenia: A comparison between self-report questionnaires and clinical interviews.
    Psychiatry Res. 2020;284:112755.
    PubMed    


    December 2019
  201. HERRMANN ML, Bruchner N, Martin P, Wildgruber D, et al
    Psychosis associated to CASPR2 autoantibodies and ovarian teratoma: A case report.
    Psychiatry Res. 2019 Dec 14:112725. doi: 10.1016/j.psychres.2019.112725.
    PubMed    


  202. CHAO XL, Jiang SZ, Xiong JW, Zhan JQ, et al
    The association between serum insulin-like growth factor 1 and cognitive impairments in patients with schizophrenia.
    Psychiatry Res. 2019 Dec 6:112731. doi: 10.1016/j.psychres.2019.112731.
    PubMed     Abstract available


  203. BALAJI R, Subbanna M, Shivakumar V, Abdul F, et al
    Pattern of expression of Toll like receptor (TLR)-3 and -4 genes in drug-naive and antipsychotic treated patients diagnosed with schizophrenia.
    Psychiatry Res. 2019 Dec 4:112727. doi: 10.1016/j.psychres.2019.112727.
    PubMed     Abstract available


    November 2019
  204. HANSSEN E, Balvert S, Oorschot M, Borkelmans K, et al
    An ecological momentary intervention incorporating personalised feedback to improve symptoms and social functioning in schizophrenia spectrum disorders.
    Psychiatry Res. 2019 Nov 28:112695. doi: 10.1016/j.psychres.2019.112695.
    PubMed     Abstract available


  205. A P, V D, A S, A Z, et al
    Active behaviors and screen time in offspring of parents with major depressive disorder, bipolar disorder and schizophrenia.
    Psychiatry Res. 2019 Nov 26:112709. doi: 10.1016/j.psychres.2019.112709.
    PubMed     Abstract available


  206. MOODLIAR S, Naguy A, Elsori DH
    Add-on mirtazapine to clozapine-responsive early-onset schizophrenia.
    Psychiatry Res. 2019 Nov 22:112701. doi: 10.1016/j.psychres.2019.112701.
    PubMed    


  207. CHEUNG A, Polavarapu M, Kosuru S, Chiang M, et al
    Treatment and services for psychosis: Are college campuses a novel frontier for early detection and intervention?
    Psychiatry Res. 2019 Nov 22:112699. doi: 10.1016/j.psychres.2019.112699.
    PubMed    


  208. KEANE BP, Paterno D, Crespo LP, Kastner S, et al
    Smaller visual arrays are harder to integrate in schizophrenia: Evidence for impaired lateral connections in early vision.
    Psychiatry Res. 2019 Nov 15:112636. doi: 10.1016/j.psychres.2019.112636.
    PubMed     Abstract available


  209. BROKMEIER LL, Firth J, Vancampfort D, Smith L, et al
    Does physical activity reduce the risk of psychosis? A systematic review and meta-analysis of prospective studies.
    Psychiatry Res. 2019 Nov 14:112675. doi: 10.1016/j.psychres.2019.112675.
    PubMed     Abstract available


  210. ALAMEDA L, Ashok A, Avery S, Bani-Fatemi A, et al
    The 2019 Schizophrenia International Research Society Conference, 10-14 April, Orlando, Florida: A summary of topics and trends.
    Psychiatry Res. 2019 Nov 9:112672. doi: 10.1016/j.psychres.2019.112672.
    PubMed     Abstract available


  211. PUVEENDRAKUMARAN P, Fervaha G, Caravaggio F, Remington G, et al
    Assessing analytic and intuitive reasoning using the cognitive reflection test in young patients with schizophrenia.
    Psychiatry Res. 2019 Nov 7:112683. doi: 10.1016/j.psychres.2019.112683.
    PubMed     Abstract available


  212. OLIVERI LN, Awerbuch AW, Jarskog LF, Penn DL, et al
    Depression predicts self assessment of social function in both patients with schizophrenia and healthy people.
    Psychiatry Res. 2019 Nov 6:112681. doi: 10.1016/j.psychres.2019.112681.
    PubMed     Abstract available


  213. GROSSMAN MJ, Woolridge S, Lichtenstein S, McLaughlin D, et al
    Patterns and perceptions of face-to-face and digital communication in the clinical high risk and early stages of psychosis.
    Psychiatry Res. 2019 Nov 5:112667. doi: 10.1016/j.psychres.2019.112667.
    PubMed     Abstract available


  214. WRIGHT A, Fowler D, Greenwood K
    Influences on functional outcome and subjective recovery in individuals with and without First Episode Psychosis: A metacognitive model.
    Psychiatry Res. 2019 Nov 2:112643. doi: 10.1016/j.psychres.2019.112643.
    PubMed     Abstract available


  215. SMITH RC, Md WL, Wang Y, Jiang J, et al
    Effects of transcranial direct current stimulation on cognition and symptoms in Chinese patients with schizophrenia().
    Psychiatry Res. 2019 Nov 2:112617. doi: 10.1016/j.psychres.2019.112617.
    PubMed     Abstract available


  216. SHIMADA T, Ito S, Makabe A, Yamanushi A, et al
    Aerobic exercise and cognitive functioning in schizophrenia: A pilot randomized controlled trial.
    Psychiatry Res. 2019 Nov 1:112638. doi: 10.1016/j.psychres.2019.112638.
    PubMed     Abstract available


    October 2019
  217. DE LA IGLESIA-LARRAD JI, Barral C, Casado-Espada NM, de Alarcon R, et al
    Benzodiazepine abuse, misuse, dependence, and withdrawal among schizophrenic patients: A review of the literature.
    Psychiatry Res. 2019 Oct 28:112660. doi: 10.1016/j.psychres.2019.112660.
    PubMed     Abstract available


  218. CHISHOLM K, Pelton M, Duncan N, Kidd K, et al
    A cross-sectional examination of the clinical significance of autistic traits in individuals experiencing a first episode of psychosis.
    Psychiatry Res. 2019 Oct 18:112623. doi: 10.1016/j.psychres.2019.112623.
    PubMed     Abstract available


  219. VANCAMPFORT D, Kimbowa S, Basangwa D, Smith L, et al
    Test-retest reliability, concurrent validity and correlates of the two-minute walk test in outpatients with psychosis.
    Psychiatry Res. 2019;282:112619.
    PubMed     Abstract available


  220. LI XB, Wang LB, Xiong YB, Bo QJ, et al
    Altered resting-state functional connectivity of the insula in individuals with clinical high-risk and patients with first-episode schizophrenia.
    Psychiatry Res. 2019;282:112608.
    PubMed     Abstract available


  221. MA X, Zheng W, Li C, Li Z, et al
    Decreased regional homogeneity and increased functional connectivity of default network correlated with neurocognitive deficits in subjects with genetic high-risk for schizophrenia: A resting-state fMRI study.
    Psychiatry Res. 2019;281:112603.
    PubMed     Abstract available


  222. PEPPER KL, Demetriou EA, Park SH, Boulton KA, et al
    Self-reported empathy in adults with autism, early psychosis, and social anxiety disorder.
    Psychiatry Res. 2019;281:112604.
    PubMed     Abstract available


  223. CHANG CH, Lane HY, Liu CY, Chen SJ, et al
    Paliperidone is associated with reduced risk of severe hepatic outcome in patients with schizophrenia and viral hepatitis: A nationwide population-based cohort study.
    Psychiatry Res. 2019;281:112597.
    PubMed     Abstract available


  224. ZHOU Q, Chan RCK, Yu X, Zheng M, et al
    Modification and validation of a performance-based functional capacity instrument for individuals with schizophrenia.
    Psychiatry Res. 2019;281:112572.
    PubMed     Abstract available


    September 2019
  225. WALLACE S, Morton SE, Linscott RJ
    Relationships between intra-individual variability and subclinical psychosis.
    Psychiatry Res. 2019;281:112592.
    PubMed     Abstract available


  226. NDETEI D, Pike K, Mutiso V, Tele A, et al
    The psychometric properties of the Washington Early Recognition Center Affectivity and Psychosis (WERCAP) screen in adults in the Kenyan context: Towards combined large scale community screening for affectivity and psychosis.
    Psychiatry Res. 2019 Sep 17:112569. doi: 10.1016/j.psychres.2019.112569.
    PubMed     Abstract available


  227. ALLI S, Tasmim S, Adanty C, Graff A, et al
    Childhood trauma predicts multiple, high lethality suicide attempts in patients with schizophrenia.
    Psychiatry Res. 2019;281:112567.
    PubMed     Abstract available


  228. GARCIA-FERNANDEZ L, Cabot-Ivorra N, Rodriguez-Garcia V, Perez-Martin J, et al
    Computerized cognitive remediation therapy, REHACOM, in first episode of schizophrenia: A randomized controlled trial.
    Psychiatry Res. 2019;281:112563.
    PubMed     Abstract available


  229. GORWOOD P, Bouju S, Deal C, Gary C, et al
    Predictive factors of functional remission in patients with early to mid-stage schizophrenia treated by long acting antipsychotics and the specific role of clinical remission.
    Psychiatry Res. 2019;281:112560.
    PubMed     Abstract available


  230. NYBOE L, Lemcke S, Moller AV, Stubbs B, et al
    Non-pharmacological interventions for preventing weight gain in patients with first episode schizophrenia or bipolar disorder: A systematic review.
    Psychiatry Res. 2019;281:112556.
    PubMed     Abstract available


  231. ENGEN MJ, Simonsen C, Melle I, Faerden A, et al
    Cognitive functioning in patients with first-episode psychosis stratified by level of negative symptoms: A 1-year follow-up study.
    Psychiatry Res. 2019;281:112554.
    PubMed     Abstract available


  232. ALLSOPP K, Read J, Corcoran R, Kinderman P, et al
    Heterogeneity in psychiatric diagnostic classification.
    Psychiatry Res. 2019;279:15-22.
    PubMed     Abstract available


    August 2019
  233. REID S, Bhattacharyya S
    Antipsychotic treatment failure in patients with psychosis and co-morbid cannabis use: A systematic review.
    Psychiatry Res. 2019;280:112523.
    PubMed     Abstract available


  234. FANG X, Chen L, Wang D, Yu L, et al
    Metabolic profiling identifies TC and LDL as potential serum biomarkers for depressive symptoms in schizophrenia.
    Psychiatry Res. 2019;281:112522.
    PubMed     Abstract available


  235. GONZALEZ-BLANCO L, Garcia-Portilla MP, Dal Santo F, Garcia-Alvarez L, et al
    Predicting real-world functioning in outpatients with schizophrenia: Role of inflammation and psychopathology.
    Psychiatry Res. 2019;280:112509.
    PubMed     Abstract available


  236. VAN OMMEN MM, van Laar T, Cornelissen FW, Bruggeman R, et al
    Visual hallucinations in psychosis.
    Psychiatry Res. 2019;280:112517.
    PubMed     Abstract available


  237. THOMAS N, Gurvich C, Hudaib AR, Gavrilidis E, et al
    Dissecting the syndrome of schizophrenia: Associations between symptomatology and hormone levels in women with schizophrenia.
    Psychiatry Res. 2019;280:112510.
    PubMed     Abstract available


  238. LODHI RJ, Wang Y, Macintyre G, Crocker C, et al
    Trend level gene-gender interaction effect for the BDNF rs6265 variant on age of onset of psychosis.
    Psychiatry Res. 2019;280:112500.
    PubMed     Abstract available


  239. COMACCHIO C, Lasalvia A, Ruggeri M
    Current evidence of childhood traumatic experiences in psychosis - focus on gender differences.
    Psychiatry Res. 2019;281:112507.
    PubMed     Abstract available


  240. GOINES KB, LoPilato AM, Addington J, Bearden CE, et al
    Sleep problems and attenuated psychotic symptoms in youth at clinical high-risk for psychosis.
    Psychiatry Res. 2019 Aug 3:112492. doi: 10.1016/j.psychres.2019.112492.
    PubMed     Abstract available


  241. WALSH-MESSINGER J, Jiang H, Lee H, Rothman K, et al
    Relative importance of symptoms, cognition, and other multilevel variables for psychiatric disease classifications by machine learning.
    Psychiatry Res. 2019;278:27-34.
    PubMed     Abstract available


  242. DE BOER JN, Vingerhoets C, Hirdes M, McAlonan GM, et al
    Efficacy and tolerability of riluzole in psychiatric disorders: A systematic review and preliminary meta-analysis.
    Psychiatry Res. 2019;278:294-302.
    PubMed     Abstract available


  243. KUO SS, Wojtalik JA, Mesholam-Gately RI, Keshavan MS, et al
    Establishing a standard emotion processing battery for treatment evaluation in adults with autism spectrum disorder: Evidence supporting the Mayer-Salovey-Caruso Emotion Intelligence Test (MSCEIT).
    Psychiatry Res. 2019;278:116-124.
    PubMed     Abstract available


    July 2019
  244. OWENS SJ, Purves-Tyson TD, Webster MJ, Shannon Weickert C, et al
    Evidence for enhanced androgen action in the prefrontal cortex of people with bipolar disorder but not schizophrenia or major depressive disorder.
    Psychiatry Res. 2019;280:112503.
    PubMed     Abstract available


  245. HAHN B, Shrieves ME, Yuille MB, Buchanan RW, et al
    Nicotine effects on cognitive remediation training outcome in people with schizophrenia: A pilot study.
    Psychiatry Res. 2019;280:112498.
    PubMed     Abstract available


  246. WEICKERT TW, Salimuddin H, Lenroot RK, Bruggemann J, et al
    Preliminary findings of four-week, task-based anodal prefrontal cortex transcranial direct current stimulation transferring to other cognitive improvements in schizophrenia.
    Psychiatry Res. 2019;280:112487.
    PubMed     Abstract available


  247. DIAZ-FERNANDEZ S, Frias-Ortiz DF, Fernandez-Miranda JJ
    Suicide attempts in people with schizophrenia before and after participating in an intensive case managed community program: A 20-year follow-up.
    Psychiatry Res. 2019 Jul 10:112479. doi: 10.1016/j.psychres.2019.112479.
    PubMed     Abstract available


  248. CARTER JW, Nordgaard J, Parnas J
    Identifying non-affective psychosis in first admission patients: MMPI-2, structured diagnostic interview, and consensus lifetime best estimate.
    Psychiatry Res. 2019;279:71-76.
    PubMed     Abstract available


  249. HAZLETT EA, Vaccaro DH, Haznedar MM, Goldstein KE, et al
    Reprint of: (F-18)Fluorodeoxyglucose positron emission tomography studies of the schizophrenia spectrum: The legacy of Monte S. Buchsbaum, M.D.
    Psychiatry Res. 2019;277:39-44.
    PubMed     Abstract available


  250. MAK M, Tyburski E, Starkowska A, Karabanowicz E, et al
    The efficacy of computer-based cognitive training for executive dysfunction in schizophrenia.
    Psychiatry Res. 2019;279:62-70.
    PubMed     Abstract available


  251. F MIRSKY A
    Monte S. Buchsbaum and the Genain Quadruplets.
    Psychiatry Res. 2019;277:70-71.
    PubMed     Abstract available


    June 2019
  252. MALASPINA D, Walsh-Messinger J, Brunner A, Rahman N, et al
    Features of schizophrenia following premorbid eating disorders.
    Psychiatry Res. 2019;278:275-280.
    PubMed     Abstract available


  253. ARSALAN A, Iqbal Z, Tariq M, Ayonrinde O, et al
    Association of smoked cannabis with treatment resistance in schizophrenia.
    Psychiatry Res. 2019;278:242-247.
    PubMed     Abstract available


  254. TOH WL, McCarthy-Jones S, Copolov D, Rossell SL, et al
    Have we overlooked the significance of multinodal hallucinations in schizophrenia?
    Psychiatry Res. 2019 Jun 18. pii: S0165-1781(19)31048.
    PubMed     Abstract available


  255. MILLER AP, Gizer IR, Fleming Iii WA, Otto JM, et al
    Polygenic liability for schizophrenia predicts shifting-specific executive function deficits and tobacco use in a moderate drinking community sample.
    Psychiatry Res. 2019;279:47-54.
    PubMed     Abstract available


  256. MYLLYAHO T, Siira V, Wahlberg KE, Hakko H, et al
    Interaction of genetic vulnerability to schizophrenia and family functioning in adopted-away offspring of mothers with schizophrenia.
    Psychiatry Res. 2019;278:205-212.
    PubMed     Abstract available


  257. SCHWAB SG
    Dissecting the molecular biology of schizophrenia: A call for emphasising genetic and phenotypic heterogeneity: commentary on Torrey and Yolken (this issue).
    Psychiatry Res. 2019 Jun 4. pii: S0165-1781(19)31208.
    PubMed    


  258. TORREY EF, Yolken RH
    Schizophrenia as a pseudogenetic disease: A call for more gene-environmental studies.
    Psychiatry Res. 2019;278:146-150.
    PubMed     Abstract available


  259. FUNAHASHI Y, Yoshino Y, Yamazaki K, Ozaki Y, et al
    Analysis of methylation and -141C Ins/Del polymorphisms of the dopamine receptor D2 gene in patients with schizophrenia.
    Psychiatry Res. 2019;278:135-140.
    PubMed     Abstract available


  260. CURLEY A, Murphy R, Plunkett R, Kelly BD, et al
    Concordance of mental capacity assessments based on legal and clinical criteria: A cross-sectional study of psychiatry inpatients.
    Psychiatry Res. 2019;276:160-166.
    PubMed     Abstract available


    May 2019
  261. WILKINS LK, Girard TA, Christensen BK, King J, et al
    Spontaneous spatial navigation circuitry in schizophrenia spectrum disorders.
    Psychiatry Res. 2019;278:125-128.
    PubMed     Abstract available


  262. VILLAGONZALO KA, Arnold C, Farhall J, Rossell SL, et al
    Predictors of overall and mental health-related internet use in adults with psychosis.
    Psychiatry Res. 2019;278:12-18.
    PubMed     Abstract available


  263. GROVER S, R P, Sahoo S, Gopal S, et al
    Relationship of metabolic syndrome and neurocognitive deficits in patients with schizophrenia.
    Psychiatry Res. 2019;278:56-64.
    PubMed     Abstract available


  264. CHATZIIOANNIDIS S, Andreou C, Agorastos A, Kaprinis S, et al
    The role of attachment anxiety in the relationship between childhood trauma and schizophrenia-spectrum psychosis.
    Psychiatry Res. 2019;276:223-231.
    PubMed     Abstract available


  265. FREITAS R, Dos Santos B, Altamura C, Bernasconi C, et al
    Can the Positive and Negative Syndrome scale (PANSS) differentiate treatment-resistant from non-treatment-resistant schizophrenia? A factor analytic investigation based on data from the Pattern cohort study.
    Psychiatry Res. 2019;276:210-217.
    PubMed     Abstract available


  266. PALOMAR-CIRIA N, Cegla-Schvartzman F, Lopez-Morinigo JD, Bello HJ, et al
    Diagnostic stability of schizophrenia: A systematic review.
    Psychiatry Res. 2019 May 2. pii: S0165-1781(18)32033.
    PubMed     Abstract available


  267. ZIVKOVIC M, Mihaljevic-Peles A, Muck-Seler D, Sagud M, et al
    The lack of association between COMT rs4680 polymorphism and symptomatic remission to olanzapine monotherapy in male schizophrenic patients: A longitudinal study.
    Psychiatry Res. 2019 May 1. pii: S0165-1781(19)30980.
    PubMed    


  268. CHIANG M, Reid-Varley WB, Fan X
    Creative art therapy for mental illness.
    Psychiatry Res. 2019;275:129-136.
    PubMed     Abstract available


  269. LIU BH, Huang J, Shan HD, Liu YF, et al
    Humour processing deficits in individuals with social anhedonia.
    Psychiatry Res. 2019;275:345-350.
    PubMed     Abstract available


  270. AKUN E, Batigun AD
    Negative symptoms and recollections of parental rejection: The moderating roles of psychological maladjustment and gender.
    Psychiatry Res. 2019;275:332-337.
    PubMed     Abstract available


    April 2019
  271. WATKINS A, John A, Bradshaw C, Jones J, et al
    Schizophrenia in high risk opioid users: A short communication on an autopsy study.
    Psychiatry Res. 2019;276:112-114.
    PubMed     Abstract available


  272. BERGER P, Bitsch F, Jakobi B, Nagels A, et al
    Cognitive and emotional empathy in patients with schizophrenia spectrum disorders: A replication and extension study.
    Psychiatry Res. 2019;276:56-59.
    PubMed     Abstract available


  273. NUTTALL AK, Thakkar KN, Luo X, Mueser KT, et al
    Longitudinal associations of family burden and patient quality of life in the context of first-episode schizophrenia in the RAISE-ETP study.
    Psychiatry Res. 2019;276:60-68.
    PubMed     Abstract available


  274. KAFALI HY, Bildik T, Bora E, Yuncu Z, et al
    Distinguishing prodromal stage of bipolar disorder and early onset schizophrenia spectrum disorders during adolescence.
    Psychiatry Res. 2019;275:315-325.
    PubMed     Abstract available


  275. ZHUO C, Jiang D, Liu C, Lin X, et al
    Understanding auditory verbal hallucinations in healthy individuals and individuals with psychiatric disorders.
    Psychiatry Res. 2019;274:213-219.
    PubMed     Abstract available


    March 2019
  276. HU TM, Chen SJ, Hsu SH, Cheng MC, et al
    Functional analyses and effect of DNA methylation on the EGR1 gene in patients with schizophrenia.
    Psychiatry Res. 2019;275:276-282.
    PubMed     Abstract available


  277. CHAN EHC, Kong SDX, Park SH, Song YJC, et al
    Validation of the social functioning scale: Comparison and evaluation in early psychosis, autism spectrum disorder and social anxiety disorder.
    Psychiatry Res. 2019;276:45-55.
    PubMed     Abstract available


  278. ABOU KASSM S, Hoertel N, Naja W, McMahon K, et al
    Metabolic syndrome among older adults with schizophrenia spectrum disorder: Prevalence and associated factors in a multicenter study.
    Psychiatry Res. 2019;275:238-246.
    PubMed     Abstract available


  279. TORREGROSSA LJ, Bian D, Wade J, Adery LH, et al
    Decoupling of spontaneous facial mimicry from emotion recognition in schizophrenia.
    Psychiatry Res. 2019;275:169-176.
    PubMed     Abstract available


  280. KITOKO GMB, Maurage P, Peyroux E, Ma Miezi SM, et al
    Do patients from the Democratic Republic of Congo with schizophrenia have facial emotion recognition deficits?
    Psychiatry Res. 2019;275:233-237.
    PubMed     Abstract available


  281. DAOD E, Krivoy A, Shoval G, Zubedat S, et al
    Psychiatrists' attitude towards the use of clozapine in the treatment of refractory schizophrenia: A nationwide survey.
    Psychiatry Res. 2019;275:155-161.
    PubMed     Abstract available


  282. UCOK A, Yagcioglu EA, Yildiz M, Kaymak SU, et al
    Reasons for clozapine discontinuation in patients with treatment-resistant schizophrenia.
    Psychiatry Res. 2019;275:149-154.
    PubMed     Abstract available


  283. LEE KH
    A randomized controlled trial of mindfulness in patients with schizophrenia().
    Psychiatry Res. 2019;275:137-142.
    PubMed     Abstract available


  284. ARRARAS JI, Ibanez B, Pereda N, Iribarren S, et al
    The association of clinical insight and depression with quality of life in schizophrenia.
    Psychiatry Res. 2019 Mar 19:12285. doi: 10.1016/j.psychres.2019.
    PubMed     Abstract available


  285. DEL CACHO N, Butjosa A, Vila-Badia R, Cuadras D, et al
    Prolactin levels in drug-naive first episode nonaffective psychosis patients compared with healthy controls. Sex differences.
    Psychiatry Res. 2019;276:218-222.
    PubMed     Abstract available


  286. XU SW, Dong M, Zhang Q, Yang SY, et al
    Clozapine prescription pattern in patients with schizophrenia in Asia: The REAP survey (2016).
    Psychiatry Res. 2019 Mar 15. pii: S0165-1781(18)32218.
    PubMed     Abstract available


  287. PELLET J, Golay P, Nguyen A, Suter C, et al
    The relationship between self-stigma and depression among people with schizophrenia-spectrum disorders: A longitudinal study.
    Psychiatry Res. 2019;275:115-119.
    PubMed     Abstract available


  288. MOHAMMADZADEH A, Azadi S, King S, Khosravani V, et al
    Childhood trauma and the likelihood of increased suicidal risk in schizophrenia.
    Psychiatry Res. 2019;275:100-107.
    PubMed     Abstract available


  289. VOGEL JS, van der Gaag M, Slofstra C, Knegtering H, et al
    The effect of mind-body and aerobic exercise on negative symptoms in schizophrenia: A meta-analysis.
    Psychiatry Res. 2019 Mar 14. pii: S0165-1781(19)30017.
    PubMed     Abstract available


  290. GOLAY P, Baumann PS, Jaton L, Restellini R, et al
    Migration in patients with early psychosis: A 3-year prospective follow-up study.
    Psychiatry Res. 2019;275:108-114.
    PubMed     Abstract available


  291. IKONEN H, Palaniswamy S, Nordstrom T, Jarvelin MR, et al
    Vitamin D status and correlates of low vitamin D in schizophrenia, other psychoses and non-psychotic depression - The Northern Finland Birth Cohort 1966 study.
    Psychiatry Res. 2019 Mar 12. pii: S0165-1781(18)32026.
    PubMed     Abstract available


  292. GIRGIS RR, Baker S, Mao X, Gil R, et al
    Effects of acute N-acetylcysteine challenge on cortical glutathione and glutamate in schizophrenia: A pilot in vivo proton magnetic resonance spectroscopy study.
    Psychiatry Res. 2019;275:78-85.
    PubMed     Abstract available


  293. FEOLA B, Armstrong K, Woodward ND, Heckers S, et al
    Childhood temperament is associated with distress, anxiety and reduced quality of life in schizophrenia spectrum disorders.
    Psychiatry Res. 2019;275:196-203.
    PubMed     Abstract available


  294. FERNANDES TP, Shaqiri A, Brand A, Nogueira RL, et al
    Schizophrenia patients using atypical medication perform better in visual tasks than patients using typical medication.
    Psychiatry Res. 2019;275:31-38.
    PubMed     Abstract available


  295. WU TH, Chiu CC, Chen PY, Huang MC, et al
    Obsessive-compulsive symptoms in patients with schizophrenia: Relationships with olanzapine pharmacological parameters, psychopathology, and quality of life.
    Psychiatry Res. 2019;276:1-5.
    PubMed     Abstract available


  296. ABDIN E, Chong SA, Seow E, Peh CX, et al
    A comparison of the reliability and validity of SF-6D, EQ-5D and HUI3 utility measures in patients with schizophrenia and patients with depression in Singapore.
    Psychiatry Res. 2019;274:400-408.
    PubMed     Abstract available


  297. BOLL KM, Noto C, Bonifacio KL, Bortolasci CC, et al
    Corrigendum to "Oxidative and nitrosative stress biomarkers in chronic schizophrenia".
    Psychiatry Res. 2019;273:809.
    PubMed    


  298. XU C, Yang X, Sun L, Yang T, et al
    An investigation of calcium-independent phospholipase A2 (iPLA2) and cytosolic phospholipase A2 (cPLA2) in schizophrenia.
    Psychiatry Res. 2019;273:782-787.
    PubMed     Abstract available


  299. YOUN T, Jeong SH, Kim YS, Chung IW, et al
    Long-term clinical efficacy of maintenance electroconvulsive therapy in patients with treatment-resistant schizophrenia on clozapine.
    Psychiatry Res. 2019;273:759-766.
    PubMed     Abstract available


  300. GALLI L, Del Grande C, Rindi L, Mangia C, et al
    Lack of circulating toxoplasma gondii DNA in seropositive patients with bipolar or schizophrenia spectrum disorders.
    Psychiatry Res. 2019;273:706-711.
    PubMed     Abstract available


  301. VIDARSDOTTIR OG, Roberts DL, Twamley EW, Gudmundsdottir B, et al
    Integrative cognitive remediation for early psychosis: Results from a randomized controlled trial.
    Psychiatry Res. 2019;273:690-698.
    PubMed     Abstract available


  302. LIAN J, Deng C
    Early antipsychotic exposure affects NMDA and GABAA receptor binding in the brains of juvenile rats.
    Psychiatry Res. 2019;273:739-745.
    PubMed     Abstract available


  303. DEROSSE P, Barber AD, Fales CL, Malhotra AK, et al
    Deconstructing Avolition: Initiation vs persistence of reward-directed effort.
    Psychiatry Res. 2019;273:647-652.
    PubMed     Abstract available


  304. YANG F, Fang X, Tang W, Hui L, et al
    Effects and potential mechanisms of transcranial direct current stimulation (tDCS) on auditory hallucinations: A meta-analysis.
    Psychiatry Res. 2019;273:343-349.
    PubMed     Abstract available


    February 2019
  305. TEMESGEN WA, Chien WT, Bressington D
    Factors influencing subjective recovery of people with recent-onset psychosis: A cross-sectional study in a low-income Sub-Saharan country.
    Psychiatry Res. 2019;274:421-429.
    PubMed     Abstract available


  306. TEMESGEN WA, Chien WT, Bressington D
    Factors influencing subjective recovery of people with recent-onset psychosis: A cross-sectional study in a low-income sub-Saharan country.
    Psychiatry Res. 2019 Feb 27:12282. doi: 10.1016/j.psychres.2019.
    PubMed     Abstract available


  307. BELANGERO SI, Ota VK, Gadelha A, Berberian AA, et al
    DGCR2 influences cortical thickness through a mechanism independent of schizophrenia pathogenesis.
    Psychiatry Res. 2019;274:391-394.
    PubMed     Abstract available


  308. LEE EE, Martin AS, Kaufmann CN, Liu J, et al
    Comparison of schizophrenia outpatients in residential care facilities with those living with someone: Study of mental and physical health, cognitive functioning, and biomarkers of aging.
    Psychiatry Res. 2019;275:162-168.
    PubMed     Abstract available


  309. KIM SJ, Hong YJ, Kim MW, Jung YH, et al
    Inflexible eye fixation pattern in schizophrenia affecting decision-making on daily life.
    Psychiatry Res. 2019;274:414-420.
    PubMed     Abstract available


  310. OKRUSZEK L, Jarkiewicz M, Szrubarz P, Wichniak A, et al
    Many ways to forget - Neurophysiology of directed forgetting mechanisms in schizophrenia.
    Psychiatry Res. 2019;274:358-364.
    PubMed     Abstract available


  311. SONG J, Borlido C, De Luca V, Burton L, et al
    Patient versus rater evaluation of symptom severity in treatment resistant schizophrenia receiving clozapine.
    Psychiatry Res. 2019;274:409-413.
    PubMed     Abstract available


  312. DEL RE EC, Bouix S, Fitzsimmons J, Blokland GAM, et al
    Diffusion abnormalities in the corpus callosum in first episode schizophrenia: Associated with enlarged lateral ventricles and symptomatology.
    Psychiatry Res. 2019 Feb 18. pii: S0165-1781(19)30342.
    PubMed     Abstract available


  313. SI TM, Zhang YL, Feng Y, Zhuo JM, et al
    Association between symptom control and functional improvement in patients with acute schizophrenia: A post hoc analysis of an open-label, single-arm, multi-center study of paliperidone-extended release formulation.
    Psychiatry Res. 2019;274:301-305.
    PubMed     Abstract available


  314. CORRELL CU, Stanford AD, Claxton A, Du Y, et al
    Social and functional outcomes with two doses of aripiprazole lauroxil vs placebo in patients with schizophrenia: a post-hoc analysis of a 12-week phase 3 efficacy study.
    Psychiatry Res. 2019;274:176-181.
    PubMed     Abstract available


  315. BARRY EF, Vanes LD, Andrews DS, Patel K, et al
    Mapping cortical surface features in treatment resistant schizophrenia with in vivo structural MRI.
    Psychiatry Res. 2019;274:335-344.
    PubMed     Abstract available


  316. KALINOWSKA S, Trzesniowska-Drukala B, Safranow K, Pelka-Wysiecka J, et al
    Association between thyroid function and metabolic syndrome in male and female schizophrenia patients.
    Psychiatry Res. 2019;274:167-175.
    PubMed     Abstract available


  317. RAKHSHAN ROUHAKHTAR PJ, Pitts SC, Millman ZB, Andorko ND, et al
    The impact of age on the validity of psychosis-risk screening in a sample of help-seeking youth.
    Psychiatry Res. 2019;274:30-35.
    PubMed     Abstract available


  318. DURING SW, Nielsen MO, Bak N, Glenthoj BY, et al
    Sexual dysfunction and hyperprolactinemia in schizophrenia before and after six weeks of D2/3 receptor blockade - An exploratory study.
    Psychiatry Res. 2019;274:58-65.
    PubMed     Abstract available


  319. NIZNIKIEWICZ MA
    Neurobiological approaches to the study of clinical and genetic high risk for developing psychosis.
    Psychiatry Res. 2019 Feb 5. pii: S0165-1781(18)32301.
    PubMed     Abstract available


  320. HWANG DK, Nam M, Lee YG
    The effect of cognitive behavioral therapy for insomnia in schizophrenia patients with sleep Disturbance: A non-randomized, assessor-blind trial.
    Psychiatry Res. 2019;274:182-188.
    PubMed     Abstract available


  321. LIU Y, Wang G, Jin H, Lyu H, et al
    Cognitive deficits in subjects at risk for psychosis, first-episode and chronic schizophrenia patients.
    Psychiatry Res. 2019;274:235-242.
    PubMed     Abstract available


  322. MIKE L, Guimond S, Kelly S, Thermenos H, et al
    Social cognition in early course of schizophrenia: Exploratory factor analysis.
    Psychiatry Res. 2019;272:737-743.
    PubMed     Abstract available


  323. BUCHMANN CB, Pedersen G, Aminoff SR, Laskemoen JF, et al
    Validity of the Birchwood insight scale in patients with schizophrenia spectrum- and bipolar disorders.
    Psychiatry Res. 2019;272:715-722.
    PubMed     Abstract available


  324. FAGIOLINI A, Aguglia E, Ballerini A, Callista G, et al
    Real-world effectiveness of long acting aripiprazole: Treatment persistence and its correlates in the Italian clinical practice.
    Psychiatry Res. 2019;272:698-706.
    PubMed     Abstract available


    January 2019
  325. PALMA C, Farriols N, Frias A, Canete J, et al
    Randomized controlled trial of cognitive-motivational therapy program (PIPE) for the initial phase of schizophrenia: Maintenance of efficacy at 5-year follow up().
    Psychiatry Res. 2019;273:586-594.
    PubMed     Abstract available


  326. DORE-GAUTHIER V, Cote H, Jutras-Aswad D, Ouellet-Plamondon C, et al
    How to help homeless youth suffering from first episode psychosis and substance use disorders? The creation of a new intensive outreach intervention team.
    Psychiatry Res. 2019;273:603-612.
    PubMed     Abstract available


  327. CHENG Z, Yuan Y, Han X, Yang L, et al
    Rates and predictors of one-year antipsychotic treatment discontinuation in first-episode schizophrenia: Results from an open-label, randomized, "real world" clinical trial.
    Psychiatry Res. 2019;273:631-640.
    PubMed     Abstract available


  328. YANG Y, Liu Y, Wang G, Hei G, et al
    Brain-derived neurotrophic factor is associated with cognitive impairments in first-episode and chronic schizophrenia.
    Psychiatry Res. 2019;273:528-536.
    PubMed     Abstract available


  329. LIEN YJ, Kao YC
    Public beliefs and attitudes toward schizophrenia and depression in Taiwan: A nationwide survey.
    Psychiatry Res. 2019;273:435-442.
    PubMed     Abstract available


  330. HUANG ZH, Hou CL, Huang YH, He XY, et al
    Individuals at high risk for psychosis experience more childhood trauma, life events and social support deficit in comparison to healthy controls.
    Psychiatry Res. 2019;273:296-302.
    PubMed     Abstract available


  331. GOTOH L, Yamada M, Hattori K, Sasayama D, et al
    Levels of lysophosphatidic acid in cerebrospinal fluid and plasma of patients with schizophrenia.
    Psychiatry Res. 2019;273:331-335.
    PubMed     Abstract available


  332. HARVEY PD, Khan A, Atkins A, Keefe RS, et al
    Virtual reality assessment of functional capacity in people with Schizophrenia: Associations with reduced emotional experience and prediction of functional outcomes.
    Psychiatry Res. 2019 Jan 15. pii: S0165-1781(18)32384.
    PubMed     Abstract available


  333. CALIGIURI MP, Teulings HL, Dean CE, Lohr JB, et al
    The nature of bradykinesia in schizophrenia treated with antipsychotics.
    Psychiatry Res. 2019;273:537-543.
    PubMed     Abstract available


  334. OSPINA LH, Shanahan M, Perez-Rodriguez MM, Chan CC, et al
    Alexithymia predicts poorer social and everyday functioning in schizophrenia and bipolar disorder.
    Psychiatry Res. 2019;273:218-226.
    PubMed     Abstract available


  335. ANDORKO ND, Rakhshan-Rouhakhtar P, Hinkle C, Mittal VA, et al
    Assessing validity of retrospective recall of physical activity in individuals with psychosis-like experiences.
    Psychiatry Res. 2019;273:211-217.
    PubMed     Abstract available


  336. CARRUTHERS SP, Cropley V, Bousman C, Everall IP, et al
    The effects of a muscarinic receptor 1 gene variant on executive and non-executive cognition in schizophrenia spectrum disorders.
    Psychiatry Res. 2019;273:178-180.
    PubMed     Abstract available


  337. KREZOLEK M, Pionke R, Banaszak B, Kokoszka A, et al
    The relationship between jumping to conclusions and neuropsychological functioning in schizophrenia.
    Psychiatry Res. 2019;273:443-449.
    PubMed     Abstract available


  338. SEOW LSE, Tan THG, Abdin E, Chong SA, et al
    Comparing disease-specific and generic quality of life measures in patients with schizophrenia.
    Psychiatry Res. 2019;273:387-393.
    PubMed     Abstract available


  339. KARGAR M, Askari S, Khoshaman A, Mohammadi A, et al
    Differential diagnosis of schizophrenia and schizoaffective disorder from normal subjects using virtual reality.
    Psychiatry Res. 2019;273:378-386.
    PubMed     Abstract available


  340. TRAUELSEN AM, Gumley A, Jansen JE, Pedersen MB, et al
    Does childhood trauma predict poorer metacognitive abilities in people with first-episode psychosis?
    Psychiatry Res. 2019;273:163-170.
    PubMed     Abstract available


  341. SIMOILA L, Isometsa E, Gissler M, Suvisaari J, et al
    Maternal schizophrenia and out-of-home placements of offspring: A national follow-up study among Finnish women born 1965-1980 and their children.
    Psychiatry Res. 2019;273:9-14.
    PubMed     Abstract available


  342. ZOURARAKI C, Karagiannopoulou L, Karamaouna P, Pallis EG, et al
    Schizotypal traits, neurocognition, and paternal age in unaffected first degree relatives of patients with familial or sporadic schizophrenia.
    Psychiatry Res. 2019;273:422-429.
    PubMed     Abstract available


  343. MORGADES-BAMBA CI, Fuster-Ruizdeapodaca MJ, Molero F
    The impact of internalized stigma on the well-being of people with Schizophrenia.
    Psychiatry Res. 2019;271:621-627.
    PubMed     Abstract available


  344. RICHTER J, Hesse K, Schreiber L, Burmeister CP, et al
    Evidence for two distinct domains of negative symptoms: Confirming the factorial structure of the CAINS.
    Psychiatry Res. 2019;271:693-701.
    PubMed     Abstract available


  345. KALLAI J, Rozsa S, Hupuczi E, Hargitai R, et al
    Cognitive fusion and affective isolation: Blurred self-concept and empathy deficits in schizotypy.
    Psychiatry Res. 2019;271:178-186.
    PubMed     Abstract available


    December 2018
  346. CHAN CC, Shanahan M, Ospina LH, Larsen EM, et al
    Premorbid adjustment trajectories in schizophrenia and bipolar disorder: A transdiagnostic cluster analysis.
    Psychiatry Res. 2018;272:655-662.
    PubMed     Abstract available


  347. YANG H, Jiang Y, Chen Z, Wu J, et al
    A study of anti-gliadin antibodies in first-episode patients with schizophrenia among a Chinese population.
    Psychiatry Res. 2018;272:454-457.
    PubMed     Abstract available


  348. KURTZ MM, Gopal S, John S, Thara R, et al
    Objective psychosocial function vs. subjective quality-of-life in schizophrenia within 5-years after diagnosis: A study from southern India.
    Psychiatry Res. 2018;272:419-424.
    PubMed     Abstract available


  349. LI MZ, Chen LC, Rong H, Xu SX, et al
    Low-charge electrotherapy for patients with schizophrenia: A double-blind, randomised controlled pilot clinical trial.
    Psychiatry Res. 2018;272:676-681.
    PubMed     Abstract available


  350. LAMPROPOULOS D, Fonte D, Apostolidis T
    Exploring the link between stigma and social representations among people with and without schizophrenia in the French context.
    Psychiatry Res. 2018;272:595-601.
    PubMed     Abstract available


  351. KOZLOWSKA E, Agier J, Wysokinski A, Lucka A, et al
    The expression of toll-like receptors in peripheral blood mononuclear cells is altered in schizophrenia.
    Psychiatry Res. 2018;272:540-550.
    PubMed     Abstract available


  352. ALFIMOVA M, Kondratyev N, Golov A, Golimbet V, et al
    Relationship between Alzheimer's disease-associated SNPs within the CLU gene, local DNA methylation and episodic verbal memory in healthy and schizophrenia subjects.
    Psychiatry Res. 2018;272:380-386.
    PubMed     Abstract available


  353. NAGELS A, Kircher T, Grosvald M, Steines M, et al
    Evidence for gesture-speech mismatch detection impairments in schizophrenia.
    Psychiatry Res. 2018;273:15-21.
    PubMed     Abstract available


  354. NAKATA S, Yoshino Y, Okita M, Kawabe K, et al
    Differential expression of the ghrelin-related mRNAs GHS-R1a, GHS-R1b, and MBOAT4 in Japanese patients with schizophrenia.
    Psychiatry Res. 2018;272:334-339.
    PubMed     Abstract available


  355. LIU Y, Yang X, Gillespie A, Guo Z, et al
    Targeting relapse prevention and positive symptom in first-episode schizophrenia using brief cognitive behavioral therapy: A pilot randomized controlled study.
    Psychiatry Res. 2018;272:275-283.
    PubMed     Abstract available


  356. BYRNE M, Codjoe L, Morgan C, Stahl D, et al
    The relationship between ethnicity and service access, treatment uptake and the incidence of psychosis among people at ultra high risk for psychosis.
    Psychiatry Res. 2018;272:618-627.
    PubMed     Abstract available


  357. THAI ML, Andreassen AK, Bliksted V
    A meta-analysis of executive dysfunction in patients with schizophrenia: Different degree of impairment in the ecological subdomains of the Behavioural Assessment of the Dysexecutive Syndrome.
    Psychiatry Res. 2018;272:230-236.
    PubMed     Abstract available


  358. FOUNTOULAKIS KN, Panagiotidis P, Kimiskidis V, Nimatoudis I, et al
    Neurological soft signs in familial and sporadic schizophrenia.
    Psychiatry Res. 2018;272:222-229.
    PubMed     Abstract available


  359. CHASE KA, Melbourne JK, Rosen C, McCarthy-Jones S, et al
    Traumagenics: At the intersect of childhood trauma, immunity and psychosis.
    Psychiatry Res. 2018;273:369-377.
    PubMed     Abstract available


  360. HUANG LJ, Hu FC, Wu C, Yang YH, et al
    Traditional-Chinese Dispositional Flow Scale-2 and Flow State Scale-2 in Taiwanese subjects with schizophrenia or schizoaffective disorder.
    Psychiatry Res. 2018;274:287-293.
    PubMed     Abstract available


  361. STRAMECKI F, Kotowicz K, Piotrowski P, Beszlej JA, et al
    Coping styles and symptomatic manifestation of first-episode psychosis: Focus on cognitive performance.
    Psychiatry Res. 2018;272:246-251.
    PubMed     Abstract available


  362. ENGELSTAD KN, Rund BR, Torgalsboen AK, Lau B, et al
    Large social cognitive impairments characterize homicide offenders with schizophrenia.
    Psychiatry Res. 2018;272:209-215.
    PubMed     Abstract available


  363. TAN EJ, Fletcher K, Rossell SL
    Exploring the relationship between fantasy proneness and delusional beliefs in psychosis and non-clinical individuals.
    Psychiatry Res. 2018;272:80-85.
    PubMed     Abstract available


  364. HE Y, Li Z, Ma X, Yuan L, et al
    Olfactory and cognitive functions in Chinese individuals at clinical high risk for psychosis.
    Psychiatry Res. 2018;272:51-53.
    PubMed     Abstract available


  365. ISHIDA T, Nakamura K, Miyazaki K, Yukawa T, et al
    Mortality from sepsis among patients with schizophrenia and mood disorders in an intensive care unit: A chart review.
    Psychiatry Res. 2018 Dec 10. pii: S0165-1781(18)31786.
    PubMed    


  366. BERNA F, Zou F, Danion JM, Kwok SC, et al
    Overconfidence in false autobiographical memories in patients with schizophrenia.
    Psychiatry Res. 2018 Dec 10. pii: S0165-1781(18)32123.
    PubMed    


  367. DURNA G, Yorulmaz O, Aktac A
    Public stigma of obsessive compulsive disorder and schizophrenic disorder: Is there really any difference?
    Psychiatry Res. 2018;271:559-564.
    PubMed     Abstract available


  368. WANG YY, Wang S, Zheng W, Zhong BL, et al
    Cognitive functions in smoking and non-smoking patients with schizophrenia: A systematic review and meta-analysis of comparative studies.
    Psychiatry Res. 2018;272:155-163.
    PubMed     Abstract available


  369. ETCHEPARE A, Roux S, Destaillats JM, Cady F, et al
    What are the specificities of social cognition in schizophrenia? A cluster-analytic study comparing schizophrenia with the general population.
    Psychiatry Res. 2018;272:369-379.
    PubMed     Abstract available


  370. GADEA M, Herrero N, Pico A, Espert R, et al
    Psychobiological response to an anger induction task in schizophrenia: The key role of anxiety.
    Psychiatry Res. 2018;271:541-547.
    PubMed     Abstract available


  371. HAZLETT EA, Vaccaro DH, Haznedar MM, Goldstein KE, et al
    (F-18)Fluorodeoxyglucose positron emission tomography studies of the schizophrenia spectrum: The legacy of Monte S. Buchsbaum, M.D.
    Psychiatry Res. 2018;271:535-540.
    PubMed     Abstract available


  372. WANG D, Cheng SL, Fei Q, Gu H, et al
    Metabolic profiling identifies phospholipids as potential serum biomarkers for schizophrenia.
    Psychiatry Res. 2018;272:18-29.
    PubMed     Abstract available


  373. BOSIA M, Bechi M, Bosinelli F, Politi E, et al
    From cognitive and clinical substrates to functional profiles: Disentangling heterogeneity in schizophrenia.
    Psychiatry Res. 2018;271:446-453.
    PubMed     Abstract available


  374. HOFER A, Post F, Pardeller S, Frajo-Apor B, et al
    Self-stigma versus stigma resistance in schizophrenia: Associations with resilience, premorbid adjustment, and clinical symptoms.
    Psychiatry Res. 2018;271:396-401.
    PubMed     Abstract available


  375. MCCARTHY NS, Clark ML, Jablensky A, Badcock JC, et al
    No association between common genetic variation in FOXP2 and language impairment in schizophrenia.
    Psychiatry Res. 2018;271:590-597.
    PubMed     Abstract available


  376. KENT JS, Caligiuri MP, Skorheim MK, Lano TJ, et al
    Instrument-based assessment of motor function yields no evidence of dyskinesia in adult first-degree biological relatives of individuals with schizophrenia and schizoaffective disorder.
    Psychiatry Res. 2018;272:135-140.
    PubMed     Abstract available


  377. HUANG N, Cao B, Brietzke E, Park C, et al
    A pilot case-control study on the association between N-acetyl derivatives in serum and first-episode schizophrenia.
    Psychiatry Res. 2018;272:36-41.
    PubMed     Abstract available


  378. GAWEDA L, Krezolek M
    Cognitive mechanisms of alexithymia in schizophrenia: Investigating the role of basic neurocognitive functioning and cognitive biases.
    Psychiatry Res. 2018;271:573-580.
    PubMed     Abstract available


  379. MAK M, Samochowiec J, Frydecka D, Pelka-Wysiecka J, et al
    First-episode schizophrenia is associated with a reduction of HERV-K methylation in peripheral blood.
    Psychiatry Res. 2018;271:459-463.
    PubMed     Abstract available


  380. SWETS M, van Dijk FA, Schirmbeck F, Peen J, et al
    Patterns of obsessive-compulsive symptoms and social functioning in schizophrenia; a replication study.
    Psychiatry Res. 2018;271:421-427.
    PubMed     Abstract available


  381. LI AWY, Hui CLM, Lee EHM, Chang WC, et al
    Gender differences in correlates of cognition in first-episode psychosis.
    Psychiatry Res. 2018;271:412-420.
    PubMed     Abstract available


  382. RHEE TG, Rosenheck RA
    Does improvement in symptoms and quality of life in chronic schizophrenia reduce family caregiver Burden?
    Psychiatry Res. 2018;271:402-404.
    PubMed     Abstract available


  383. STRALIN P, Skott M, Cullberg J
    Early recovery and employment outcome 13 years after first episode psychosis.
    Psychiatry Res. 2018;271:374-380.
    PubMed     Abstract available


  384. MCLEAN RT, Halley L, Clair DS, Wei J, et al
    No correlation between HLA-DQ 2.5, DQ 8.1 and DQ 6.2 and circulating levels of antibodies against gliadins in schizophrenia.
    Psychiatry Res. 2018;271:325-327.
    PubMed     Abstract available


  385. YUKAWA T, Iwakura Y, Takei N, Saito M, et al
    Pathological alterations of chondroitin sulfate moiety in postmortem hippocampus of patients with schizophrenia.
    Psychiatry Res. 2018;270:940-946.
    PubMed     Abstract available


  386. GRZECZKOWSKI L, Roinishvili M, Chkonia E, Brand A, et al
    Is the perception of illusions abnormal in schizophrenia?
    Psychiatry Res. 2018;270:929-939.
    PubMed     Abstract available


  387. RITSNER MS, Ratner Y, Mendyk N, Gooding DC, et al
    The characterization of social anhedonia and its correlates in schizophrenia and schizoaffective patients.
    Psychiatry Res. 2018;270:922-928.
    PubMed     Abstract available


  388. TIBBER MS, Kirkbride JB, Joyce EM, Mutsatsa S, et al
    The component structure of the scales for the assessment of positive and negative symptoms in first-episode psychosis and its dependence on variations in analytic methods.
    Psychiatry Res. 2018;270:869-879.
    PubMed     Abstract available


  389. PHALEN PL, Rouhakhtar PR, Millman ZB, Thompson E, et al
    Validity of a two-item screen for early psychosis.
    Psychiatry Res. 2018;270:861-868.
    PubMed     Abstract available


  390. KOELKEBECK K, Vosseler A, Kohl W, Fasshauer T, et al
    Masked ambiguity - Emotion identification in schizophrenia and major depressive disorder.
    Psychiatry Res. 2018;270:852-860.
    PubMed     Abstract available


  391. PAN J, Zhou Y, Xiang Y, Yu J, et al
    Retinal nerve fiber layer thickness changes in Schizophrenia: A meta-analysis of case-control studies.
    Psychiatry Res. 2018;270:786-791.
    PubMed     Abstract available


  392. DESTE G, Barlati S, Gregorelli M, Lisoni J, et al
    Looking through autistic features in schizophrenia using the PANSS Autism Severity Score (PAUSS).
    Psychiatry Res. 2018;270:764-768.
    PubMed     Abstract available


  393. CHEN LJ, Hao JC, Ku PW, Stubbs B, et al
    Prospective associations of physical fitness and cognitive performance among inpatients with Schizophrenia.
    Psychiatry Res. 2018;270:738-743.
    PubMed     Abstract available


  394. THIBODEAU R, Peterson KM
    On continuum beliefs and psychiatric stigma: Similarity to a person with schizophrenia can feel too close for comfort.
    Psychiatry Res. 2018;270:731-737.
    PubMed     Abstract available


  395. AHUIR M, Cabezas A, Minano MJ, Algora MJ, et al
    Improvement in cognitive biases after group psychoeducation and metacognitive training in recent-onset psychosis: A randomized crossover clinical trial.
    Psychiatry Res. 2018;270:720-723.
    PubMed     Abstract available


  396. CHUNG KF, Poon YPY, Ng TK, Kan CK, et al
    Correlates of sleep irregularity in schizophrenia.
    Psychiatry Res. 2018;270:705-714.
    PubMed     Abstract available


  397. LE TP, Holden JL, Link PC, Granholm EL, et al
    Neurocognitive and theory of mind deficits and poor social competence in schizophrenia: The moderating role of social disinterest attitudes.
    Psychiatry Res. 2018;270:459-466.
    PubMed     Abstract available


  398. KAKELA J, Nordstrom T, Haapea M, Jaaskelainen E, et al
    Association between family history of mental disorders and outcome in psychotic disorders.
    Psychiatry Res. 2018;270:616-621.
    PubMed     Abstract available


  399. CAPUZZI E, Bartoli F, Crocamo C, Malerba MR, et al
    Recent suicide attempts and serum lipid profile in subjects with mental disorders: A cross-sectional study.
    Psychiatry Res. 2018;270:611-615.
    PubMed     Abstract available


  400. PINGANI L, Sampogna G, Borghi G, Nasi A, et al
    How the use of the term "schizo*" has changed in an Italian newspaper from 2001 to 2015: Findings from a descriptive analysis.
    Psychiatry Res. 2018;270:792-800.
    PubMed     Abstract available


  401. REMPFER MV, Fowler CA
    Relationships among functional capacity, cognition, and naturalistic skill performance in people with serious mental illness.
    Psychiatry Res. 2018;270:453-458.
    PubMed     Abstract available


  402. FERNANDEZ-SOTOS P, Navarro E, Torio I, Dompablo M, et al
    Pharmacological interventions in social cognition deficits: A systematic mapping review.
    Psychiatry Res. 2018;270:57-67.
    PubMed     Abstract available


  403. O'CONNOR LK, Yanos PT, Firmin RL
    Correlates and moderators of stigma resistance among people with severe mental illness.
    Psychiatry Res. 2018;270:198-204.
    PubMed     Abstract available


    November 2018
  404. DUNCAN MJ, Arbour-Nicitopoulos K, Subramaniapillai M, Remington G, et al
    Revisiting the International Physical Activity Questionnaire (IPAQ): Assessing sitting time among individuals with schizophrenia.
    Psychiatry Res. 2018;271:311-318.
    PubMed     Abstract available


  405. FANG X, Chen Y, Wang Y, Zhang C, et al
    Identification of risk factors for suicidal ideation in patients with schizophrenia.
    Psychiatry Res. 2018;271:195-199.
    PubMed     Abstract available


  406. DAVIS PE, Webster LAD, Fernyhough C, Ralston K, et al
    Adult report of childhood imaginary companions and adversity relates to concurrent prodromal psychosis symptoms.
    Psychiatry Res. 2018;271:150-152.
    PubMed     Abstract available


  407. SKIBINSKA M, Kapelski P, Rajewska-Rager A, Szczepankiewicz A, et al
    Elevated brain-derived neurotrophic factor (BDNF) serum levels in an acute episode of schizophrenia in polish women: Correlation with clinical and metabolic parameters.
    Psychiatry Res. 2018;271:89-95.
    PubMed     Abstract available


  408. OZDIN S, Boke O
    Neutrophil/lymphocyte, platelet/lymphocyte and monocyte/lymphocyte ratios in different stages of schizophrenia.
    Psychiatry Res. 2018;271:131-135.
    PubMed     Abstract available


  409. WANG J, Zhang SM, Zhong SL, Mellsop G, et al
    Gender differences among homicide offenders with schizophrenia in Hunan Province, China.
    Psychiatry Res. 2018;271:124-130.
    PubMed     Abstract available


  410. VERAS AB, Chao MV, Getz M, Goetz R, et al
    Traumatic experiences and cognitive profiles of schizophrenia cases influenced by the BDNF Val66met polymorphism.
    Psychiatry Res. 2018;271:111-113.
    PubMed     Abstract available


  411. FRANKE ML, Lersner UV, Essel OQ, Adorjan K, et al
    The relationship between causal beliefs and desire for social distance towards people with schizophrenia and depression: Results from a survey of young Ghanaian adults.
    Psychiatry Res. 2018;271:220-225.
    PubMed     Abstract available


  412. PUGLIESE V, Bruni A, Carbone EA, Calabro G, et al
    Maternal stress, prenatal medical illnesses and obstetric complications: Risk factors for schizophrenia spectrum disorder, bipolar disorder and major depressive disorder.
    Psychiatry Res. 2018;271:23-30.
    PubMed     Abstract available


  413. KANG C, Zhou H, Yang J, Yang R, et al
    Course, outcome and diagnosis stability of early-onset schizophrenia in Yunnan Province, China-a three years follow-up study.
    Psychiatry Res. 2018;271:144-149.
    PubMed     Abstract available


  414. HOLM T, Thomsen DK, Bliksted V
    Themes of unfulfilled agency and communion in life stories of patients with schizophrenia.
    Psychiatry Res. 2018;269:772-778.
    PubMed     Abstract available


  415. HILLMANN TE, Riehle M, Lincoln TM
    Reduced scanning of salient facial features mediates the association between paranoia and emotion recognition.
    Psychiatry Res. 2018;269:430-436.
    PubMed     Abstract available


    October 2018
  416. IZON E, Berry K, Law H, French P, et al
    Expressed emotion (EE) in families of individuals at-risk of developing psychosis: A systematic review.
    Psychiatry Res. 2018;270:661-672.
    PubMed     Abstract available


  417. FAIOLA E, Meyhofer I, Steffens M, Kasparbauer AM, et al
    Combining trait and state model systems of psychosis: The effect of sleep deprivation on cognitive functions in schizotypal individuals.
    Psychiatry Res. 2018;270:639-648.
    PubMed     Abstract available


  418. KAIZERMAN-DINERMAN A, Roe D, Josman N
    An efficacy study of a metacognitive group intervention for people with schizophrenia.
    Psychiatry Res. 2018 Oct 13. pii: S0165-1781(17)32371.
    PubMed     Abstract available


  419. ROMERO-FERREIRO V, Aguado L, Torio I, Sanchez-Morla EM, et al
    Influence of emotional contexts on facial emotion attribution in schizophrenia.
    Psychiatry Res. 2018;270:554-559.
    PubMed     Abstract available


  420. KEINANEN J, Suvisaari J, Reinikainen J, Kieseppa T, et al
    Low-grade inflammation in first-episode psychosis is determined by increased waist circumference.
    Psychiatry Res. 2018;270:547-553.
    PubMed     Abstract available


  421. ADERY LH, Ichinose M, Torregrossa LJ, Wade J, et al
    The acceptability and feasibility of a novel virtual reality based social skills training game for schizophrenia: Preliminary findings.
    Psychiatry Res. 2018;270:496-502.
    PubMed     Abstract available


  422. OKUMURA Y, Sugiyama N, Noda T
    Timely follow-up visits after psychiatric hospitalization and readmission in schizophrenia and bipolar disorder in Japan.
    Psychiatry Res. 2018;270:490-495.
    PubMed     Abstract available


  423. CHEN S, Xia HS, Zhu F, Yin GZ, et al
    Association between decreased serum albumin levels and depressive symptoms in patients with schizophrenia in a Chinese Han population: A pilot study.
    Psychiatry Res. 2018;270:438-442.
    PubMed     Abstract available


  424. KRANE-GARTISER K, Henriksen TEG, Morken G, Vaaler AE, et al
    Motor activity patterns in acute schizophrenia and other psychotic disorders can be differentiated from bipolar mania and unipolar depression.
    Psychiatry Res. 2018;270:418-425.
    PubMed     Abstract available


  425. HASAN AA
    The correlation between the quality of life and clinical variables among outpatients with schizophrenia.
    Psychiatry Res. 2018;271:39-45.
    PubMed     Abstract available


  426. KASANOVA Z, Oorschot M, Myin-Germeys I
    Social anhedonia and asociality in psychosis revisited. An experience sampling study.
    Psychiatry Res. 2018;270:375-381.
    PubMed     Abstract available


    September 2018
  427. SACCHETTI E, Valsecchi P, Tamussi E, Paulli L, et al
    Psychomotor agitation in subjects hospitalized for an acute exacerbation of Schizophrenia.
    Psychiatry Res. 2018;270:357-364.
    PubMed     Abstract available


  428. GARCIA-CABEZA I, Diaz-Caneja CM, Ovejero M, de Portugal E, et al
    Adherence, insight and disability in paranoid schizophrenia.
    Psychiatry Res. 2018;270:274-280.
    PubMed     Abstract available


  429. MA JH, Sun XY, Guo TJ, Barot E, et al
    Association on DISC1 SNPs with schizophrenia risk: A meta-analysis.
    Psychiatry Res. 2018;270:306-309.
    PubMed     Abstract available


  430. GOMEZ-GASTIASORO A, Pena J, Zubiaurre-Elorza L, Ibarretxe-Bilbao N, et al
    Spanish adaptation and validation of the situational feature recognition test 2 (SFRT-2) in patients with schizophrenia and healthy controls.
    Psychiatry Res. 2018;270:225-231.
    PubMed     Abstract available


  431. KINCAID D, Shannon C, Boyd A, Hanna D, et al
    An investigation of associations between experience of childhood trauma and political violence and theory of mind impairments in schizophrenia.
    Psychiatry Res. 2018;270:293-297.
    PubMed     Abstract available


  432. KINSON RM, Hon C, Lee H, Abdin EB, et al
    Stigma and discrimination in individuals with first episode psychosis; one year after first contact with psychiatric services.
    Psychiatry Res. 2018;270:298-305.
    PubMed     Abstract available


  433. FEFEU M, De Maricourt P, Cachia A, Hoertel N, et al
    One-year mirror-image study of the impact of olanzapine long-acting injection on healthcare resource utilization and costs in severe schizophrenia.
    Psychiatry Res. 2018;270:205-210.
    PubMed     Abstract available


  434. KLEIN HS, Pinkham AE
    Examining reasoning biases in schizophrenia using a modified "Jumping to Conclusions" probabilistic reasoning task.
    Psychiatry Res. 2018;270:180-186.
    PubMed     Abstract available


  435. BERGSTROM T, Seikkula J, Alakare B, Maki P, et al
    The family-oriented open dialogue approach in the treatment of first-episode psychosis: Nineteen-year outcomes.
    Psychiatry Res. 2018;270:168-175.
    PubMed     Abstract available


  436. KO YS, Tsai HC, Chi MH, Su CC, et al
    Higher mortality and years of potential life lost of suicide in patients with schizophrenia.
    Psychiatry Res. 2018;270:531-537.
    PubMed     Abstract available


  437. LIU Y, Zhu H, Qian Z, Xu Y, et al
    Further evidence for the association between CMYA5 rs7714250 and schizophrenia in a Han Chinese population.
    Psychiatry Res. 2018 Sep 17. pii: S0165-1781(18)30747.
    PubMed    


  438. ALBERT U, Tomassi S, Maina G, Tosato S, et al
    Prevalence of non-psychotic disorders in ultra-high risk individuals and transition to psychosis: A systematic review.
    Psychiatry Res. 2018;270:1-12.
    PubMed     Abstract available


  439. FOND G, Godin O, Schurhoff F, Berna F, et al
    Hypovitaminosis D is associated with depression and anxiety in schizophrenia: Results from the national FACE-SZ cohort.
    Psychiatry Res. 2018;270:104-110.
    PubMed     Abstract available


  440. SMITH LM, Onwumere J, Craig T, Kuipers E, et al
    Caregiver correlates of patient-initiated violence in early psychosis.
    Psychiatry Res. 2018;270:412-417.
    PubMed     Abstract available


  441. KELLY DL, Li X, Kilday C, Feldman S, et al
    Increased circulating regulatory T cells in medicated people with schizophrenia.
    Psychiatry Res. 2018;269:517-523.
    PubMed     Abstract available


  442. DEPP CA, Villa J, Schembari BC, Harvey PD, et al
    Social cognition and short-term prediction of suicidal ideation in schizophrenia.
    Psychiatry Res. 2018;270:13-19.
    PubMed     Abstract available


  443. MILJEVIC CD, Nikolic-Kokic A, Blagojevic D, Milovanovic M, et al
    Association between neurological soft signs and antioxidant enzyme activity in schizophrenic patients.
    Psychiatry Res. 2018;269:746-752.
    PubMed     Abstract available


  444. BECATTINI-OLIVEIRA AC, Dutra DF, Spenciere de Oliveira Campos B, de Araujo VC, et al
    A systematic review of a functional assessment Tool: UCSD Performance-based skill assessment (UPSA).
    Psychiatry Res. 2018;267:12-18.
    PubMed     Abstract available


    August 2018
  445. IASEVOLI F, Avagliano C, Altavilla B, Barone A, et al
    Evaluation of a few discrete clinical markers may predict categorization of actively symptomatic non-acute schizophrenia patients as treatment resistant or responders: A study by ROC curve analysis and multivariate analyses.
    Psychiatry Res. 2018;269:481-493.
    PubMed     Abstract available


  446. MA J, Wang B, Gao X, Wu H, et al
    A comparative study of the typical toxic metals in serum by patients of schizophrenia and healthy controls in China.
    Psychiatry Res. 2018;269:558-564.
    PubMed     Abstract available


  447. SAUVE G, Malla A, Joober R, Brodeur MB, et al
    Comparing cognitive clusters across first- and multiple-episode of psychosis.
    Psychiatry Res. 2018;269:707-718.
    PubMed     Abstract available


  448. KOUIDRAT Y, Amad A, Stubbs B, Louhou R, et al
    Disordered eating behaviors as a potential obesogenic factor in schizophrenia.
    Psychiatry Res. 2018;269:450-454.
    PubMed     Abstract available


  449. CACCIOTTI-SAIJA C, Quintana DS, Alvares GA, Hickie IB, et al
    Reduced heart rate variability in a treatment-seeking early psychosis sample.
    Psychiatry Res. 2018;269:293-300.
    PubMed     Abstract available


  450. WANG X, Zhao J, Hu Y, Jiao Z, et al
    Sodium nitroprusside treatment for psychotic symptoms and cognitive deficits of schizophrenia: A randomized, double-blind, placebo-controlled trial.
    Psychiatry Res. 2018;269:271-277.
    PubMed     Abstract available


  451. WALSH-MESSINGER J, Wong PS, Antonius D, McMahon K, et al
    Sex differences in hedonic judgement of odors in schizophrenia cases and healthy controls.
    Psychiatry Res. 2018;269:345-353.
    PubMed     Abstract available


  452. MANSUETO G, Palmieri S, Faravelli C
    Parental style and Cloninger's model in psychosis.
    Psychiatry Res. 2018;269:221-228.
    PubMed     Abstract available


  453. FISH S, Toumaian M, Pappa E, Davies TJ, et al
    Modelling reaction time distribution of fast decision tasks in schizophrenia: Evidence for novel candidate endophenotypes.
    Psychiatry Res. 2018;269:212-220.
    PubMed     Abstract available


  454. AJNAKINA O, Trotta A, Forti MD, Stilo SA, et al
    Different types of childhood adversity and 5-year outcomes in a longitudinal cohort of first-episode psychosis patients.
    Psychiatry Res. 2018;269:199-206.
    PubMed     Abstract available


  455. LOPEZ-NAVARRO E
    Contributions of executive functions components to affective and cognitive theory of mind in outpatients diagnosed with schizophrenia.
    Psychiatry Res. 2018;269:124-125.
    PubMed     Abstract available


  456. GONZALEZ-BLANCO L, Maria P Garcia-Portilla, Garcia-Alvarez L, Lorena de la Fuente-Tomas, et al
    Elevated C-reactive protein as a predictor of a random one-year clinical course in the first ten years of schizophrenia.
    Psychiatry Res. 2018;269:688-691.
    PubMed     Abstract available


  457. LUO Y, Guo C, Zhang L, Pang L, et al
    County-level social factors and schizophrenia: A multilevel study of 1.9 million Chinese adults.
    Psychiatry Res. 2018;271:286-290.
    PubMed     Abstract available


  458. LANSER I, Browne J, Pinkham AE, Harvey PD, et al
    Evaluating social skill in individuals with schizophrenia with the brief impression questionnaire (BIQ).
    Psychiatry Res. 2018;269:38-44.
    PubMed     Abstract available


  459. PESTANA-SANTOS A, Loureiro L, Santos V, Carvalho I, et al
    Patients with schizophrenia assessing psychiatrists' communication skills.
    Psychiatry Res. 2018;269:13-20.
    PubMed     Abstract available


  460. DUDLEY R, Aynsworth C, Cheetham R, McCarthy-Jones S, et al
    Prevalence and characteristics of multi-modal hallucinations in people with psychosis who experience visual hallucinations.
    Psychiatry Res. 2018;269:25-30.
    PubMed     Abstract available


  461. DENG H, Verrico CD, Kosten TR, Nielsen DA, et al
    Psychosis and synthetic cannabinoids.
    Psychiatry Res. 2018;268:400-412.
    PubMed     Abstract available


  462. STRZELECKI D, Urban-Kowalczyk M, Wysokinski A
    Serum levels of TNF-alpha in patients with chronic schizophrenia during treatment augmentation with sarcosine (results of the PULSAR study).
    Psychiatry Res. 2018;268:447-453.
    PubMed     Abstract available


  463. LAGGER N, Amering M, Sibitz I, Gmeiner A, et al
    Stability and mutual prospective relationships of stereotyped beliefs about mental illness, hope and depressive symptoms among people with schizophrenia spectrum disorders.
    Psychiatry Res. 2018;268:484-489.
    PubMed     Abstract available


  464. COLIZZI M, Burnett N, Costa R, De Agostini M, et al
    Longitudinal assessment of the effect of cannabis use on hospital readmission rates in early psychosis: A 6-year follow-up in an inpatient cohort.
    Psychiatry Res. 2018;268:381-387.
    PubMed     Abstract available


  465. DRVARIC L, Bagby RM, Kiang M, Mizrahi R, et al
    Maladaptive personality traits in patients identified at lower-risk and higher-risk for psychosis.
    Psychiatry Res. 2018;268:348-353.
    PubMed     Abstract available


  466. DUCHATEL RJ, Meehan CL, Harms LR, Michie PT, et al
    Late gestation immune activation increases IBA1-positive immunoreactivity levels in the corpus callosum of adult rat offspring.
    Psychiatry Res. 2018;266:175-185.
    PubMed     Abstract available


  467. NGO DYJ, Thomson WM, Subramaniam M, Abdin E, et al
    The oral health of long-term psychiatric inpatients in Singapore.
    Psychiatry Res. 2018;266:206-211.
    PubMed     Abstract available


    July 2018
  468. DAHAN S, Bragazzi NL, Yogev A, Bar-Gad M, et al
    The relationship between serum cytokine levels and degree of psychosis in patients with schizophrenia.
    Psychiatry Res. 2018;268:467-472.
    PubMed     Abstract available


  469. BUONOCORE M, Bosia M, Baraldi MA, Bechi M, et al
    Exploring anxiety in schizophrenia: New light on a hidden figure.
    Psychiatry Res. 2018;268:312-316.
    PubMed     Abstract available


  470. ROY MA, Vallieres C, Lehoux C, Leclerc LD, et al
    More intensive probing increases the detection of social anxiety disorders in schizophrenia.
    Psychiatry Res. 2018;268:358-360.
    PubMed     Abstract available


  471. LALOYAUX J, Van der Linden M, Nuechterlein KH, Thonon B, et al
    A direct examination of the cognitive underpinnings of multitasking abilities: A first study examining schizophrenia.
    Psychiatry Res. 2018;268:288-296.
    PubMed     Abstract available


  472. CATHER C, Brunette MF, Mueser KT, Babbin SF, et al
    Impact of comprehensive treatment for first episode psychosis on substance use outcomes: A randomized controlled trial.
    Psychiatry Res. 2018;268:303-311.
    PubMed     Abstract available


  473. CHIU VW, Ree M, Janca A, Iyyalol R, et al
    Sleep profiles and CBT-I response in schizophrenia and related psychoses.
    Psychiatry Res. 2018;268:279-287.
    PubMed     Abstract available


  474. LU L, Zeng LN, Zong QQ, Rao WW, et al
    Quality of life in Chinese patients with schizophrenia: A meta-analysis.
    Psychiatry Res. 2018;268:392-399.
    PubMed     Abstract available


  475. CATALAN A, Angosto V, Diaz A, Martinez N, et al
    The relationship between theory of mind deficits and neurocognition in first episode-psychosis.
    Psychiatry Res. 2018;268:361-367.
    PubMed     Abstract available


  476. PAPP-HERTELENDI R, Tenyi T, Hadzsiev K, Hau L, et al
    First report on the association of SCN1A mutation, childhood schizophrenia and autism spectrum disorder without epilepsy.
    Psychiatry Res. 2018 Jul 19. pii: S0165-1781(18)30354.
    PubMed    


  477. KRISTOF Z, Kresznerits S, Olah M, Gyollai A, et al
    Mentalization and empathy as predictors of violence in schizophrenic patients: Comparison with nonviolent schizophrenic patients, violent controls and nonviolent controls.
    Psychiatry Res. 2018;268:198-205.
    PubMed     Abstract available


  478. SHAH P, Iwata Y, Plitman E, Brown EE, et al
    The impact of delay in clozapine initiation on treatment outcomes in patients with treatment-resistant schizophrenia: A systematic review.
    Psychiatry Res. 2018;268:114-122.
    PubMed     Abstract available


  479. ZHOU C, Chen J, Tang X, Feng X, et al
    DNA methylation and gene expression of the chemokine (C-X-C motif) ligand 1 in patients with deficit and non-deficit schizophrenia.
    Psychiatry Res. 2018;268:82-86.
    PubMed     Abstract available


  480. GORWOOD P, Mallet J, Lancrenon S
    Functional remission in schizophrenia: A FROGS-based definition and its convergent validity.
    Psychiatry Res. 2018;268:94-101.
    PubMed     Abstract available


    June 2018
  481. SANADA K, de Azua SR, Nakajima S, Alberich S, et al
    Correlates of neurocognitive functions in individuals at ultra-high risk for psychosis - A 6-month follow-up study.
    Psychiatry Res. 2018;268:1-7.
    PubMed     Abstract available


  482. KEANE BP, Peng Y, Demmin D, Silverstein SM, et al
    Intact perception of coherent motion, dynamic rigid form, and biological motion in chronic schizophrenia.
    Psychiatry Res. 2018;268:53-59.
    PubMed     Abstract available


  483. LEANZA L, Egloff L, Studerus E, Andreou C, et al
    The relationship between negative symptoms and cognitive functioning in patients at clinical high risk for psychosis.
    Psychiatry Res. 2018;268:21-27.
    PubMed     Abstract available


  484. LYSAKER PH, Irarrazaval L, Gagen EC, Armijo I, et al
    Metacognition in schizophrenia disorders: Comparisons with community controls and bipolar disorder: Replication with a Spanish language Chilean sample.
    Psychiatry Res. 2018;267:528-534.
    PubMed     Abstract available


  485. RAN MS, Xiao Y, Chui CHK, Hu XZ, et al
    Duration of untreated psychosis (DUP) and outcome of people with schizophrenia in rural China: 14-year follow-up study.
    Psychiatry Res. 2018;267:340-345.
    PubMed     Abstract available


  486. PURI P, Kumar D, Muralidharan K, Kishore MT, et al
    Individuals with Borderline Personality Disorder manifest cognitive biases implicated in psychosis.
    Psychiatry Res. 2018;267:414-419.
    PubMed     Abstract available


  487. LAMBDEN B, Berge J, Forsell Y
    Structured physical exercise and recovery from first episode psychosis in young adults, the FitForLife study.
    Psychiatry Res. 2018;267:346-353.
    PubMed     Abstract available


  488. DU X, Hong LE
    Test-retest reliability of short-interval intracortical inhibition and intracortical facilitation in patients with schizophrenia.
    Psychiatry Res. 2018;267:575-581.
    PubMed     Abstract available


  489. COSTA R, Bastos T, Probst M, Seabra A, et al
    Association of lifestyle-related factors and psychological factors on quality of life in people with schizophrenia.
    Psychiatry Res. 2018;267:382-393.
    PubMed     Abstract available


  490. FU S, Czajkowski N, Torgalsboen AK
    Cognitive improvement in first-episode schizophrenia and healthy controls: A 6-year multi-assessment follow-up study.
    Psychiatry Res. 2018;267:319-326.
    PubMed     Abstract available


  491. STEFANATOU P, Karatosidi CS, Tsompanaki E, Kattoulas E, et al
    Premorbid adjustment predictors of cognitive dysfunction in schizophrenia.
    Psychiatry Res. 2018;267:249-255.
    PubMed     Abstract available


  492. MARTENSEN LK, Hahn E, Cao TD, Schomerus G, et al
    Impact of perceived course of illness on the desire for social distance towards people with symptoms of schizophrenia in Hanoi, Vietnam.
    Psychiatry Res. 2018;268:206-210.
    PubMed     Abstract available


  493. KLAUNIG MJ, Trask CL, Neis AM, Cohn JR, et al
    Associations among domains of self-disturbance in schizophrenia.
    Psychiatry Res. 2018;267:187-194.
    PubMed     Abstract available


  494. BARRIOS M, Gomez-Benito J, Pino O, Rojo E, et al
    Functioning in patients with schizophrenia: A multicentre study evaluating the clinical perspective.
    Psychiatry Res. 2018 Jun 3. pii: S0165-1781(17)31379.
    PubMed     Abstract available


  495. MOHN C, Olsson AK, Helldin L
    Positive and negative affect in schizophrenia spectrum disorders: A forgotten dimension?
    Psychiatry Res. 2018;267:148-153.
    PubMed     Abstract available


  496. PFLUM MJ, Gooding DC
    Context matters: Social cognition task performance in psychometric schizotypes.
    Psychiatry Res. 2018;264:398-403.
    PubMed     Abstract available


  497. ROSEN C, McCarthy-Jones S, Chase KA, Humpston CS, et al
    The tangled roots of inner speech, voices and delusions.
    Psychiatry Res. 2018;264:281-289.
    PubMed     Abstract available


    May 2018
  498. PAWELCZYK A, Lojek E, Zurner N, Gawlowska-Sawosz M, et al
    Higher-order language dysfunctions as a possible neurolinguistic endophenotype for schizophrenia: Evidence from patients and their unaffected first degree relatives.
    Psychiatry Res. 2018;267:63-72.
    PubMed     Abstract available


  499. FAERDEN A, Lyngstad SH, Simonsen C, Ringen PA, et al
    Reliability and validity of the self-report version of the apathy evaluation scale in first-episode Psychosis: Concordance with the clinical version at baseline and 12 months follow-up.
    Psychiatry Res. 2018;267:140-147.
    PubMed     Abstract available


  500. TAN CS, Lim LW, Ting DS
    Assessment of choroidal and retinal thickness in psychosis.
    Psychiatry Res. 2018 May 30. pii: S0165-1781(18)30704.
    PubMed    


  501. AHMAD M, Joe P, Malaspina D, Smith RT, et al
    Reply to comments on "A pilot study assessing retinal pathology in psychosis using optical coherence tomography: Choroidal and macular thickness".
    Psychiatry Res. 2018 May 30. pii: S0165-1781(18)30957.
    PubMed    


  502. HAMILTON JE, Heads AM, Meyer TD, Desai PV, et al
    Ethnic differences in the diagnosis of schizophrenia and mood disorders during admission to an academic safety-net psychiatric hospital.
    Psychiatry Res. 2018;267:160-167.
    PubMed     Abstract available


  503. HASEGAWA T, Hashimoto T, Kanahara N, Yamanaka H, et al
    Identifying improvable employment-related factors in schizophrenia patients.
    Psychiatry Res. 2018;266:199-205.
    PubMed     Abstract available


  504. CAQUEO-URIZAR A, Fond G, Urzua A, Boyer L, et al
    Gender differences in schizophrenia: A multicentric study from three Latin-America countries.
    Psychiatry Res. 2018;266:65-71.
    PubMed     Abstract available


  505. CHEN CK, Lee CY, Lee Y, Hung CF, et al
    Could schizoaffective disorder, schizophrenia and bipolar I disorder be distinguishable using cognitive profiles?
    Psychiatry Res. 2018;266:79-84.
    PubMed     Abstract available


  506. BRETT BL, McGovern JE, Choi J, Fiszdon JM, et al
    Improving treatment motivation in individuals with psychosis: Predictors of response to motivational enhancement.
    Psychiatry Res. 2018;266:36-39.
    PubMed     Abstract available


  507. CHUNG KH, Chen PH, Kuo CJ, Tsai SY, et al
    Risk factors for early circulatory mortality in patients with schizophrenia.
    Psychiatry Res. 2018;267:7-11.
    PubMed     Abstract available


  508. VASS E, Fekete Z, Simon V, Simon L, et al
    Interventions for the treatment of theory of mind deficits in schizophrenia: Systematic literature review.
    Psychiatry Res. 2018;267:37-47.
    PubMed     Abstract available


  509. SAVITZ A, Melkote R, Riley R, Pobre MA, et al
    Use of antipsychotic blood levels in clinician decision making: A cross-over study using clinical vignettes of patients with schizophrenia.
    Psychiatry Res. 2018;267:25-29.
    PubMed     Abstract available


  510. DE NIJS J, Meijer JH, de Haan L, Meijer CJ, et al
    Associations between olfactory identification and (social) cognitive functioning: A cross-sectional study in schizophrenia patients and healthy controls.
    Psychiatry Res. 2018;266:147-151.
    PubMed     Abstract available


  511. YANG Z, Li L, Li M
    De novo mutations as causes of schizophrenia.
    Psychiatry Res. 2018 May 18. pii: S0165-1781(18)30610.
    PubMed    


  512. JAGANNATH V, Gerstenberg M, Walitza S, Franscini M, et al
    Neuregulin 1 (NRG1) gene expression predicts functional outcomes in individuals at clinical high-risk for psychosis.
    Psychiatry Res. 2018;266:143-146.
    PubMed     Abstract available


  513. DE PAGE L, Mercenier S, Titeca P
    Assessing psychopathy in forensic schizophrenia spectrum disorders: Validating the Comprehensive Assessment of the Psychopathic Personality-Institutional Rating Scale (CAPP-IRS).
    Psychiatry Res. 2018;265:303-308.
    PubMed     Abstract available


  514. SIDDIQUI I, Remington G, Fervaha G, Fletcher PJ, et al
    Objective investigation of activity preference in schizophrenia: A pilot study.
    Psychiatry Res. 2018;267:551-559.
    PubMed     Abstract available


  515. HU TM, Ping LY, Hsu SH, Tsai HY, et al
    Mutation analysis of the WNT7A gene in patients with schizophrenia.
    Psychiatry Res. 2018;265:246-248.
    PubMed     Abstract available


  516. KANNO-NOZAKI K, Miura I, Kaneko H, Horikoshi S, et al
    Influences of the T102C polymorphism in the 5-HT2A receptor gene on the five-factor model of Positive and Negative Syndrome Scale and treatment response to aripiprazole in patients with acute schizophrenia.
    Psychiatry Res. 2018;265:244-245.
    PubMed    


  517. LABAD J, Armario A, Nadal R, Sole M, et al
    Clinical correlates of hypothalamic-pituitary-adrenal axis measures in individuals at risk for psychosis and with first-episode psychosis.
    Psychiatry Res. 2018;265:284-291.
    PubMed     Abstract available


  518. GROVE TB, Yao B, Mueller SA, McLaughlin M, et al
    A Bayesian model comparison approach to test the specificity of visual integration impairment in schizophrenia or psychosis.
    Psychiatry Res. 2018;265:271-278.
    PubMed     Abstract available


  519. CHOW TJ, Tee SF, Loh SY, Yong HS, et al
    Variants in ZNF804A and DTNBP1 assessed for cognitive impairment in schizophrenia using a multiplex family-based approach.
    Psychiatry Res. 2018 May 7. pii: S0165-1781(18)30118.
    PubMed    


  520. TAS C, Brown EC, Eskikurt G, Irmak S, et al
    Cortisol response to stress in schizophrenia: Associations with oxytocin, social support and social functioning.
    Psychiatry Res. 2018 May 7. pii: S0165-1781(17)31470.
    PubMed     Abstract available


  521. ZHU B, Chen C, Loftus EF, Dong Q, et al
    Intellectual factors in false memories of patients with schizophrenia.
    Psychiatry Res. 2018;265:256-262.
    PubMed     Abstract available


  522. HJARPE J, Soderman E, Andreou D, Sedvall GC, et al
    No major influence of regular tobacco smoking on cerebrospinal fluid monoamine metabolite concentrations in patients with psychotic disorder and healthy individuals.
    Psychiatry Res. 2018;263:30-34.
    PubMed     Abstract available


  523. CONSTANTINE RJ, Andel R, McPherson M, Tandon R, et al
    Is the risk of antipsychotic polypharmacy discontinuation dependent on the agents used?
    Psychiatry Res. 2018;263:238-244.
    PubMed     Abstract available


  524. ROMINGER C, Schulter G, Fink A, Weiss EM, et al
    Meaning in meaninglessness: The propensity to perceive meaningful patterns in coincident events and randomly arranged stimuli is linked to enhanced attention in early sensory processing.
    Psychiatry Res. 2018;263:225-232.
    PubMed     Abstract available


    April 2018
  525. DAS S, Punnoose VP, Doval N, Nair VY, et al
    Spirituality, religiousness and coping in patients with schizophrenia: A cross sectional study in a tertiary care hospital.
    Psychiatry Res. 2018;265:238-243.
    PubMed     Abstract available


  526. KURTZ MM, Gopal S, John S, Thara R, et al
    Cognition, social cognition and functional disability in early-stage schizophrenia: A study from southern India.
    Psychiatry Res. 2018;265:231-237.
    PubMed     Abstract available


  527. ZHOU W, Shi Y, Li F, Wu X, et al
    Study of the association between Schizophrenia and microduplication at the 16p11.2 locus in the Han Chinese population.
    Psychiatry Res. 2018;265:198-199.
    PubMed     Abstract available


  528. DE JONG S, van Donkersgoed R, Renard S, Carter S, et al
    Social-cognitive risk factors for violence in psychosis: A discriminant function analysis.
    Psychiatry Res. 2018;265:93-99.
    PubMed     Abstract available


  529. BONFILS KA, Minor KS, Leonhardt BL, Lysaker PH, et al
    Metacognitive self-reflectivity moderates the relationship between distress tolerance and empathy in schizophrenia.
    Psychiatry Res. 2018;265:1-6.
    PubMed     Abstract available


  530. MOHAMMADI A, Rashidi E, Amooeian VG
    Brain, blood, cerebrospinal fluid, and serum biomarkers in schizophrenia.
    Psychiatry Res. 2018;265:25-38.
    PubMed     Abstract available


  531. STRUGSTAD B, Lau B, Glenne Oie M
    Associations between cognition and internalizing problems in young adults with early-onset schizophrenia: A 13-year follow-up study.
    Psychiatry Res. 2018;265:161-166.
    PubMed     Abstract available


  532. YE F, Zhan Q, Xiao W, Tang X, et al
    Altered serum levels of vascular endothelial growth factor in first-episode drug-naive and chronic medicated schizophrenia.
    Psychiatry Res. 2018;264:361-365.
    PubMed     Abstract available


  533. HARO JM, Altamura C, Corral R, Elkis H, et al
    Understanding the course of persistent symptoms in schizophrenia: Longitudinal findings from the pattern study.
    Psychiatry Res. 2018;267:56-62.
    PubMed     Abstract available


  534. ZHAO S, Xia H, Mu J, Wang L, et al
    10-year CVD risk in Han Chinese mainland patients with schizophrenia.
    Psychiatry Res. 2018;264:322-326.
    PubMed     Abstract available


  535. MA J, Shang S, Wang J, Zhang T, et al
    Identification of miR-22-3p, miR-92a-3p, and miR-137 in peripheral blood as biomarker for schizophrenia.
    Psychiatry Res. 2018;265:70-76.
    PubMed     Abstract available


  536. ANDERSEN EH, Lewis GF, Belger A
    Aberrant parasympathetic reactivity to acute psychosocial stress in male patients with schizophrenia spectrum disorders.
    Psychiatry Res. 2018;265:39-47.
    PubMed     Abstract available


  537. XU YM, Li F, Liu XB, Zhong BL, et al
    Depressive symptoms in Chinese male inpatients with schizophrenia: Prevalence and clinical correlates.
    Psychiatry Res. 2018;264:380-384.
    PubMed     Abstract available


  538. VOCE A, McKetin R, Burns R, Castle D, et al
    The relationship between illicit amphetamine use and psychiatric symptom profiles in schizophrenia and affective psychoses.
    Psychiatry Res. 2018;265:19-24.
    PubMed     Abstract available


  539. HICKLING LM, Kouvaras S, Nterian Z, Perez-Iglesias R, et al
    Non-adherence to antipsychotic medication in first-episode psychosis patients.
    Psychiatry Res. 2018;264:151-154.
    PubMed     Abstract available


  540. LOPEZ-NAVARRO E, Del Canto C, Mayol A, Fernandez-Alonso O, et al
    Psychotic symptoms and quality of life: A mediation analysis of daily-life coping.
    Psychiatry Res. 2018;262:505-509.
    PubMed     Abstract available


  541. KELLY BD, Duffy RM, Curley A
    Which involuntary admissions are revoked by mental health tribunals? A report from the Dublin Involuntary Admission Study (DIAS).
    Psychiatry Res. 2018;262:583-585.
    PubMed     Abstract available


    March 2018
  542. KANG M, Bang M, Lee SY, Lee E, et al
    Coping styles in individuals at ultra-high risk for psychosis: Associations with cognitive appraisals.
    Psychiatry Res. 2018;264:162-168.
    PubMed     Abstract available


  543. GUO W, Zhang F, Liu F, Chen J, et al
    Cerebellar abnormalities in first-episode, drug-naive schizophrenia at rest.
    Psychiatry Res. 2018 Mar 29. pii: S0925-4927(17)30308.
    PubMed     Abstract available


  544. MATSUMOTO J, Nagaoka A, Kunii Y, Miura I, et al
    Effects of the -141C insertion/deletion polymorphism in the dopamine D2 receptor gene on the dopamine system in the striatum in patients with schizophrenia.
    Psychiatry Res. 2018;264:116-118.
    PubMed     Abstract available


  545. ABUSH H, Ghose S, Van Enkevort EA, Clementz BA, et al
    Associations between adolescent cannabis use and brain structure in psychosis.
    Psychiatry Res. 2018 Mar 28. pii: S0925-4927(17)30314.
    PubMed     Abstract available


  546. THONSE U, Behere RV, Praharaj SK, Sharma PSVN, et al
    Facial emotion recognition, socio-occupational functioning and expressed emotions in schizophrenia versus bipolar disorder.
    Psychiatry Res. 2018;264:354-360.
    PubMed     Abstract available


  547. AYDIN O, Lysaker PH, Balikci K, Unal-Aydin P, et al
    Associations of oxytocin and vasopressin plasma levels with neurocognitive, social cognitive and meta cognitive function in schizophrenia.
    Psychiatry Res. 2018 Mar 23. pii: S0165-1781(17)31776.
    PubMed     Abstract available


  548. LIN CH, Lin SC, Huang YH, Wang FC, et al
    Early prediction of olanzapine-induced weight gain for schizophrenia patients.
    Psychiatry Res. 2018;263:207-211.
    PubMed     Abstract available


  549. KIM DD, Barr AM, Thornton AE, Honer WG, et al
    Statin add-on therapy for schizophrenia: Is the effect the same for clozapine?
    Psychiatry Res. 2018 Mar 22. pii: S0165-1781(18)30090.
    PubMed    


  550. VAZQUEZ MOREJON AJ, Vazquez-Morejon R, Bellido Zanin G
    Behavior Problems Inventory (BPI): Psychometric characteristics of an instrument for routine assessment of persons with psychoses and related disorders.
    Psychiatry Res. 2018 Mar 22. pii: S0165-1781(17)31662.
    PubMed     Abstract available


  551. KOTHER U, Lincoln TM, Moritz S
    Emotion perception and overconfidence in errors under stress in psychosis.
    Psychiatry Res. 2018 Mar 21. pii: S0165-1781(17)31081.
    PubMed     Abstract available


  552. WARD HB, Szabo ST, Rakesh G
    Maintenance ECT in schizophrenia: A systematic review.
    Psychiatry Res. 2018;264:131-142.
    PubMed     Abstract available


  553. DEGNAN A, Berry K, James S, Edge D, et al
    Development, validation and cultural-adaptation of the knowledge about psychosis questionnaire for African-Caribbean people in the UK.
    Psychiatry Res. 2018;263:199-206.
    PubMed     Abstract available


  554. LINDGREN M, Torniainen-Holm M, Heiskanen I, Voutilainen G, et al
    Theory of mind in a first-episode psychosis population using the Hinting Task.
    Psychiatry Res. 2018;263:185-192.
    PubMed     Abstract available


  555. XIU MH, Wang D, Chen S, Du XD, et al
    Interleukin-3, symptoms and cognitive deficits in first-episode drug-naive and chronic medicated schizophrenia.
    Psychiatry Res. 2018;263:147-153.
    PubMed     Abstract available


  556. DE MOURA AM, Pinaya WHL, Gadelha A, Zugman A, et al
    Investigating brain structural patterns in first episode psychosis and schizophrenia using MRI and a machine learning approach.
    Psychiatry Res. 2018 Mar 6. pii: S0925-4927(17)30133.
    PubMed     Abstract available


  557. THOMAS EC, Murakami-Brundage J, Bertolami N, Beck AT, et al
    Beck Self-Esteem Scale-Short Form: Development and psychometric evaluation of a scale for the assessment of self-concept in schizophrenia.
    Psychiatry Res. 2018;263:173-180.
    PubMed     Abstract available


  558. JOE P, Ahmad M, Riley G, Weissman J, et al
    A pilot study assessing retinal pathology in psychosis using optical coherence tomography: Choroidal and macular thickness.
    Psychiatry Res. 2018;263:158-161.
    PubMed     Abstract available


  559. KRUKOW P, Jonak K, Karakula-Juchnowicz H, Podkowinski A, et al
    Disturbed functional connectivity within the left prefrontal cortex and sensorimotor areas predicts impaired cognitive speed in patients with first-episode schizophrenia.
    Psychiatry Res. 2018 Mar 4. pii: S0925-4927(18)30018.
    PubMed     Abstract available


  560. BHAT NA, Sharma V, Kumar D
    Prospective memory in obsessive compulsive disorder.
    Psychiatry Res. 2018;261:124-131.
    PubMed     Abstract available


    February 2018
  561. AIKAWA S, Kobayashi H, Nemoto T, Matsuo S, et al
    Social anxiety and risk factors in patients with schizophrenia: Relationship with duration of untreated psychosis.
    Psychiatry Res. 2018;263:94-100.
    PubMed     Abstract available


  562. BRIEND F, Nathou C, Kauffmann F, Delcroix N, et al
    Theta burst stimulation on social cognition and N-Acetyl aspartate in two patients with schizophrenia.
    Psychiatry Res. 2018 Feb 18. pii: S0925-4927(17)30344.
    PubMed    


  563. HANSBAUER M, Wobrock T, Kunze B, Langguth B, et al
    Efficacy of high-frequency repetitive transcranial magnetic stimulation on PANSS factors in schizophrenia with predominant negative symptoms - Results from an exploratory re-analysis.
    Psychiatry Res. 2018;263:22-29.
    PubMed     Abstract available


  564. PAUSELLI L, Halpern B, Cleary SD, Ku B, et al
    Computational linguistic analysis applied to a semantic fluency task to measure derailment and tangentiality in schizophrenia.
    Psychiatry Res. 2018;263:74-79.
    PubMed     Abstract available


  565. MAN L, Lv X, Du XD, Yin G, et al
    Cognitive impairments and low BDNF serum levels in first-episode drug-naive patients with schizophrenia.
    Psychiatry Res. 2018;263:1-6.
    PubMed     Abstract available


  566. SUM MY, Tay KH, Sengupta S, Sim K, et al
    Neurocognitive functioning and quality of life in patients with and without deficit syndrome of schizophrenia.
    Psychiatry Res. 2018;263:54-60.
    PubMed     Abstract available


  567. BUSTAN Y, Drapisz A, Ben Dor DH, Avrahami M, et al
    Elevated neutrophil to lymphocyte ratio in non-affective psychotic adolescent inpatients: Evidence for early association between inflammation and psychosis.
    Psychiatry Res. 2018;262:149-153.
    PubMed     Abstract available


  568. CANTISANI A, Stegmayer K, Federspiel A, Bohlhalter S, et al
    Blood perfusion in left inferior and middle frontal gyrus predicts communication skills in schizophrenia.
    Psychiatry Res. 2018 Feb 10. pii: S0925-4927(17)30229.
    PubMed     Abstract available


  569. CLELLAND JD, Read LL, Smeed J, Clelland CL, et al
    Regulation of cortical and peripheral GCH1 expression and biopterin levels in schizophrenia-spectrum disorders.
    Psychiatry Res. 2018;262:229-236.
    PubMed     Abstract available


  570. MCGREGOR N, Thompson N, O'Connell KS, Emsley R, et al
    Modification of the association between antipsychotic treatment response and childhood adversity by MMP9 gene variants in a first-episode schizophrenia cohort.
    Psychiatry Res. 2018;262:141-148.
    PubMed     Abstract available


  571. ZHANG T, Xu L, Cui H, Tang Y, et al
    Changes in correlation characteristics of time consumption and mind-reading performance in pre-onset and post-onset psychosis.
    Psychiatry Res. 2018;262:168-174.
    PubMed     Abstract available


  572. JOHANNESEN JK, Fiszdon JM, Weinstein A, Ciosek D, et al
    The Social Attribution Task - Multiple Choice (SAT-MC): Psychometric comparison with social cognitive measures for schizophrenia research.
    Psychiatry Res. 2018;262:154-161.
    PubMed     Abstract available


  573. SHEN H, Li R, Yan R, Zhou X, et al
    Adjunctive therapy with statins in schizophrenia patients: A meta-analysis and implications.
    Psychiatry Res. 2018;262:84-93.
    PubMed     Abstract available


  574. GHAJAR A, Khoaie-Ardakani MR, Shahmoradi Z, Alavi AR, et al
    L-carnosine as an add-on to risperidone for treatment of negative symptoms in patients with stable schizophrenia: A double-blind, randomized placebo-controlled trial.
    Psychiatry Res. 2018;262:94-101.
    PubMed     Abstract available


  575. LEE SC, Tang SF, Lu WS, Huang SL, et al
    Corrigendum to "Minimal detectable change of the Personal and Social Performance scale in individuals with schizophrenia" [Psychiatry Research 246 (2016) 725-729].
    Psychiatry Res. 2018;260:508.
    PubMed    


  576. MARGULSKA A, Kozlowska E, Wysokinski A
    Effect of clozapine dose and concentration on fasting concentration of appetite regulating peptides.
    Psychiatry Res. 2018;260:473-477.
    PubMed     Abstract available


  577. VANCAMPFORT D, Probst M, Basangwa D, De Hert M, et al
    Adherence to physical activity recommendations and physical and mental health risk in people with severe mental illness in Uganda.
    Psychiatry Res. 2018;260:236-240.
    PubMed     Abstract available


  578. OLUWOYE O, Hirchak K, Leickly E, Skalisky J, et al
    Interaction between pre-treatment drug use and heterogeneity of psychiatric diagnosis predicts outcomes in outpatients with co-occurring disorders.
    Psychiatry Res. 2018;260:233-235.
    PubMed     Abstract available


  579. SIMON JJ, Zimmermann J, Cordeiro SA, Maree I, et al
    Psychometric evaluation of the Temporal Experience of Pleasure Scale (TEPS) in a German sample.
    Psychiatry Res. 2018;260:138-143.
    PubMed     Abstract available


    January 2018
  580. PLITMAN E, Chavez S, Nakajima S, Iwata Y, et al
    Striatal neurometabolite levels in patients with schizophrenia undergoing long-term antipsychotic treatment: A proton magnetic resonance spectroscopy and reliability study.
    Psychiatry Res. 2018;273:16-24.
    PubMed     Abstract available


  581. LI X, Tian Q, Bo Q, Zhang G, et al
    Impact of childhood trauma on sensorimotor gating in Chinese patients with chronic schizophrenia.
    Psychiatry Res. 2018;263:69-73.
    PubMed     Abstract available


  582. ZHANG X, Gao J, Zhu F, Wang W, et al
    Reduced white matter connectivity associated with auditory verbal hallucinations in first-episode and chronic schizophrenia: A diffusion tensor imaging study.
    Psychiatry Res. 2018 Jan 25. pii: S0925-4927(17)30315.
    PubMed     Abstract available


  583. KIM DD, Lang DJ, Procyshyn RM, Woodward ML, et al
    Reduced cardiovascular fitness associated with exposure to clozapine in individuals with chronic schizophrenia.
    Psychiatry Res. 2018;262:28-33.
    PubMed     Abstract available


  584. SEVILLA-LLEWELLYN-JONES J, Camino G, Russo DA, Painter M, et al
    Clinically significant personality traits in individuals at high risk of developing psychosis.
    Psychiatry Res. 2018;261:498-503.
    PubMed     Abstract available


  585. MORKVED N, Winje D, Dovran A, Arefjord K, et al
    Childhood trauma in schizophrenia spectrum disorders as compared to substance abuse disorders.
    Psychiatry Res. 2018;261:481-487.
    PubMed     Abstract available


  586. FELDHAUS T, Falke S, von Gruchalla L, Maisch B, et al
    The impact of self-stigmatization on medication attitude in schizophrenia patients.
    Psychiatry Res. 2018;261:391-399.
    PubMed     Abstract available


  587. HO KKY, Lui SSY, Wang Y, Yeung HKH, et al
    Theory of mind performances in first-episode schizophrenia patients: An 18-month follow-up study.
    Psychiatry Res. 2018;261:357-360.
    PubMed     Abstract available


  588. SOYATA AZ, Akisik S, Inhanli D, Noyan H, et al
    Relationship of obsessive-compulsive symptoms to clinical variables and cognitive functions in individuals at ultra high risk for psychosis.
    Psychiatry Res. 2018;261:332-337.
    PubMed     Abstract available


  589. SURI G, Lavaysse LM, Young G, Moodie C, et al
    An investigation into the drivers of avolition in schizophrenia.
    Psychiatry Res. 2018;261:225-231.
    PubMed     Abstract available


  590. DENG H, Mohite S, Suchting R, Nielsen DA, et al
    Impact of synthetic cannabinoid use on hospital stay in patients with bipolar disorder versus schizophrenia, or other psychotic disorders.
    Psychiatry Res. 2018;261:248-252.
    PubMed     Abstract available


  591. KOIKE S, Yamaguchi S, Ojio Y, Ando S, et al
    Social distance toward people with schizophrenia is associated with favorable understanding and negative stereotype.
    Psychiatry Res. 2018;261:264-268.
    PubMed     Abstract available


  592. MARGGRAF MP, Cohen AS, Davis BJ, DeCrescenzo P, et al
    Semantic coherence in psychometric schizotypy: An investigation using Latent Semantic Analysis.
    Psychiatry Res. 2018;259:63-67.
    PubMed     Abstract available


    December 2017
  593. NIMGAONKAR VL, Dickerson F, Pouget JG, Chowdari K, et al
    Joint evaluation of serum C-Reactive Protein levels and polygenic risk scores as risk factors for schizophrenia.
    Psychiatry Res. 2017;261:148-153.
    PubMed     Abstract available


  594. WANG L, Jin S, He K, Chen X, et al
    Increased delayed reward during intertemporal decision-making in schizophrenic patients and their unaffected siblings.
    Psychiatry Res. 2017;262:246-253.
    PubMed     Abstract available


  595. UNAL K, Yuksel RN, Turhan T, Sezer S, et al
    The association of serum nesfatin-1 and ghrelin levels with metabolic syndrome in patients with schizophrenia.
    Psychiatry Res. 2017;261:45-49.
    PubMed     Abstract available


  596. MEZQUIDA G, Cabrera B, Martinez-Aran A, Vieta E, et al
    Detection of early psychotic symptoms: Validation of the Spanish version of the "Symptom Onset in Schizophrenia (SOS) inventory".
    Psychiatry Res. 2017;261:68-72.
    PubMed     Abstract available


  597. WON GH, Kim JW, Choi TY, Lee YS, et al
    Theta-phase gamma-amplitude coupling as a neurophysiological marker in neuroleptic-naive schizophrenia.
    Psychiatry Res. 2017;260:406-411.
    PubMed     Abstract available


  598. WOOD L, Byrne R, Enache G, Morrison AP, et al
    A brief cognitive therapy intervention for internalised stigma in acute inpatients who experience psychosis: A feasibility randomised controlled trial.
    Psychiatry Res. 2017;262:303-310.
    PubMed     Abstract available


  599. BEHDANI F, Roudbaraki SN, Saberi-Karimian M, Tayefi M, et al
    Assessment of the efficacy of omega-3 fatty acids on metabolic and inflammatory parameters in patients with schizophrenia taking clozapine and sodium valproate.
    Psychiatry Res. 2017;261:243-247.
    PubMed     Abstract available


  600. VAN NIEROP M, Lecei A, Myin-Germeys I, Collip D, et al
    Stress reactivity links childhood trauma exposure to an admixture of depressive, anxiety, and psychosis symptoms.
    Psychiatry Res. 2017;260:451-457.
    PubMed     Abstract available


  601. PENNER J, Osuch EA, Schaefer B, Theberge J, et al
    Higher order thalamic nuclei resting network connectivity in early schizophrenia and major depressive disorder.
    Psychiatry Res. 2017;272:7-16.
    PubMed     Abstract available


  602. MOODY G, Miller BJ
    Total and differential white blood cell counts and hemodynamic parameters in first-episode psychosis.
    Psychiatry Res. 2017;260:307-312.
    PubMed     Abstract available


  603. LEENDERTSE P, Myin-Germeys I, Lataster T, Simons CJP, et al
    Subjective quality of life in psychosis: Evidence for an association with real world functioning?
    Psychiatry Res. 2017;261:116-123.
    PubMed     Abstract available


  604. OLIVEIRA IAF, Guimaraes TM, Souza RM, Dos Santos AC, et al
    Brain functional and perfusional alterations in schizophrenia: an arterial spin labeling study.
    Psychiatry Res. 2017 Dec 5. pii: S0925-4927(17)30214.
    PubMed     Abstract available


  605. MOHN C, Torgalsboen AK
    Details of attention and learning change in first-episode schizophrenia.
    Psychiatry Res. 2017;260:324-330.
    PubMed     Abstract available


  606. LIN YC, Lai CL, Chan HY
    The association between rehabilitation programs and metabolic syndrome in chronic inpatients with schizophrenia.
    Psychiatry Res. 2017;260:227-232.
    PubMed     Abstract available


    November 2017
  607. ZHOU SS, Zhou Y
    Is the association between season of birth and schizophrenia due to neonatal cold exposure-induced permanent defects in skin functions?
    Psychiatry Res. 2017 Nov 28. pii: S0165-1781(17)30390.
    PubMed    


  608. TANG SF, Chen IH, Chiang HY, Wu CT, et al
    A comparison between the original and Tablet-based Symbol Digit Modalities Test in patients with schizophrenia: Test-retest agreement, random measurement error, practice effect, and ecological validity.
    Psychiatry Res. 2017;260:199-206.
    PubMed     Abstract available


  609. CHIU EC, Hung TM, Huang CM, Lee SC, et al
    Responsiveness of the Personal and Social Performance scale in patients with schizophrenia.
    Psychiatry Res. 2017;260:338-342.
    PubMed     Abstract available


  610. PAROLA A, Berardinelli L, Bosco FM
    Cognitive abilities and theory of mind in explaining communicative-pragmatic disorders in patients with schizophrenia.
    Psychiatry Res. 2017;260:144-151.
    PubMed     Abstract available


  611. SHARMA A, Kumar A, Singh S, Bhatia T, et al
    Altered resting state functional connectivity in early course schizophrenia.
    Psychiatry Res. 2017;271:17-23.
    PubMed     Abstract available


  612. DOMANY Y, Levy A, Cassan SM, Tarrasch R, et al
    Clinical utility of biomarkers of the hand in the diagnosis of schizophrenia.
    Psychiatry Res. 2017;260:105-110.
    PubMed     Abstract available


  613. ALLOTT KA, Yuen HP, Bartholomeusz CF, Rapado-Castro M, et al
    Stress hormones and verbal memory in young people over the first 12 weeks of treatment for psychosis.
    Psychiatry Res. 2017;260:60-66.
    PubMed     Abstract available


  614. VINGERHOETS C, Bloemen OJN, Boot E, Bakker G, et al
    Dopamine in high-risk populations: A comparison of subjects with 22q11.2 deletion syndrome and subjects at ultra high-risk for psychosis.
    Psychiatry Res. 2017 Nov 21. pii: S0925-4927(17)30192.
    PubMed     Abstract available


  615. CROCA M, Lagodka A, Gadel R, Bourdel MC, et al
    Theory of mind and schizophrenia in young and middle-aged patients: Influence of executive functions.
    Psychiatry Res. 2017;259:532-537.
    PubMed     Abstract available


  616. GUR S, Weizman S, Stubbs B, Matalon A, et al
    Mortality, morbidity and medical resources utilization of patients with schizophrenia: A case-control community-based study.
    Psychiatry Res. 2017;260:177-181.
    PubMed     Abstract available


  617. SUN Q, Huang X, Niu W, Yu T, et al
    The promoter polymorphisms in HTR2A gene associated with schizophrenia in Chinese of Han ethnicity.
    Psychiatry Res. 2017 Nov 15. pii: S0165-1781(17)30794.
    PubMed    


  618. RUZIBIZA C, Grattan RE, Eder R, Linscott RJ, et al
    Components of schizophrenia liability are not uniformly associated with stress sensitivity, resilience, and coping.
    Psychiatry Res. 2017;260:10-16.
    PubMed     Abstract available


  619. NOMURA I, Kishi T, Ikuta T, Iwata N, et al
    Statin add-on therapy in the antipsychotic treatment of schizophrenia: A meta-analysis.
    Psychiatry Res. 2017;260:41-47.
    PubMed     Abstract available


  620. PERLINI C, Bellani M, Finos L, Lasalvia A, et al
    Non literal language comprehension in a large sample of first episode psychosis patients in adulthood.
    Psychiatry Res. 2017;260:78-89.
    PubMed     Abstract available


  621. DAS S, Sengupta S, Pathak K, Sah D, et al
    Aggression as an independent entity even in psychosis - The role of cortisol.
    Psychiatry Res. 2017;259:405-411.
    PubMed     Abstract available


  622. VAN DIJK FA, Schirmbeck F, Haan L
    A longitudinal analysis of the effects of neuroticism and extraversion on subjective well-being in patients with schizophrenia.
    Psychiatry Res. 2017;259:538-544.
    PubMed     Abstract available


  623. CAO B, Sun XY, Zhang CB, Yan JJ, et al
    Association between B vitamins and schizophrenia: A population-based case-control study.
    Psychiatry Res. 2017;259:501-505.
    PubMed     Abstract available


  624. AHMED AO, Richardson J, Buckner A, Romanoff S, et al
    Do cognitive deficits predict negative emotionality and aggression in schizophrenia?
    Psychiatry Res. 2017;259:350-357.
    PubMed     Abstract available


  625. UNGPRASERT P, Wijarnpreecha K, Cheungpasitporn W
    Patients with schizophrenia have a higher risk of psoriasis: A systematic review and meta-analysis.
    Psychiatry Res. 2017;259:422-426.
    PubMed     Abstract available


  626. LANGEVELD J, Bjorkly S, Evensen J, Joa I, et al
    A 10-year follow-up study of violent victimization in first episode psychosis: Risk and protective factors.
    Psychiatry Res. 2017;259:545-549.
    PubMed     Abstract available


  627. DE LEON PP, Gerretsen P, Shah P, Saracco-Alvarez R, et al
    Cross-cultural psychometric assessment of the VAGUS insight into psychosis scale - Spanish version.
    Psychiatry Res. 2017;259:450-454.
    PubMed     Abstract available


    October 2017
  628. GSPANDL S, Peirson RP, Nahhas RW, Skale TG, et al
    Comparing Global Assessment of Functioning (GAF) and World Health Organization Disability Assessment Schedule (WHODAS) 2.0 in schizophrenia.
    Psychiatry Res. 2017;259:251-253.
    PubMed     Abstract available


  629. LUBEIRO A, de Luis-Garcia R, Rodriguez M, Alvarez A, et al
    Biological and cognitive correlates of cortical curvature in schizophrenia.
    Psychiatry Res. 2017;270:68-75.
    PubMed     Abstract available


  630. GUIMOND S, Beland S, Lepage M
    Strategy for Semantic Association Memory (SESAME) training: Effects on brain functioning in schizophrenia.
    Psychiatry Res. 2017 Oct 25. pii: S0925-4927(17)30167.
    PubMed     Abstract available


  631. KRETCHY IA, Osafo J, Agyemang SA, Appiah B, et al
    Psychological burden and caregiver-reported non-adherence to psychotropic medications among patients with schizophrenia.
    Psychiatry Res. 2017;259:289-294.
    PubMed     Abstract available


  632. MUKERJI CE, Lincoln SH, Tully LM, Dodell-Feder D, et al
    Neural simulation mechanisms and social-emotional function in schizophrenia.
    Psychiatry Res. 2017 Oct 24. pii: S0925-4927(17)30101.
    PubMed     Abstract available


  633. MARTINELLI C, Rigoli F, Dolan RJ, Shergill SS, et al
    Decreased value-sensitivity in schizophrenia.
    Psychiatry Res. 2017;259:295-301.
    PubMed     Abstract available


  634. HIRASAWA-FUJITAA M, Tudor L, Nikolac Pekovic M, Kozumplik O, et al
    Genotypic and haplotypic associations of catechol-O-methyltransferase (COMT) rs4680 and rs4818 with salivary cortisol in patients with schizophrenia.
    Psychiatry Res. 2017;259:262-264.
    PubMed    


  635. DAUVERMANN MR, Moorhead TW, Watson AR, Duff B, et al
    Verbal working memory and functional large-scale networks in schizophrenia.
    Psychiatry Res. 2017;270:86-96.
    PubMed     Abstract available


  636. SELLERS R, Wells A, Parker S, Morrison AP, et al
    Do people with psychosis engage in unhelpful metacognitive coping strategies? A test of the validity of the Cognitive Attentional Syndrome (CAS) in a clinical sample.
    Psychiatry Res. 2017;259:243-250.
    PubMed     Abstract available


  637. JAJODIA A, Kaur H, Srivastava A, Kumari K, et al
    Schizophrenia susceptibility and neuregulin signaling pathway genes: A rare haplotype combination based association study in Indian population.
    Psychiatry Res. 2017 Oct 10. pii: S0165-1781(17)30253.
    PubMed    


  638. LIUHANEN J, Suvisaari J, Kajantie E, Miettunen J, et al
    Interaction between compound genetic risk for schizophrenia and high birth weight contributes to social anhedonia and schizophrenia in women.
    Psychiatry Res. 2017;259:148-153.
    PubMed     Abstract available


  639. LEE H, Kim HK, Kwon JT, Park S, et al
    BBOX1 is down-regulated in maternal immune-activated mice and implicated in genetic susceptibility to human schizophrenia.
    Psychiatry Res. 2017;259:197-202.
    PubMed     Abstract available


  640. SUBRAMANIAM A, Danivas V, Mahavir Agarwal S, Kalmady S, et al
    Clinical correlates of saccadic eye movement in antipsychotic-naive schizophrenia.
    Psychiatry Res. 2017;259:154-159.
    PubMed     Abstract available


  641. CHEN GF, Liu LL, Cui JF, Chen T, et al
    Life review therapy enhances mental time travel in patients with schizophrenia.
    Psychiatry Res. 2017;258:145-152.
    PubMed     Abstract available


  642. RUIZ JC, Soler MJ, Dasi C, Fuentes I, et al
    The effect of associative strength on semantic priming in schizophrenia.
    Psychiatry Res. 2017;259:1-6.
    PubMed     Abstract available


  643. CAMPELLONE TR, Kring AM
    Anticipated pleasure for positive and negative social interaction outcomes in schizophrenia.
    Psychiatry Res. 2017;259:203-209.
    PubMed     Abstract available


  644. JEONG SH, Chung IW, Jung HY, Hwang SS, et al
    Comparison of clinician-rated and self-report insight in Korean patients with schizophrenia using VAGUS insight scale.
    Psychiatry Res. 2017;258:93-100.
    PubMed     Abstract available


    September 2017
  645. DANAHER H, Allott K, Killackey E, Hester R, et al
    An examination of sex differences in neurocognition and social cognition in first-episode psychosis.
    Psychiatry Res. 2017;259:36-43.
    PubMed     Abstract available


  646. CREMASCHI L, Kardell M, Johansson V, Isgren A, et al
    Prevalences of autoimmune diseases in schizophrenia, bipolar I and II disorder, and controls.
    Psychiatry Res. 2017;258:9-14.
    PubMed     Abstract available


  647. ERDENIZ B, Serin E, Ibadi Y, Tas C, et al
    Decreased functional connectivity in schizophrenia: The relationship between social functioning, social cognition and graph theoretical network measures.
    Psychiatry Res. 2017;270:22-31.
    PubMed     Abstract available


  648. BELAND S, Lepage M
    The relative contributions of social cognition and self-reflectiveness to clinical insight in enduring schizophrenia.
    Psychiatry Res. 2017;258:116-123.
    PubMed     Abstract available


  649. TSUI MCM, Tsang HWH
    Views of people with schizophrenia and their caregivers towards the needs for psychiatric rehabilitation in urban and rural areas of mainland China.
    Psychiatry Res. 2017;258:72-77.
    PubMed     Abstract available


  650. FUJIMAKI K, Toki S, Yamashita H, Oyamada T, et al
    Predictors of negative symptoms in the chronic phase of schizophrenia: A cross-sectional study.
    Psychiatry Res. 2017 Sep 24. pii: S0165-1781(17)30729.
    PubMed     Abstract available


  651. VITOLO E, Tatu MK, Pignolo C, Cauda F, et al
    White matter and schizophrenia: A meta-analysis of voxel-based morphometry and diffusion tensor imaging studies.
    Psychiatry Res. 2017;270:8-21.
    PubMed     Abstract available


  652. DOROFEIKOVA M, Neznanov N, Petrova N
    Cognitive deficit in patients with paranoid schizophrenia: Its clinical and laboratory correlates.
    Psychiatry Res. 2017 Sep 20. pii: S0165-1781(17)31459.
    PubMed     Abstract available


  653. CUESTA MJ, Lecumberri P, Cabada T, Moreno-Izco L, et al
    Basal ganglia and ventricle volume in first-episode psychosis. A family and clinical study.
    Psychiatry Res. 2017;269:90-96.
    PubMed     Abstract available


  654. MELBOURNE JK, Chase KA, Feiner B, Rosen C, et al
    Long non-coding and endogenous retroviral RNA levels are associated with proinflammatory cytokine mRNA expression in peripheral blood cells: Implications for schizophrenia.
    Psychiatry Res. 2017 Sep 14. pii: S0165-1781(16)32171.
    PubMed     Abstract available


  655. BRIGHT M, Parker S, French P, Fowler D, et al
    Metacognitive beliefs as psychological predictors of social functioning: An investigation with young people at risk of psychosis.
    Psychiatry Res. 2017 Sep 14. pii: S0165-1781(17)30197.
    PubMed     Abstract available


  656. CONTRERAS NA, Tan EJ, Lee SJ, Castle DJ, et al
    Using visual processing training to enhance standard cognitive remediation outcomes in schizophrenia: A pilot study.
    Psychiatry Res. 2017 Sep 14. pii: S0165-1781(16)30805.
    PubMed     Abstract available


  657. RATHEE R, Luhrmann TM, Bhatia T, Deshpande SN, et al
    Cognitive insight and objective quality of life in people with schizophrenia and auditory hallucinations.
    Psychiatry Res. 2017;259:223-228.
    PubMed     Abstract available


  658. FRESAN A, Robles-Garcia R, Madrigal E, Tovilla-Zarate CA, et al
    Demographic and clinical features related to perceived discrimination in schizophrenia.
    Psychiatry Res. 2017 Sep 9. pii: S0165-1781(17)30314.
    PubMed     Abstract available


  659. VANCAMPFORT D, Gorczynski P, De Hert M, Probst M, et al
    Exercise self-efficacy correlates in people with psychosis.
    Psychiatry Res. 2017 Sep 8. pii: S0165-1781(17)30413.
    PubMed     Abstract available


  660. CATHERINE FA, Aurelie V, Eric G, Pierre M, et al
    Defining functioning levels in patients with schizophrenia: A combination of a novel clustering method and brain SPECT analysis.
    Psychiatry Res. 2017;270:32-38.
    PubMed     Abstract available


  661. KILICASLAN EE, Esen AT, Kasal MI, Ozelci E, et al
    Childhood trauma, depression, and sleep quality and their association with psychotic symptoms and suicidality in schizophrenia.
    Psychiatry Res. 2017 Sep 7. pii: S0165-1781(17)30902.
    PubMed     Abstract available


  662. MORENO-SAMANIEGO L, Gaviria AM, Vilella E, Valero J, et al
    Schizotypal traits and cognitive performance in siblings of patients with psychosis.
    Psychiatry Res. 2017 Sep 7. pii: S0165-1781(17)30539.
    PubMed     Abstract available


  663. WATSON AJ, Joyce EM, Fugard AJB, Leeson VC, et al
    More haste less speed: A meta-analysis of thinking latencies during planning in people with psychosis.
    Psychiatry Res. 2017 Sep 5. pii: S0165-1781(17)30175.
    PubMed     Abstract available


    August 2017
  664. LINDGREN M, Mantyla T, Rikandi E, Torniainen-Holm M, et al
    Childhood adversities and clinical symptomatology in first-episode psychosis.
    Psychiatry Res. 2017 Aug 26. pii: S0165-1781(17)30756.
    PubMed     Abstract available


  665. NIIMURA J, Nakanishi M, Yamasaki S, Nishida A, et al
    Regional supply of outreach service and length of stay in psychiatric hospital among patients with schizophrenia: National case mix data analysis in Japan.
    Psychiatry Res. 2017 Aug 24. pii: S0165-1781(16)32185.
    PubMed     Abstract available


  666. REMPFER MV, McDowd JM, Brown CE
    Measuring learning potential in people with schizophrenia: A comparison of two tasks.
    Psychiatry Res. 2017 Aug 24. pii: S0165-1781(17)30544.
    PubMed     Abstract available


  667. BO Q, Li F, Li X, Wang Z, et al
    Symptomatic remission in schizophrenia: Results from a risperidone maintenance treatment study.
    Psychiatry Res. 2017 Aug 24. pii: S0165-1781(16)31337.
    PubMed     Abstract available


  668. WU C, Dagg P, Molgat C
    Measuring stability of cognitive impairment in inpatients with schizophrenia with alternate forms of the Montreal Cognitive Assessment during acute hospitalization.
    Psychiatry Res. 2017 Aug 24. pii: S0165-1781(17)30592.
    PubMed     Abstract available


  669. SU CT, Yang AL, Lin CY
    Comparing two schizophrenia-specific quality of life instruments in institutionalized people with schizophrenia.
    Psychiatry Res. 2017 Aug 23. pii: S0165-1781(17)30674.
    PubMed     Abstract available


  670. AGAY N, Flaks-Manov N, Nitzan U, Hoshen MB, et al
    Cancer prevalence in men and women with schizophrenia.
    Psychiatry Res. 2017 Aug 19. pii: S0165-1781(17)30123.
    PubMed     Abstract available


  671. POS K, de Wit IE, van Dijk FA, Bartels-Velthuis AA, et al
    An experience sampling study on the ecological validity of the SWN-20: Indication that subjective well-being is associated with momentary affective states above and beyond psychosis susceptibility.
    Psychiatry Res. 2017 Aug 18. pii: S0165-1781(16)31386.
    PubMed     Abstract available


  672. CHIU YL, Lin HC, Kao NW, Kao S, et al
    Increased risk of concurrent hepatitis C among Male patients with schizophrenia.
    Psychiatry Res. 2017 Aug 18. pii: S0165-1781(16)31998.
    PubMed     Abstract available


  673. CHEN KW, Lee SC, Chiang HY, Syu YC, et al
    Psychometric properties of three measures assessing advanced theory of mind: Evidence from people with schizophrenia.
    Psychiatry Res. 2017;257:490-496.
    PubMed     Abstract available


  674. JIANG T, Zong L, Zhou L, Hou Y, et al
    Variation in global DNA hydroxymethylation with age associated with schizophrenia.
    Psychiatry Res. 2017;257:497-500.
    PubMed     Abstract available


  675. ANDERSON AE, Mansolf M, Reise SP, Savitz A, et al
    Measuring pathology using the PANSS across diagnoses: Inconsistency of the positive symptom domain across schizophrenia, schizoaffective, and bipolar disorder.
    Psychiatry Res. 2017 Aug 16. pii: S0165-1781(16)31411.
    PubMed     Abstract available


  676. WESTERMANN S, Grezellschak S, Oravecz Z, Moritz S, et al
    Untangling the complex relationships between symptoms of schizophrenia and emotion dynamics in daily life: Findings from an experience sampling pilot study.
    Psychiatry Res. 2017;257:514-518.
    PubMed     Abstract available


  677. HUANG H, Shu C, Chen J, Zou J, et al
    Altered corticostriatal pathway in first-episode paranoid schizophrenia: Resting-state functional and causal connectivity analyses.
    Psychiatry Res. 2017 Aug 15. pii: S0925-4927(17)30093.
    PubMed     Abstract available


  678. HSWEN Y, Naslund JA, Chandrashekar P, Siegel R, et al
    Exploring online communication about cigarette smoking among Twitter users who self-identify as having schizophrenia.
    Psychiatry Res. 2017;257:479-484.
    PubMed     Abstract available


  679. VADHAN NP, Corcoran CM, Bedi G, Keilp JG, et al
    Acute effects of smoked marijuana in marijuana smokers at clinical high-risk for psychosis: A preliminary study.
    Psychiatry Res. 2017;257:372-374.
    PubMed     Abstract available


  680. LYSAKER PH, George S, Chaudoin-Patzoldt KA, Pec O, et al
    Contrasting metacognitive, social cognitive and alexithymia profiles in adults with borderline personality disorder, schizophrenia and substance use disorder.
    Psychiatry Res. 2017;257:393-399.
    PubMed     Abstract available


  681. FAVROD O, Sierro G, Roinishvili M, Chkonia E, et al
    Electrophysiological correlates of visual backward masking in high schizotypic personality traits participants.
    Psychiatry Res. 2017;254:251-257.
    PubMed     Abstract available


  682. WANG YY, Shi HS, Liu WH, Yan C, et al
    Invariance of factor structure of the 21-item Peters et al. Delusions Inventory (PDI-21) over time and across samples.
    Psychiatry Res. 2017;254:190-197.
    PubMed     Abstract available


    July 2017
  683. TESSIER A, Boyer L, Husky M, Bayle F, et al
    Medication adherence in schizophrenia: The role of insight, therapeutic alliance and perceived trauma associated with psychiatric care.
    Psychiatry Res. 2017;257:315-321.
    PubMed     Abstract available


  684. ABRAHAMSE E, Ruitenberg M, Boddewyn S, Oreel E, et al
    Conflict adaptation in patients diagnosed with schizophrenia.
    Psychiatry Res. 2017;257:260-264.
    PubMed     Abstract available


  685. WILKINS LK, Girard TA, Herdman KA, Christensen BK, et al
    Hippocampal activation and memory in schizophrenia depend on spatial strategy use in a virtual maze.
    Psychiatry Res. 2017;268:1-8.
    PubMed     Abstract available


  686. TULLY S, Wells A, Morrison AP
    Attentional avoidance increases voice hearing in an analogue task in people with psychosis: An experimental study.
    Psychiatry Res. 2017;257:186-192.
    PubMed     Abstract available


  687. VERAS AB, Cougo S, Meira F, Peixoto C, et al
    Schizophrenia dissection by five anxiety and depressive subtype comorbidities: Clinical implications and evolutionary perspective.
    Psychiatry Res. 2017;257:172-178.
    PubMed     Abstract available


  688. SMIRNOVA D, Clark M, Jablensky A, Badcock JC, et al
    Action (verb) fluency deficits in schizophrenia spectrum disorders: linking language, cognition and interpersonal functioning.
    Psychiatry Res. 2017;257:203-211.
    PubMed     Abstract available


  689. DEMRO C, Rowland L, Wijtenburg SA, Waltz J, et al
    Glutamatergic metabolites among adolescents at risk for psychosis.
    Psychiatry Res. 2017;257:179-185.
    PubMed     Abstract available


  690. LI H, Shen Y, Wang G, Shi J, et al
    A 6-week, multicenter, double-blind, double-dummy, chlorpromazine-controlled non-inferiorityrandomized phase iiitrial to evaluate the efficacy and safety of quetiapine fumarate (SEROQUEL) extended-release (XR) in the treatment of patients with schizop
    Psychiatry Res. 2017;259:117-124.
    PubMed     Abstract available


  691. SU YA, Yan F, Li Q, Xiang YT, et al
    Anticholinergic use trends in 14,013 patients with schizophrenia from three national surveys on the use of psychotropic medications in China (2002-2012).
    Psychiatry Res. 2017;257:132-136.
    PubMed     Abstract available


  692. HILL K, Bolo N, Sarvode Mothi S, Lizano P, et al
    Subcortical surface shape in youth at familial high risk for schizophrenia.
    Psychiatry Res. 2017;267:36-44.
    PubMed     Abstract available


  693. POPOLO R, Smith E, Lysaker PH, Lestingi K, et al
    Metacognitive profiles in schizophrenia and bipolar disorder: Comparisons with healthy controls and correlations with negative symptoms.
    Psychiatry Res. 2017;257:45-50.
    PubMed     Abstract available


  694. MANOUILENKO I, Humble MB, Georgieva J, Bejerot S, et al
    Brainstem Auditory Evoked Potentials for diagnosing Autism Spectrum Disorder, ADHD and Schizophrenia Spectrum Disorders in adults. A blinded study.
    Psychiatry Res. 2017;257:21-26.
    PubMed     Abstract available


  695. SKIBINSKA M, Kapelski P, Pawlak J, Rajewska-Rager A, et al
    Glial Cell Line-Derived Neurotrophic Factor (GDNF) serum level in women with schizophrenia and depression, correlation with clinical and metabolic parameters.
    Psychiatry Res. 2017;256:396-402.
    PubMed     Abstract available


  696. TRIXLER D, Tenyi T
    Iris structure and minor physical anomalies in schizophrenia.
    Psychiatry Res. 2017;256:412-416.
    PubMed     Abstract available


  697. PETRIKIS P, Voulgari PV, Tzallas AT, Boumba VA, et al
    Changes in the cytokine profile in first-episode, drug-naive patients with psychosis after short-term antipsychotic treatment.
    Psychiatry Res. 2017;256:378-383.
    PubMed     Abstract available


  698. KULKARNI K, Arasappa R, Prasad M K, Zutshi A, et al
    Risperidone versus olanzapine in the acute treatment of Persistent Delusional Disorder: A retrospective analysis.
    Psychiatry Res. 2017;253:270-273.
    PubMed     Abstract available


    June 2017
  699. ROSSI A, Galderisi S, Rocca P, Bertolino A, et al
    Personal resources and depression in schizophrenia: The role of self-esteem, resilience and internalized stigma.
    Psychiatry Res. 2017;256:359-364.
    PubMed     Abstract available


  700. WEISMAN DE MAMANI A, Weintraub MJ, Maura J, Martinez de Andino A, et al
    Acculturation styles and their associations with psychiatric symptoms and quality of life in ethnic minorities with schizophrenia.
    Psychiatry Res. 2017;255:418-423.
    PubMed     Abstract available


  701. HARROW M, Jobe TH, Faull RN, Yang J, et al
    A 20-Year multi-followup longitudinal study assessing whether antipsychotic medications contribute to work functioning in schizophrenia.
    Psychiatry Res. 2017;256:267-274.
    PubMed     Abstract available


  702. WANG Y, Wang Y, Zhao Q, Cui JF, et al
    Preliminary study of visual perspective in mental time travel in schizophrenia.
    Psychiatry Res. 2017;256:225-227.
    PubMed     Abstract available


  703. LEE HS, Jang SK, Lee GY, Park SC, et al
    Informationally administered reward enhances intrinsic motivation in schizophrenia.
    Psychiatry Res. 2017;256:290-297.
    PubMed     Abstract available


  704. KISHI T, Inada K, Matsui Y, Iwata N, et al
    Z-drug for schizophrenia: A systematic review and meta-analysis.
    Psychiatry Res. 2017;256:365-370.
    PubMed     Abstract available


  705. LANGDON R, Connors M, Connaughton E
    Indirect task instructions better reveal theory-of-mind impairment, independent of executive dysfunction, in schizophrenia.
    Psychiatry Res. 2017;256:342-344.
    PubMed     Abstract available


  706. CASTRO-DE-ARAUJO LFS, Kanaan RAA
    First episode psychosis moderates the effect of gray matter volume on cognition.
    Psychiatry Res. 2017;266:108-113.
    PubMed     Abstract available


  707. SHE S, Zhang B, Li X, Zhang X, et al
    Face-related visual search deficits in first-episode schizophrenia.
    Psychiatry Res. 2017;256:144-149.
    PubMed     Abstract available


  708. HANLON MC, Campbell LE, Single N, Coleman C, et al
    Men and women with psychosis and the impact of illness-duration on sex-differences: The second Australian national survey of psychosis.
    Psychiatry Res. 2017;256:130-143.
    PubMed     Abstract available


  709. MANSUETO G, Faravelli C
    Recent life events and psychosis: The role of childhood adversities.
    Psychiatry Res. 2017;256:111-117.
    PubMed     Abstract available


  710. PERRY BI, Salimkumar D, Green D, Meakin A, et al
    Associated illness severity in schizophrenia and diabetes mellitus: A systematic review.
    Psychiatry Res. 2017;256:102-110.
    PubMed     Abstract available


  711. OKUBO R, Inoue T, Hashimoto N, Suzukawa A, et al
    The mediator effect of personality traits on the relationship between childhood abuse and depressive symptoms in schizophrenia.
    Psychiatry Res. 2017;257:126-131.
    PubMed     Abstract available


  712. HUANG ACW, Bo-Han He A, Chen CC
    An examination of the roles of glutamate and sex in latent inhibition: Relevance to the glutamate hypothesis of schizophrenia?
    Psychiatry Res. 2017;256:46-52.
    PubMed     Abstract available


  713. HOFER A, Radner V, Edlinger M, Kemmler G, et al
    Why do indiviuals with schizophrenia drop out of observational clinical trials?
    Psychiatry Res. 2017;256:1-5.
    PubMed     Abstract available


  714. CALDANI S, Amado I, Bendjemaa N, Vialatte F, et al
    Oculomotricity and Neurological Soft Signs: Can we refine the endophenotype? A study in subjects belonging to the spectrum of schizophrenia.
    Psychiatry Res. 2017;256:490-497.
    PubMed     Abstract available


  715. RAPP C, Canela C, Studerus E, Walter A, et al
    Duration of untreated psychosis/illness and brain volume changes in early psychosis.
    Psychiatry Res. 2017;255:332-337.
    PubMed     Abstract available


  716. KARPOUZIAN TM, Schroeder MP, Abram SV, Wanar H, et al
    Neural correlates of preserved facial affect perception in high functioning schizophrenia.
    Psychiatry Res. 2017;266:83-85.
    PubMed     Abstract available


  717. SURMANN M, Gruchalla LV, Falke S, Maisch B, et al
    The importance of strengthening competence and control beliefs in patients with psychosis to reduce treatment hindering self-stigmatization.
    Psychiatry Res. 2017;255:314-320.
    PubMed     Abstract available


    May 2017
  718. CANAL-RIVERO M, Lopez-Morinigo JD, Barrigon ML, Perona-Garcelan S, et al
    The role of premorbid personality and social cognition in suicidal behaviour in first-episode psychosis: A one-year follow-up study.
    Psychiatry Res. 2017;256:13-20.
    PubMed     Abstract available


  719. GABRIEL D, Jakubovski E, Taylor JH, Artukoglu BB, et al
    Predictors of treatment response and drop out in the Treatment of Early-Onset Schizophrenia Spectrum Disorders (TEOSS) study.
    Psychiatry Res. 2017;255:248-255.
    PubMed     Abstract available


  720. BJORNESTAD J, Hegelstad WTV, Joa I, Davidson L, et al
    "With a little help from my friends" social predictors of clinical recovery in first-episode psychosis.
    Psychiatry Res. 2017;255:209-214.
    PubMed     Abstract available


  721. LI J, Guo YB, Huang YG, Liu JW, et al
    Stigma and discrimination experienced by people with schizophrenia living in the community in Guangzhou, China.
    Psychiatry Res. 2017;255:225-231.
    PubMed     Abstract available


  722. TIMUCIN OB, Mutlu EA, Timucin D, Aslanci ME, et al
    Psychophysical assessment of koniocellular pathway in patients with schizophrenia versus healthy controls.
    Psychiatry Res. 2017;266:27-34.
    PubMed     Abstract available


  723. NENADIC I, Hoof A, Dietzek M, Langbein K, et al
    Diffusion tensor imaging of cingulum bundle and corpus callosum in schizophrenia vs. bipolar disorder.
    Psychiatry Res. 2017;266:96-100.
    PubMed     Abstract available


  724. NENADIC I, Dietzek M, Langbein K, Sauer H, et al
    BrainAGE score indicates accelerated brain aging in schizophrenia, but not bipolar disorder.
    Psychiatry Res. 2017;266:86-89.
    PubMed     Abstract available


  725. PRISTED SG, Correll CU, Nielsen J
    Frequency and correlates of anticholinergic use among patients with schizophrenia in Denmark: A Nation-wide pharmacoepidemiological study.
    Psychiatry Res. 2017;255:198-203.
    PubMed     Abstract available


  726. TAKAHASHI T, Takayanagi Y, Nishikawa Y, Nakamura M, et al
    Brain neurodevelopmental markers related to the deficit subtype of schizophrenia.
    Psychiatry Res. 2017;266:10-18.
    PubMed     Abstract available


  727. HUHTANISKA S, Jaaskelainen E, Heikka T, Moilanen JS, et al
    Long-term antipsychotic and benzodiazepine use and brain volume changes in schizophrenia: The Northern Finland Birth Cohort 1966 study.
    Psychiatry Res. 2017;266:73-82.
    PubMed     Abstract available


  728. CARNEY R, Cotter J, Bradshaw T, Yung AR, et al
    Examining the physical health and lifestyle of young people at ultra-high risk for psychosis: A qualitative study involving service users, parents and clinicians.
    Psychiatry Res. 2017;255:87-93.
    PubMed     Abstract available


  729. FLAHERTY LR, Daniels K, Luther J, Haas GL, et al
    Reduction of medical hospitalizations in veterans with schizophrenia using home telehealth.
    Psychiatry Res. 2017;255:153-155.
    PubMed     Abstract available


  730. SCHOELER T, Petros N, Di Forti M, Klamerus E, et al
    Effect of continued cannabis use on medication adherence in the first two years following onset of psychosis.
    Psychiatry Res. 2017;255:36-41.
    PubMed     Abstract available


  731. WOOD L, Byrne R, Burke E, Enache G, et al
    The impact of stigma on emotional distress and recovery from psychosis: The mediatory role of internalised shame and self-esteem.
    Psychiatry Res. 2017;255:94-100.
    PubMed     Abstract available


  732. BOUAZIZ N, Moulier V, Lettelier-Galle T, Osmond I, et al
    Impact of reward on pain threshold and tolerance to experimental pain (Cold Pressor Task) in healthy subjects and patients with schizophrenia.
    Psychiatry Res. 2017;254:275-278.
    PubMed    


  733. BIAGIARELLI M, Curto M, Di Pomponio I, Comparelli A, et al
    Antipsychotic treatment and the Rorschach Perceptual Thinking Index (PTI) in psychotic disorder patients: Effects of treatment.
    Psychiatry Res. 2017;251:294-297.
    PubMed     Abstract available


    April 2017
  734. TERACHI S, Yamada T, Pu S, Yokoyama K, et al
    Comparison of neurocognitive function in major depressive disorder, bipolar disorder, and schizophrenia in later life: A cross-sectional study of euthymic or remitted, non-demented patients using the Japanese version of the Brief Assessment of Cogniti
    Psychiatry Res. 2017;254:205-210.
    PubMed     Abstract available


  735. GARRIDO G, Penades R, Barrios M, Aragay N, et al
    Computer-assisted cognitive remediation therapy in schizophrenia: Durability of the effects and cost-utility analysis.
    Psychiatry Res. 2017;254:198-204.
    PubMed     Abstract available


  736. ISHIWATA S, Hattori K, Sasayama D, Teraishi T, et al
    Plasma and cerebrospinal fluid G72 protein levels in schizophrenia and major depressive disorder.
    Psychiatry Res. 2017;254:244-250.
    PubMed     Abstract available


  737. SHE S, Deng Y, Chen Y, Wu C, et al
    Two-stage integrated care versus antipsychotic medication alone on outcomes of schizophrenia: One-year randomized controlled trial and follow-up.
    Psychiatry Res. 2017;254:164-172.
    PubMed     Abstract available


  738. DEMPSTER K, Norman R, Theberge J, Densmore M, et al
    Cognitive performance is associated with gray matter decline in first-episode psychosis.
    Psychiatry Res. 2017;264:46-51.
    PubMed     Abstract available


  739. GUO W, Liu F, Chen J, Wu R, et al
    Using short-range and long-range functional connectivity to identify schizophrenia with a family-based case-control design.
    Psychiatry Res. 2017;264:60-67.
    PubMed     Abstract available


  740. ERTEKIN E, Ucok A, Keskin-Ergen Y, Devrim-Ucok M, et al
    Deficits in Go and NoGo P3 potentials in patients with schizophrenia.
    Psychiatry Res. 2017;254:126-132.
    PubMed     Abstract available


  741. SIMONSEN C, Faerden A, Romm KL, Berg AO, et al
    Early clinical recovery in first-episode psychosis: Symptomatic remission and its correlates at 1-year follow-up.
    Psychiatry Res. 2017;254:118-125.
    PubMed     Abstract available


  742. LI Y, Hou CL, Ma XR, Zhong BL, et al
    Quality of life in Chinese patients with schizophrenia treated in primary care.
    Psychiatry Res. 2017;254:80-84.
    PubMed     Abstract available


  743. GALLETTI C, Paolini E, Tortorella A, Compton MT, et al
    Auditory and non-auditory hallucinations in first-episode psychosis: Differential associations with diverse clinical features.
    Psychiatry Res. 2017;254:268-274.
    PubMed     Abstract available


  744. TSOTSI S, Kosmidis MH, Bozikas VP
    Improved facial affect recognition in schizophrenia following an emotion intervention, but not training attention-to-facial-features or treatment-as-usual.
    Psychiatry Res. 2017;254:135-142.
    PubMed     Abstract available


  745. DA SILVA S, Saperia S, Siddiqui I, Fervaha G, et al
    Investigating consummatory and anticipatory pleasure across motivation deficits in schizophrenia and healthy controls.
    Psychiatry Res. 2017;254:112-117.
    PubMed     Abstract available


  746. OHMURO N, Matsumoto K, Ishii Y, Katsura M, et al
    The associations between quality of life and clinical symptoms in individuals with an at-risk mental state and first-episode psychosis.
    Psychiatry Res. 2017;254:54-59.
    PubMed     Abstract available


  747. ARMANDO M, Lin A, Pontillo M, Vicari S, et al
    Prevalence and treatment of psychiatric disorders other than psychosis in children and adolescents with 22q11DS: Examining associations with social and role functioning.
    Psychiatry Res. 2017;254:238-243.
    PubMed     Abstract available


  748. FOND G, Godin O, Boyer L, Llorca PM, et al
    Advanced paternal age is associated with earlier schizophrenia onset in offspring. Results from the national multicentric FACE-SZ cohort.
    Psychiatry Res. 2017;254:218-223.
    PubMed     Abstract available


  749. ORLIAC F, Delamillieure P, Delcroix N, Naveau M, et al
    Network modeling of resting state connectivity points towards the bottom up theories of schizophrenia.
    Psychiatry Res. 2017;266:19-26.
    PubMed     Abstract available


  750. BELGE JB, Maurage P, Mangelinckx C, Leleux D, et al
    Facial decoding in schizophrenia is underpinned by basic visual processing impairments.
    Psychiatry Res. 2017;255:167-172.
    PubMed     Abstract available


  751. LO CASCIO N, Curto M, Pasqualetti P, Lindau JF, et al
    Impairment in Social Functioning differentiates youth meeting Ultra-High Risk for psychosis criteria from other mental health help-seekers: A validation of the Italian version of the Global Functioning: Social and Global Functioning: Role scales.
    Psychiatry Res. 2017;253:296-302.
    PubMed     Abstract available


  752. COENTRE R, Talina MC, Gois C, Figueira ML, et al
    Depressive symptoms and suicidal behavior after first-episode psychosis: A comprehensive systematic review.
    Psychiatry Res. 2017;253:240-248.
    PubMed     Abstract available


  753. RAVICHANDRAN C, Shinn AK, Ongur D, Perlis RH, et al
    Frequency of non-right-handedness in bipolar disorder and schizophrenia.
    Psychiatry Res. 2017;253:267-269.
    PubMed     Abstract available


  754. BAHORIK AL, Greeno CG, Cochran G, Cornelius JR, et al
    Motivation deficits and use of alcohol and illicit drugs among individuals with schizophrenia.
    Psychiatry Res. 2017;253:391-397.
    PubMed     Abstract available


  755. BORTOLON C, Capdevielle D, Altman R, Macgregor A, et al
    Mirror self-face perception in individuals with schizophrenia: Feelings of strangeness associated with one's own image.
    Psychiatry Res. 2017;253:205-210.
    PubMed     Abstract available


  756. HUMPSTON CS, Linden DEJ, Evans LH
    Deficits in reality and internal source monitoring of actions are associated with the positive dimension of schizotypy.
    Psychiatry Res. 2017;250:44-49.
    PubMed     Abstract available


    March 2017
  757. KALMADY SV, Shivakumar V, Arasappa R, Subramaniam A, et al
    Clinical correlates of hippocampus volume and shape in antipsychotic-naive schizophrenia.
    Psychiatry Res. 2017;263:93-102.
    PubMed     Abstract available


  758. WU XJ, Zeng LL, Shen H, Yuan L, et al
    Functional network connectivity alterations in schizophrenia and depression.
    Psychiatry Res. 2017;263:113-120.
    PubMed     Abstract available


  759. WANG C, Zhang Y
    Season of birth and schizophrenia: Evidence from China.
    Psychiatry Res. 2017;253:189-196.
    PubMed     Abstract available


  760. WUSTEN C, Lincoln TM
    The association of family functioning and psychosis proneness in five countries that differ in cultural values and family structures.
    Psychiatry Res. 2017;253:158-164.
    PubMed     Abstract available


  761. BOLL KM, Noto C, Bonifacio KL, Bortolasci CC, et al
    Oxidative and nitrosative stress biomarkers in chronic schizophrenia.
    Psychiatry Res. 2017;253:43-48.
    PubMed     Abstract available


  762. JAHSHAN C, Wolf M, Karbi Y, Shamir E, et al
    Probing the magnocellular and parvocellular visual pathways in facial emotion perception in schizophrenia.
    Psychiatry Res. 2017;253:38-42.
    PubMed     Abstract available


  763. FORNS-NADAL M, Berge D, Sem F, Mane A, et al
    Increased nucleus accumbens volume in first-episode psychosis.
    Psychiatry Res. 2017;263:57-60.
    PubMed     Abstract available


  764. RAFFARD S, Bortolon C, Stephan Y, Capdevielle D, et al
    Personality traits are associated with the valence of future imagined events in individuals with schizophrenia.
    Psychiatry Res. 2017;253:138-141.
    PubMed     Abstract available


  765. VANCAMPFORT D, De Hert M, Myin-Germeys I, van Winkel R, et al
    Lower cardiorespiratory fitness is associated with more time spent sedentary in first episode psychosis: A pilot study.
    Psychiatry Res. 2017;253:13-17.
    PubMed     Abstract available


  766. LUAN Z, Zhang D
    The anaplastic lymphoma kinase (ALK) gene is associated with schizophrenia in a Chinese population.
    Psychiatry Res. 2017 Mar 9. pii: S0165-1781(16)31996.
    PubMed    


  767. GROVER S, Sahoo S, Dua D, Chakrabarti S, et al
    Scales for assessment of depression in schizophrenia: Factor analysis of calgary depression rating scale and hamilton depression rating scale.
    Psychiatry Res. 2017;252:333-339.
    PubMed     Abstract available


  768. LARIVIERE S, Lavigne KM, Woodward TS, Gerretsen P, et al
    Altered functional connectivity in brain networks underlying self-referential processing in delusions of reference in schizophrenia.
    Psychiatry Res. 2017;263:32-43.
    PubMed     Abstract available


  769. MI W, Zhang S, Liu Q, Yang F, et al
    Prevalence and risk factors of agitation in newly hospitalized schizophrenia patients in China: An observational survey.
    Psychiatry Res. 2017;253:401-406.
    PubMed     Abstract available


    February 2017
  770. BI Y, Huang X, Niu W, Chen S, et al
    No association between SLC6A2, SLC6A3, DRD2 polymorphisms and schizophrenia in the Han Chinese population.
    Psychiatry Res. 2017;253:398-400.
    PubMed     Abstract available


  771. JAMES BO, Omoaregba JO, Raji SO, Imishue OE, et al
    Attitudes towards and rationale for antipsychotic polypharmacy among psychiatrists in Nigeria: Characteristics associated with high reported antipsychotic polypharmacy.
    Psychiatry Res. 2017;248:134-139.
    PubMed     Abstract available


    January 2017
  772. KEGEL ME, Johansson V, Wetterberg L, Bhat M, et al
    Kynurenic acid and psychotic symptoms and personality traits in twins with psychiatric morbidity.
    Psychiatry Res. 2017;247:105-112.
    PubMed     Abstract available


  773. ENGEL M, Lincoln TM
    Concordance of self- and observer-rated motivation and pleasure in patients with negative symptoms and healthy controls.
    Psychiatry Res. 2017;247:1-5.
    PubMed     Abstract available


  774. FAGIOLINI A, Rocca P, De Giorgi S, Spina E, et al
    Clinical trial methodology to assess the efficacy/effectiveness of long-acting antipsychotics: Randomized controlled trials vs naturalistic studies.
    Psychiatry Res. 2017;247:257-264.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Schizophrenia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: